Thyroid Cancer, Nonmedullary, 1; Nmtc1

Description

Nonmedullary thyroid cancer (NMTC) comprises thyroid cancers of follicular cell origin and accounts for more than 95% of all thyroid cancer cases. The remaining cancers originate from parafollicular cells (medullary thyroid cancer, MTC; {155240}). NMTC is classified into 4 groups: papillary, follicular (OMIM ), Hurthle cell (OMIM ), and anaplastic. Approximately 5% of NMTC is hereditary, occurring as a component of a familial cancer syndrome (e.g., familial adenomatous polyposis, {175100}; Carney complex, {160980}) or as a primary feature (familial NMTC or FNMTC). Papillary thyroid cancer (PTC) is the most common histologic subtype of FNMTC, accounting for approximately 85% of cases (summary by Vriens et al., 2009).PTC is characterized by distinctive nuclear alterations including pseudoinclusions, grooves, and chromatin clearing. PTCs smaller than 1 cm are referred to as papillary microcarcinomas. These tumors have been identified in up to 35% of individuals at autopsy, suggesting that they may be extremely common although rarely clinically relevant. PTC can also be multifocal but is typically slow-growing with a tendency to spread to lymph nodes and usually has an excellent prognosis (summary by Bonora et al., 2010). Genetic Heterogeneity of Susceptibility to Nonmedullary Thyroid CancerOther susceptibilities to nonmedullary thyroid cancer include NMTC2 (OMIM ), caused by mutation in the SRGAP1 gene (OMIM ); NMTC3 (OMIM ), mapped to chromosome 2q21; NMTC4 (OMIM ), caused by mutation in the FOXE1 gene (OMIM ); and NMTC5 (OMIM ), caused by mutation in the HABP2 gene (OMIM ).A susceptibility locus for familial nonmedullary thyroid carcinoma with or without cell oxyphilia (TCO ) has been mapped to chromosome 19p.

Clinical Features

Top most frequent phenotypes and symptoms related to Thyroid Cancer, Nonmedullary, 1; Nmtc1

  • Milia
  • Neoplasm
  • Tics
  • Carcinoma
  • Goiter
  • Colon cancer
  • Thyroiditis
  • Thyroid carcinoma
  • Nodular goiter
  • Papillary thyroid carcinoma
And another 5 symptoms. If you need more information about this disease we can help you.
Click here to know more about Mendelian.

Incidence and onset information

— Based on the latest data available Thyroid Cancer, Nonmedullary, 1; Nmtc1 have a estimated incidence of 5.25 per 100k in Europe.


Mendelian

Accelerate your rare disease diagnosis with us

Learn more

Thyroid Cancer, Nonmedullary, 1; Nmtc1 Recommended genes panels

Panel Name, Specifity and genes Tested/covered
Hereditary Brain, CNS, PNS Cancer Panel.

By Baylor Miraca Genetics Laboratories in United States.

SUFU, PALB2, NF2, PHOX2B, PTCH1, NBN, MRE11, ATM, ALK, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, APC, VHL
Specificity
6 %
Genes
4 %
Comprehensive Hereditary Cancer Panel.

By Baylor Miraca Genetics Laboratories in United States.

RAD51D, PMS1, ENG, BARD1, RAD51C, CDC73, PRKAR1A, PRF1, CEBPA, SBDS, PAX5, GATA2, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2, GPC3, MET , (...)

View the complete list with 41 more genes
Specificity
4 %
Genes
8 %
VistaSeq Brain/CNS/PNS Cancer Panel.

By Molecular Diagnostic Laboratory LabCorp in United States.

SMARCB1, NF1, SUFU, NF2, PHOX2B, PTCH1, NBN, ALK, MEN1, RB1, TP53, MLH1, MSH6, PMS2, MSH2, APC, VHL
Specificity
6 %
Genes
4 %
Hereditary Cancer Panel - Neuro17.

By Human Genetics Laboratory, Munroe-Meyer Institute University of Nebraska Medical Center in United States.

NF1, SUFU, NF2, PHOX2B, PTCH1, NBN, ALK, TSC1, TSC2, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, APC, VHL
Specificity
6 %
Genes
4 %
BrainTumorNext.

By Ambry Genetics in United States.

DICER1, POT1, AIP, CDKN1B, SMARCB1, SMARCA4, SMARCE1, NF1, PRKAR1A, CDKN2A, SUFU, NF2, PHOX2B, PTCH1, NBN, ALK, TSC1, TSC2, MEN1, TP53 , (...)

View the complete list with 7 more genes
Specificity
4 %
Genes
4 %
CustomNext: Cancer.

By Ambry Genetics in United States.

NTHL1, HOXB13, GALNT12, DICER1, POT1, AIP, POLE, GREM1, POLD1, CDKN1B, BAP1, XRCC2, SMARCB1, SMARCA4, SMARCE1, MITF, NF1, RAD51D, BARD1, RAD51C , (...)

View the complete list with 48 more genes
Specificity
3 %
Genes
8 %
ALK. Complete sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

ALK
Specificity
100 %
Genes
4 %
Hereditary Brain Tumor Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

SMARCB1, SUFU, PALB2, NF2, PHOX2B, PTCH1, NBN, ATM, ALK, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, APC, VHL
Specificity
6 %
Genes
4 %
Hereditary hemorrhagic telangiectasia (deletion/duplication analysis of ENG, ALK and BMPR2 genes).

By CGC Genetics in Portugal.

BMPR2, ENG, ALK
Specificity
34 %
Genes
4 %
Detection by FISH of ALK rearrangements (del(2p); t(2;5)).

By CGC Genetics in Portugal.

ALK
Specificity
100 %
Genes
4 %
Neuroblastoma Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

PHOX2B, ALK, KIF1B
Specificity
34 %
Genes
4 %
Cancer Hotspot Panel.

By Centogene AG - the Rare Disease Company in Germany.

MYCL, ROS1, RPTOR, KIF5B, GNAI2, GNA13, EML4, BRD4, ARAF, NFE2L2, GNG2, KEAP1, NRG1, CCNE1, CD74, RICTOR, ERBB4, MYC, BCL6, SMO , (...)

View the complete list with 68 more genes
Specificity
8 %
Genes
25 %
Invitae Multi-Cancer Panel.

By Invitae in United States.

DIS3L2, HOXB13, DICER1, WRN, POT1, AXIN2, POLE, PDGFRA, EGFR, GREM1, POLD1, CDKN1B, BAP1, KIT, SMARCB1, SMARCA4, SMARCE1, TERT, TERC, MITF , (...)

View the complete list with 60 more genes
Specificity
4 %
Genes
11 %
Invitae Pediatric Nervous System/Brain Tumors Panel.

By Invitae in United States.

DICER1, SMARCB1, SMARCE1, NF1, PRKAR1A, SUFU, NF2, PHOX2B, PTCH1, ALK, TSC1, TSC2, HRAS, MEN1, RB1, TP53, PTEN, MLH1, MSH6, PMS2 , (...)

View the complete list with 4 more genes
Specificity
9 %
Genes
8 %
Hereditary Cancer Syndrome: Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

BUB1B, AIP, POLD1, CDKN1B, BAP1, XRCC2, MGMT, SMARCB1, SMARCA4, RAD51D, BARD1, RAD51C, CDC73, PRKAR1A, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2 , (...)

View the complete list with 40 more genes
Specificity
4 %
Genes
8 %
Brain, CNS, and PNS Cancer: Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

SUFU, PALB2, NF2, PHOX2B, PTCH1, NBN, ATM, ALK, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, APC, VHL
Specificity
7 %
Genes
4 %
Brain, CNS, and PNS Cancer: Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

SUFU, PALB2, NF2, PHOX2B, PTCH1, NBN, ATM, ALK, MEN1, TP53, MLH1, MSH6, MSH2, APC, VHL
Specificity
7 %
Genes
4 %
Hereditary Cancer Syndrome: Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

BUB1B, POLD1, BAP1, XRCC2, SMARCB1, RAD51D, BARD1, RAD51C, CDC73, PRKAR1A, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2, GPC3, MET, FLCN, SDHD , (...)

View the complete list with 35 more genes
Specificity
4 %
Genes
8 %
ALK.

By Fulgent Genetics Fulgent Genetics in United States.

ALK
Specificity
100 %
Genes
4 %
Nervous System / Brain Cancer Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

DICER1, SMARCB1, SMARCA4, SMARCE1, NF1, PRKAR1A, SUFU, NF2, PHOX2B, PTCH1, ATM, ALK, TSC1, TSC2, HRAS, MEN1, TP53, PTEN, MLH1, MSH6 , (...)

View the complete list with 5 more genes
Specificity
8 %
Genes
8 %
Onco microarray for CLL.

By Pittsburgh Cytogenetics Laboratory University of Pittsburgh Medical Center in United States.

BCL3, FGF2, MYB, MYBL1, BCL10, BCL11A, MYC, BCL6, BCL2, CCND1, ITK, AKT1, IGH, ATM, ALK, TP53
Specificity
7 %
Genes
4 %
Comprehensive Hereditary Cancer Panel.

By Blueprint Genetics in Finland.

REST, PPM1D, EXO1, CD70, CEP57, ERCC1, MLH3, DDB2, DIS3L2, NTHL1, HOXB13, RHBDF2, CYLD, BUB1B, XPA, ERCC5, DICER1, WRN, DDX41, SAMD9L , (...)

View the complete list with 126 more genes
Specificity
5 %
Genes
25 %
EML4-ALK Rearrangement.

By Cancer Genetics, Inc. Cancer Genetics, Inc. in United States.

ALK
Specificity
100 %
Genes
4 %
Focus::Oncomine™ NGS Panel.

By Cancer Genetics, Inc. Cancer Genetics, Inc. in United States.

JAK1, ESR1, ROS1, ERBB4, SMO, ERBB2, DDR2, AKT1, GNA11, IDH1, PDGFRA, JAK2, EGFR, GNAQ, PIK3CA, JAK3, KIT, ERBB3, MTOR, CTNNB1 , (...)

View the complete list with 15 more genes
Specificity
18 %
Genes
22 %
Focus::Renal® NGS Panel.

By Cancer Genetics, Inc. Cancer Genetics, Inc. in United States.

RHEB, HIF1A, PBRM1, EPHB4, ROS1, AXL, SMO, ERBB2, PDGFRB, AKT1, ABL1, EGFR, FLT3, AKT2, PIK3CA, BAP1, KIT, ARID1A, MTOR, KDM5C , (...)

View the complete list with 12 more genes
Specificity
7 %
Genes
8 %
Neuroblastoma.

By Bioarray in Spain.

ALK
Specificity
100 %
Genes
4 %
Solid Tumor Gene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

BCL2L1, H3F3A, KLF4, TRAF7, PIK3C2B, HIST1H3B, JAK1, MCL1, PBRM1, DAXX, CDKN1A, MYB, MYBL1, RAD54B, ESR2, ESR1, KMT2C, FGFR4, ROS1, NFE2L2 , (...)

View the complete list with 102 more genes
Specificity
7 %
Genes
29 %
Thoracic Tumors Gene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

KMT2C, ROS1, KEAP1, ERBB2, DDR2, KDR, FLT1, AKT1, AKT3, AKT2, CDKN1B, BAP1, FANCA, FLT4, SMARCA4, ERBB3, MED12, KMT2D, FGFR1, NF1 , (...)

View the complete list with 16 more genes
Specificity
20 %
Genes
25 %
FoundationOne® Heme.

By Foundation Medicine, Inc. in United States.

TRAF5, PIM1, PRDM1, HIST1H2AG, HIST1H3B, HIST1H1C, HDAC1, GTSE1, HIST1H1D, HIST1H2BK, HIST1H2BO, HIST1H2BC, HIST1H2AC, HIST1H2AM, HIST1H1E, HIST1H2AL, HDAC7, HIST1H2BJ, INPP5D, IKZF2 , (...)

View the complete list with 385 more genes
Specificity
3 %
Genes
36 %
Cancer Hotspot Analysis.

By Advanced Technology Laboratory Spectrum Health in United States.

ERBB4, SMO, ERBB2, KDR, SRC, AKT1, GNA11, FBXW7, IDH1, PDGFRA, ABL1, JAK2, EGFR, NPM1, FLT3, GNAQ, CSF1R, PIK3CA, GNAS, JAK3 , (...)

View the complete list with 30 more genes
Specificity
12 %
Genes
22 %
Circulo Lung.

By Circulogene Theranostics in United States.

ALK
Specificity
100 %
Genes
4 %
NeoTYPE® Discovery Profile for Solid Tumors.

By NeoGenomics Laboratories NeoGenomics Laboratories, Inc. in United States.

IKBKE, INPP4B, HSP90AA1, LRP1B, BCL2L2, AURKB, LMO1, ARFRP1, MDM4, MAP2K4, MCL1, EMSY, CHEK1, PBRM1, DAXX, PDCD1LG2, EPHB1, EPHA3, DOT1L, EPHA5 , (...)

View the complete list with 295 more genes
Specificity
3 %
Genes
33 %
Caris MI TumorSeek 592-Gene NGS Panel.

By Caris Life Sciences in United States.

ETV1, BCL3, SET, ELL, BTG1, ADGRA2, ACSL3, AFF1, ACSL6, ACKR3, RABEP1, PSIP1, RANBP17, RAD51B, RPL22, SDC4, SH3GL1, REL, SLC45A3, SYK , (...)

View the complete list with 571 more genes
Specificity
4 %
Genes
75 %
OmniSeq Comprehensive.

By OmniSeq, Inc. in United States.

NKX2-8, RHOA, BCL2L1, ETV4, ETV1, GAS6, RPS6KB1, RHEB, SPOP, TIAF1, XPO1, ZNF217, JAK1, KNSTRN, IFITM1, APEX1, ATP11B, MDM4, BCL9, BIRC2 , (...)

View the complete list with 124 more genes
Specificity
7 %
Genes
36 %
Neuroblastoma , Panel Massive Sequencing (NGS) 4 Genes.

By Reference Laboratory Genetics in Spain.

PHOX2B, ALK, NME1, KIF1B
Specificity
25 %
Genes
4 %
GeneStrat Genomic Test.

By Biodesix, Inc. Biodesix, Inc. in United States.

ROS1, EGFR, ALK, KRAS, BRAF, RET
Specificity
67 %
Genes
15 %
152 Integrated Advantage NGS Solid Tumor Panel.

By Integrated Molecular Diagnostics Pathology, Inc. in United States.

AURKA, TOP1, ABCC1, SLC29A1, STK11IP, SYK, SULT1A1, XRCC1, TOP2A, TOP2B, PLK1, JAK1, JUN, IKBKE, BCL2L2, AURKB, MDM4, MAP2K4, EMSY, CHEK1 , (...)

View the complete list with 132 more genes
Specificity
5 %
Genes
25 %
Tempus xT assay.

By Tempus Labs, Inc. in United States.

HLA-DRB5, HLA-C, PPP6C, ZNRF3, FOXQ1, TBC1D12, WEE1, YEATS4, POU2F2, C8orf34, SEMA3C, PDPK1, HLA-G, LAG3, CCDC6, MEF2B, AURKA, TOP1, P2RY8, FGF4 , (...)

View the complete list with 571 more genes
Specificity
3 %
Genes
43 %
Tempus xO assay.

By Tempus Labs, Inc. in United States.

SETD6, PIM3, MAP3K10, PDGFA, MAP3K11, PAK2, KHSRP, WASL, CASC11, GLIS1, NRG2, SOX21, SMARCC1, CUL4A, UTY, WNT9A, TEF, CHIC1, TRIM28, CDK11B , (...)

View the complete list with 1693 more genes
Specificity
2 %
Genes
65 %
Brain, CNS, and PNS Cancer: Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

SUFU, PALB2, NF2, PHOX2B, PTCH1, NBN, ATM, ALK, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, APC, VHL
Specificity
7 %
Genes
4 %
CEN4GEN Comprehensive Hereditary Cancer Syndrome: Gene sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

RAD51B, EHBP1, POU6F2, EPHB2, MSMB, ASCC1, MSR1, XRCC3, PTCH2, PALLD, MLH3, DDB2, DIS3L2, MTAP, POLH, UROD, TMC8, TMC6, PDE11A, XPC , (...)

View the complete list with 123 more genes
Specificity
3 %
Genes
15 %
CEN4GEN Lung cancer: Extended gene sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

ADGRB3, LRP1B, EPHA5, MUC16, GRM8, PIK3CG, ROS1, NFE2L2, KEAP1, ERBB4, MYC, ERBB2, MDM2, RUNX1T1, AKT1, FBXW7, PDGFRA, EGFR, RARB, PIK3CA , (...)

View the complete list with 24 more genes
Specificity
10 %
Genes
15 %
CEN4GEN Comprehensive targeted oncogene tumor mutation screen (somatic genetic testing): Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

ERBB4, SMO, ERBB2, KDR, SRC, AKT1, GNA11, FBXW7, IDH1, PDGFRA, ABL1, JAK2, EGFR, NPM1, FLT3, GNAQ, CSF1R, PIK3CA, GNAS, JAK3 , (...)

View the complete list with 28 more genes
Specificity
13 %
Genes
22 %
Hereditary Cancer Syndrome: Gene Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

BUB1B, AIP, POLD1, CDKN1B, BAP1, XRCC2, MGMT, SMARCB1, SMARCA4, RAD51D, BARD1, RAD51C, CDC73, PRKAR1A, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2 , (...)

View the complete list with 40 more genes
Specificity
4 %
Genes
8 %
Hereditary Cancer Syndrome: Gene Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

BUB1B, POLD1, BAP1, XRCC2, SMARCB1, RAD51D, BARD1, RAD51C, CDC73, PRKAR1A, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2, GPC3, MET, FLCN, SDHD , (...)

View the complete list with 35 more genes
Specificity
4 %
Genes
8 %
Hereditary Brain, CNS, PNS Cancer Panel.

By Baylor Miraca Genetics Laboratories in United States.

SUFU, PALB2, NF2, PHOX2B, PTCH1, NBN, MRE11, ATM, ALK, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, APC, VHL
Specificity
6 %
Genes
4 %
Cancer Panel, Hereditary, Sequencing 46 Genes, Deletion/Duplication, 47 Genes.

By ARUP Laboratories, Molecular Genetics and Genomics in United States.

CDKN1B, BAP1, SMARCB1, RAD51D, BARD1, RAD51C, BRIP1, SMAD4, BMPR1A, MAX, CHEK2, MET, FLCN, SDHD, CDKN2A, CDK4, STK11, CDH1, SUFU, PALB2 , (...)

View the complete list with 27 more genes
Specificity
5 %
Genes
8 %
ALK. Sequencing of the exons 21-28.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

ALK
Specificity
100 %
Genes
4 %
Neuroblastoma - ALK Sequence Analysis.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

ALK
Specificity
100 %
Genes
4 %
Neuroblastoma -Sequence Analysis for ALK Ex 21-28 & PHOX2B Ex 1-3.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

PHOX2B, ALK
Specificity
50 %
Genes
4 %
Neuroblastoma - ALK Known Point Mutation Analysis.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

ALK
Specificity
100 %
Genes
4 %
CHOP Comprehensive Hereditary Cancer Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

DDB2, DIS3L2, MTAP, CEBPE, POLH, ARID5B, HMBS, RHBDF2, CYLD, BUB1B, XPA, ERCC5, DICER1, DDX41, COL7A1, G6PC3, ITK, ELANE, EXT1, EXT2 , (...)

View the complete list with 86 more genes
Specificity
4 %
Genes
15 %
Neuroblastoma (sequence analysis of ALK gene).

By CGC Genetics in Portugal.

ALK
Specificity
100 %
Genes
4 %
OncoRisk Plus (NGS panel for 89 genes).

By CGC Genetics in Portugal.

CEP57, DDB2, DIS3L2, XPC, CYLD, BUB1B, XPA, ERCC5, DICER1, WRN, AIP, EXT1, EXT2, ERCC4, BAP1, FANCD2, FANCI, FANCL, FANCM, SLX4 , (...)

View the complete list with 69 more genes
Specificity
3 %
Genes
8 %
Hereditary Neuroblastoma via the ALK Gene.

By PreventionGenetics PreventionGenetics in United States.

ALK
Specificity
100 %
Genes
4 %
Hereditary Cancer Syndromes - panels.

By MGZ Medical Genetics Center in Germany.

RNF43, CEP57, DDB2, DIS3L2, XPC, NTHL1, RHBDF2, CYLD, BUB1B, XPA, ERCC5, DICER1, WRN, AIP, EXT1, EXT2, AXIN2, POLE, EGFR, GREM1 , (...)

View the complete list with 80 more genes
Specificity
3 %
Genes
11 %
Solid Tumor Panel.

By Centogene AG - the Rare Disease Company in Germany.

KMT2C, FGFR4, NTRK3, ROS1, AXL, SMO, ERBB2, DDR2, KDR, PDGFRB, PIK3R1, AKT1, GNA11, IDH1, PDGFRA, ABL1, JAK2, EGFR, GNAQ, PIK3CA , (...)

View the complete list with 42 more genes
Specificity
12 %
Genes
25 %
Neuroblastoma, susceptibility to, 3.

By Centogene AG - the Rare Disease Company in Germany.

ALK
Specificity
100 %
Genes
4 %
Cancer Predisposition.

By Asper Biogene Asper Biogene LLC in Estonia.

DDB2, DIS3L2, XPC, RHBDF2, CYLD, XPA, ERCC5, DICER1, WRN, AIP, EXT1, EXT2, EGFR, ERCC4, BAP1, FANCD2, FANCI, FANCL, FANCM, SLX4 , (...)

View the complete list with 69 more genes
Specificity
4 %
Genes
11 %
Invitae Nervous System/Brain Cancer Panel.

By Invitae in United States.

DICER1, SMARCB1, SMARCA4, SMARCE1, NF1, PRKAR1A, SUFU, NF2, PHOX2B, PTCH1, ALK, TSC1, TSC2, HRAS, MEN1, RB1, TP53, PTEN, MLH1, MSH6 , (...)

View the complete list with 5 more genes
Specificity
8 %
Genes
8 %
Invitae Familial Neuroblastoma Panel.

By Invitae in United States.

PHOX2B, ALK
Specificity
50 %
Genes
4 %
Invitae Pediatric Solid Tumors Panel.

By Invitae in United States.

DIS3L2, DICER1, WRN, AXIN2, BAP1, SMARCB1, SMARCA4, SMARCE1, NF1, CDC73, PRKAR1A, SMAD4, BMPR1A, MAX, GPC3, SDHD, CDKN1C, STK11, SUFU, NF2 , (...)

View the complete list with 28 more genes
Specificity
7 %
Genes
11 %
Comprehensive Cancer Panel.

By Fulgent Genetics Fulgent Genetics in United States.

RBM15, EXO1, XRCC3, PICALM, ROBO2, MSH3, DDB2, DIS3L2, XPC, HOXB13, CYLD, GALNT12, BUB1B, RAD51, XPA, ERCC5, DICER1, EGLN1, WRN, PRKDC , (...)

View the complete list with 104 more genes
Specificity
3 %
Genes
11 %
Onco microarray for MDS/AML.

By Pittsburgh Cytogenetics Laboratory University of Pittsburgh Medical Center in United States.

SET, ELL, GAS6, AFF1, ACSL6, ARHGAP26, AFDN, MLLT10, MRTFA, NUP98, ELF4, ERG, FOXO4, MYB, RBM15, EGR1, MECOM, RPN1, MLLT1, MLLT3 , (...)

View the complete list with 40 more genes
Specificity
9 %
Genes
18 %
Hemato-oncology chromosomal microarray.

By Pittsburgh Cytogenetics Laboratory University of Pittsburgh Medical Center in United States.

NUTM2B, NUTM2A, SSX2, MALAT1, ETV4, TFEB, SSX4, NR4A3, MSI2, CREB3L2, TFE3, FOXO1, ETV1, ACSL3, RABEP1, SSX1, SS18, POU5F1, HEY1, JUN , (...)

View the complete list with 72 more genes
Specificity
6 %
Genes
18 %
Hereditary Pediatric Cancer Panel.

By Blueprint Genetics in Finland.

REST, DIS3L2, BUB1B, DICER1, WRN, AXIN2, BAP1, SMARCB1, SMARCA4, EZH2, RRAS, RASA2, NSUN2, LZTR1, NF1, CDC73, PRKAR1A, PRF1, CEBPA, PAX5 , (...)

View the complete list with 51 more genes
Specificity
9 %
Genes
22 %
ALK Break Apart FISH.

By Cancer Genetics, Inc. Cancer Genetics, Inc. in United States.

ALK
Specificity
100 %
Genes
4 %
Liquid::Lung-cfDNA™ NGS Panel.

By Cancer Genetics, Inc. Cancer Genetics, Inc. in United States.

ROS1, ERBB2, EGFR, PIK3CA, MET, ALK, NRAS, MAP2K1, KRAS, BRAF, TP53
Specificity
37 %
Genes
15 %
Melanoma Gene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

KMT2C, ROS1, RAC1, ERBB4, ERBB2, CCND1, PDGFRB, AKT1, GNA11, PDGFRA, EGFR, GNAQ, PIK3CA, BAP1, KIT, TERT, MTOR, CTNNB1, MED12, KMT2D , (...)

View the complete list with 18 more genes
Specificity
16 %
Genes
22 %
Guardant360.

By Guardant Health in United States.

MAPK3, RHOA, RHEB, MAPK1, ESR1, NTRK3, ROS1, ARAF, NFE2L2, CCNE1, MYC, SMO, ERBB2, DDR2, CCND1, CDK6, CCND2, AKT1, GNA11, FBXW7 , (...)

View the complete list with 53 more genes
Specificity
11 %
Genes
29 %
Comprehensive Panel for Individualized Cancer Threatment.

By GeneKor MSA in Greece.

ROS1, ERBB4, SMO, ERBB2, DDR2, KDR, SRC, AKT1, GNA11, FBXW7, IDH1, PDGFRA, ABL1, JAK2, EGFR, NPM1, FLT3, GNAQ, CSF1R, PIK3CA , (...)

View the complete list with 32 more genes
Specificity
14 %
Genes
25 %
Solid Tumor Targeted Mutation and Fusion Panel.

By Providence Regional Laboratories Providence Health and Services in United States.

ETV1, JAK1, ERG, ESR1, FGFR4, NTRK3, ROS1, ERBB4, AXL, MYC, SMO, ERBB2, DDR2, CCND1, CDK6, NTRK2, AKT1, AKT3, GNA11, IDH1 , (...)

View the complete list with 30 more genes
Specificity
18 %
Genes
33 %
Neuroblastoma Susceptibility to , Sequencing ALK Gene.

By Reference Laboratory Genetics in Spain.

ALK
Specificity
100 %
Genes
4 %
Oncology Genetic Panel , Panel Massive Sequencing (NGS) 90 Genes.

By Reference Laboratory Genetics in Spain.

CEP57, DDB2, DIS3L2, XPC, RHBDF2, CYLD, BUB1B, XPA, ERCC5, DICER1, WRN, AIP, EXT1, EXT2, EGFR, ERCC4, BAP1, FANCD2, FANCI, FANCL , (...)

View the complete list with 70 more genes
Specificity
3 %
Genes
8 %
Phosphorus Brain and Nervous System Cancer Panel.

By Phosphorus Diagnostics LLC in United States.

DICER1, AIP, CDKN1B, SMARCB1, SMARCA4, SMARCE1, NF1, PRKAR1A, MAX, SDHD, SUFU, NF2, PHOX2B, PTCH1, ALK, TSC1, TSC2, HRAS, SDHA, MEN1 , (...)

View the complete list with 15 more genes
Specificity
9 %
Genes
11 %
Phosphorus Pan-Cancer Panel.

By Phosphorus Diagnostics LLC in United States.

DIS3L2, HOXB13, DICER1, WRN, POT1, AIP, AXIN2, POLE, PDGFRA, EGFR, GREM1, POLD1, CDKN1B, BAP1, XRCC2, KIT, SMARCB1, SMARCA4, SMARCE1, TERT , (...)

View the complete list with 63 more genes
Specificity
4 %
Genes
11 %
Phosphorus Pediatric Cancers Panel.

By Phosphorus Diagnostics LLC in United States.

DIS3L2, DICER1, WRN, AXIN2, BAP1, SMARCB1, TERT, TERC, EZH2, NF1, CDC73, PRKAR1A, CEBPA, GATA2, SMAD4, BMPR1A, MAX, GPC3, SDHD, CDKN1C , (...)

View the complete list with 33 more genes
Specificity
6 %
Genes
11 %
Brain, CNS, and PNS Cancer: Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

SUFU, PALB2, NF2, PHOX2B, PTCH1, NBN, ATM, ALK, MEN1, TP53, MLH1, MSH6, MSH2, APC, VHL
Specificity
7 %
Genes
4 %
CEN4GEN Hematological malignancies (somatic genetic testing): Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

MYC, IDH1, MYD88, PDGFRA, TET2, ABL1, JAK2, NPM1, FLT3, ASXL1, KIT, KMT2A, DNMT3A, NOTCH1, NF1, MPL, CEBPA, ALK, PTPN11, BRAF , (...)

View the complete list with 3 more genes
Specificity
9 %
Genes
8 %
Congenital Hypothyroidism Sequencing Panel.

By Genetic Services Laboratory University of Chicago in United States.

TG, TPO, SLC5A5, FOXE1, DUOX2, DUOXA2, THRA, IGSF1, TSHB, PAX8, UBR1, GLIS3, THRB, NKX2-1, KDM6A, SLC16A2, KMT2D, POU1F1, PROP1, TSHR , (...)

View the complete list with 2 more genes
Specificity
14 %
Genes
11 %
Congenital Nongoitrous Hypothyroidism 2.

By Molecular Diagnostics Lab Nemours Alfred I. duPont Hospital for Children in United States.

PAX8
Specificity
100 %
Genes
4 %
PAX8 mutation analysis.

By Laboratory of genome diagnostics Academic Medical Center, University of Amsterdam in Netherlands.

PAX8
Specificity
100 %
Genes
4 %
Nephrology Endocrinology and Electrolytes - panels.

By MGZ Medical Genetics Center in Germany.

UPK2, DACH1, DSTYK, CHD1L, CDC5L, BMP7, SIX2, TRAP1, UPK3A, AGTR1, ANLN, FGF20, ITGA8, PTPRO, EMP2, CHRM3, BICC1, ROBO2, ARHGDIA, AGT , (...)

View the complete list with 97 more genes
Specificity
2 %
Genes
8 %
Hypothyroidism congenital nongoitrous type 2.

By Centogene AG - the Rare Disease Company in Germany.

PAX8
Specificity
100 %
Genes
4 %
CentoICU platinum plus.

By Centogene AG - the Rare Disease Company in Germany.

OPLAH, PPM1K, IKBKB, LCK, CABS1, SOX6, OPRM1, IL2, CTPS1, IRF8, CD247, ADK, UQCC2, MPC1, UPB1, CORO1A, CD3G, MCM4, UQCRC2, GPHN , (...)

View the complete list with 494 more genes
Specificity
2 %
Genes
22 %
CentoICU platinum.

By Centogene AG - the Rare Disease Company in Germany.

FRAS1, TSPYL1, IL2RA, CARD11, NOTCH2, TNFRSF13C, PRKDC, ICOS, CD81, CR2, CD19, F7, JAGN1, ABCC2, NFKB2, IL12RB1, COL7A1, COL17A1, ITGA6, ITGB4 , (...)

View the complete list with 494 more genes
Specificity
2 %
Genes
22 %
qCarrier Plus.

By Quantitative Genomic Medicine Laboratories, SL in Spain.

MPP3, FTCD, ADK, CTH, HAL, HGD, WNT10A, SLC6A19, TPO, SLC5A5, DUOX2, DUOXA2, PAX8, HJV, HOGA1, TFR2, COL7A1, SLC39A4, ARL13B, FANCA , (...)

View the complete list with 280 more genes
Specificity
1 %
Genes
4 %
CONGENITAL HYPOTHYROIDISM.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

PAX9, TRHR, TG, TPO, SLC5A5, FOXE1, DUOX2, DUOXA2, THRA, TSHB, PAX8, GNAS, THRB, NKX2-5, NKX2-1, SLC16A2, POU1F1, PROP1, TSHR, IYD , (...)

View the complete list with 2 more genes
Specificity
14 %
Genes
11 %
Congenital Hypothyroidism: PAX8 Gene Deletion/Duplication.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

PAX8
Specificity
100 %
Genes
4 %
Congenital Hypothyroidism: PAX8 and FOXE1 Gene Sequencing.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

FOXE1, PAX8
Specificity
100 %
Genes
8 %
PAX8.

By Fulgent Genetics Fulgent Genetics in United States.

PAX8
Specificity
100 %
Genes
4 %
Congenital Hypothyroidism, Nongoitrous NGS and Deletion/Duplication Panel.

By DDC Clinic Molecular Diagnostics Laboratory DDC Clinic, Center for Special Needs Children in United States.

THRA, TSHB, PAX8, NKX2-5, TSHR
Specificity
20 %
Genes
4 %
PAX8 Gene Sequencing and Deletion/Duplication Analysis.

By DDC Clinic Molecular Diagnostics Laboratory DDC Clinic, Center for Special Needs Children in United States.

PAX8
Specificity
100 %
Genes
4 %
THYROID HYPOPLASIA / ATHYREOSIS/ THYROID DYSGENESIS.

By Laboratorio de Genetica Clinica SL in Spain.

FOXE1, PAX8, NKX2-5, NKX2-1, TSHR
Specificity
60 %
Genes
11 %
CEN4GEN rapid supplemental newborn genetic screen: Full gene sequencing panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

SLC5A5, DUOX2, PAX8, HADH, PCBD1, MAT1A, CD320, HCFC1, GJB3, CYP21A2, GCH1, MCOLN1, HBA2, G6PD, HBA1, NPC2, NPC1, IDUA, GLA, GJB6 , (...)

View the complete list with 79 more genes
Specificity
2 %
Genes
4 %
Congenital hypothyroidism: gene sequencing panel (RAPID testing).

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

TG, TPO, SLC5A5, DUOX2, THRA, TSHB, PAX8, THRB, TSHR
Specificity
12 %
Genes
4 %
CEN4GEN rapid pan-ethnic carrier screen: Full gene sequencing panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

TG, TPO, SLC5A5, DUOX2, THRA, TSHB, PAX8, HADH, PCBD1, MAT1A, CD320, THRB, HCFC1, GJB3, CYP21A2, GCH1, MCOLN1, HBA2, G6PD, HBA1 , (...)

View the complete list with 84 more genes
Specificity
1 %
Genes
4 %
Congenital hypothyroidism due to thyroid dysgenesis or hypoplasia: Full gene sequencing (Rapid testing).

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

PAX8
Specificity
100 %
Genes
4 %
Congenital Hypothyroidism Deletion/Duplication Panel.

By Genetic Services Laboratory University of Chicago in United States.

TG, TPO, SLC5A5, FOXE1, DUOX2, DUOXA2, THRA, IGSF1, TSHB, PAX8, UBR1, GLIS3, THRB, NKX2-1, KDM6A, SLC16A2, KMT2D, POU1F1, PROP1, TSHR , (...)

View the complete list with 2 more genes
Specificity
14 %
Genes
11 %
Congenital Hypothyroidism (Thyroid Dysgenesis) via the PAX8 Gene.

By PreventionGenetics PreventionGenetics in United States.

PAX8
Specificity
100 %
Genes
4 %
Congenital Hypothyroidism and Thyroid Hormone Resistance Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

TRHR, TRH, TG, TPO, SLC5A5, FOXE1, DUOX2, DUOXA2, THRA, IGSF1, TSHB, PAX8, UBR1, GLIS3, GNAS, THRB, NKX2-5, NKX2-1, SLC16A2, POU1F1 , (...)

View the complete list with 6 more genes
Specificity
12 %
Genes
11 %
Single gene testing PAX8.

By CeGaT GmbH in Germany.

PAX8
Specificity
100 %
Genes
4 %
Hypothyroidism and Thyroid Hormone Resistance.

By Asper Biogene Asper Biogene LLC in Estonia.

TRHR, TG, TPO, SLC5A5, DUOX2, DUOXA2, THRA, TSHB, PAX8, GNAS, THRB, NKX2-5, NKX2-1, SLC16A2, POU1F1, PROP1, TSHR, IYD, HESX1, SECISBP2 , (...)

View the complete list with 1 more genes
Specificity
10 %
Genes
8 %
Congenital Hypothyroidism: PAX8 Gene Sequencing.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

PAX8
Specificity
100 %
Genes
4 %
Congenital Hypothyroidism: PAX8 and FOXE1 Gene Deletion/Duplication.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

FOXE1, PAX8
Specificity
100 %
Genes
8 %
Hypothyroidism and Resistance to Thyroid Hormone Panel.

By Blueprint Genetics in Finland.

TG, TPO, SLC5A5, FOXE1, DUOX2, DUOXA2, THRA, IGSF1, TSHB, PAX8, GNAS, THRB, NKX2-5, NKX2-1, SLC16A2, POU1F1, PROP1, TSHR, HESX1, SECISBP2 , (...)

View the complete list with 1 more genes
Specificity
15 %
Genes
11 %
Baby Genes Targeted Panel.

By Baby Genes Inc. Baby Genes Inc. in United States.

TG, TPO, SLC5A5, DUOX2, TSHB, PAX8, HADH, PCBD1, MAT1A, GJB3, CYP21A2, GCH1, HBA2, G6PD, HBA1, NPC2, NPC1, IDUA, GLA, GJB6 , (...)

View the complete list with 70 more genes
Specificity
2 %
Genes
4 %
CONGENITAL HYPOTHYROIDISM – NGS PANEL.

By Laboratorio de Genetica Clinica SL in Spain.

TG, TPO, SLC5A5, FOXE1, DUOX2, DUOXA2, THRA, TSHB, PAX8, NKX2-5, NKX2-1, TSHR, IYD, SLC26A4
Specificity
22 %
Genes
11 %
Congenital Hypothyroidism , Panel Massive Sequencing 20 Genes.

By Reference Laboratory Genetics in Spain.

TG, TPO, SLC5A5, FOXE1, DUOXA2, THRA, TSHB, PAX8, GNAS, THRB, NKX2-5, NKX2-1, SLC16A2, POU1F1, PROP1, TSHR, IYD, SECISBP2, SLC26A4
Specificity
16 %
Genes
11 %
Cleft lip, cleft palate and related disorders NGS panel.

By Connective Tissue Gene Tests in United States.

TBX22, SUMO1, TGDS, NECTIN1, MSX1, GRHL3, FOXE1, IRF6, BMP4, SATB2, TP63, COL11A2, COL11A1, COL9A2, COL9A3, COL9A1, COL2A1
Specificity
6 %
Genes
4 %
qGenEx Craniofacial Anomalies.

By Quantitative Genomic Medicine Laboratories, SL in Spain.

UBB, PAX7, HOXA2, TSHZ1, EIF4A3, DLX4, TBX22, SUMO1, KDM1A, SMOC2, WDR72, NOG, ODAPH, MMP20, KLK4, NECTIN1, ENAM, LTBP3, LRP6, PAX9 , (...)

View the complete list with 116 more genes
Specificity
1 %
Genes
4 %
Congenital Hypothyroidism: FOXE1 Gene Deletion/Duplication.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

FOXE1
Specificity
100 %
Genes
4 %
Cleft Lip/Palate and Associated Syndromes Panel.

By Blueprint Genetics in Finland.

TBX22, TGDS, MSX1, GRHL3, FOXE1, IRF6, SATB2, KDM6A, TP63, COL11A2, COL11A1, COL9A2, COL9A3, COL9A1, KMT2D, COL2A1
Specificity
7 %
Genes
4 %
FOXE1 mutation analysis.

By Laboratory of genome diagnostics Academic Medical Center, University of Amsterdam in Netherlands.

FOXE1
Specificity
100 %
Genes
4 %
Bamforth-Lazarus Syndrome via FOXE1 Gene Sequencing with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

FOXE1
Specificity
100 %
Genes
4 %
Cleft lip, cleft palate and related disorders Deletion / Duplication panel.

By Connective Tissue Gene Tests in United States.

TBX22, SUMO1, TGDS, NECTIN1, MSX1, GRHL3, FOXE1, IRF6, BMP4, SATB2, TP63, COL11A2, COL11A1, COL9A2, COL9A3, COL9A1, COL2A1
Specificity
6 %
Genes
4 %
Cleft lip, cleft palate and related disorders Comprehensive panel.

By Connective Tissue Gene Tests in United States.

TBX22, SUMO1, TGDS, NECTIN1, MSX1, GRHL3, FOXE1, IRF6, BMP4, SATB2, TP63, COL11A2, COL11A1, COL9A2, COL9A3, COL9A1, COL2A1
Specificity
6 %
Genes
4 %
Single gene testing FOXE1.

By CeGaT GmbH in Germany.

FOXE1
Specificity
100 %
Genes
4 %
Bamforth Lazarus Syndrome: FOXE1 Gene Sequencing.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

FOXE1
Specificity
100 %
Genes
4 %
Bamforth Lazarus Syndrome: FOXE1 Gene Deletion/Duplication.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

FOXE1
Specificity
100 %
Genes
4 %
Congenital Hypothyroidism: FOXE1 Gene Sequencing.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

FOXE1
Specificity
100 %
Genes
4 %
FOXE1.

By Fulgent Genetics Fulgent Genetics in United States.

FOXE1
Specificity
100 %
Genes
4 %
Hermansky-Pudlak and Pulmonary Fibrosis Panel.

By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center in United States.

SFTPA1, SFTPA2, SFTPB, SFTPC, ABCA3, NKX2-1, MUC5B, CSF2RA, PARN, SFTPD, TERT, ELMOD2, TERC, BLOC1S6, DKC1, RTEL1, TINF2, AP3B1, HPS3, HPS4 , (...)

View the complete list with 5 more genes
Specificity
4 %
Genes
4 %
Diffuse Lung Disease NGS Panel.

By Johns Hopkins DNA Diagnostic Laboratory Johns Hopkins Hospital in United States.

SFTPA2, SFTPB, SFTPC, ABCA3, NKX2-1, CSF2RB, CSF2RA, TERT, TERC, DKC1, SLC7A7, TINF2, FOXF1, AP3B1, HPS4, HPS1
Specificity
7 %
Genes
4 %
Pulmonary Alveolar Proteinosis NGS Panel.

By Johns Hopkins DNA Diagnostic Laboratory Johns Hopkins Hospital in United States.

SFTPB, SFTPC, ABCA3, NKX2-1, CSF2RB, CSF2RA, SLC7A7, FOXF1
Specificity
13 %
Genes
4 %
Idiopathic Pulmonary Fibrosis NGS Panel.

By Johns Hopkins DNA Diagnostic Laboratory Johns Hopkins Hospital in United States.

SFTPA2, SFTPC, ABCA3, NKX2-1, TERT, TERC, DKC1, TINF2, AP3B1, HPS4, HPS1
Specificity
10 %
Genes
4 %
Benign Hereditary Chorea.

By Johns Hopkins DNA Diagnostic Laboratory Johns Hopkins Hospital in United States.

NKX2-1
Specificity
100 %
Genes
4 %
Dystonia Exome Panel.

By Genetic Services Laboratory University of Chicago in United States.

NUP62, ACY1, SLC30A10, ADCY5, GNAL, BCAP31, ECHS1, LIPT1, KCTD17, HPCA, XPR1, ANO3, HIVEP2, GNB1, DNAJC6, SLC39A14, VAC14, UBA5, TBCD, MECR , (...)

View the complete list with 150 more genes
Specificity
1 %
Genes
4 %
Ataxia Exome Panel.

By Genetic Services Laboratory University of Chicago in United States.

PIGG, CHAMP1, THG1L, VWA3B, CWF19L1, WDR73, TMEM240, SNX14, APOPT1, CHCHD10, PRDM8, PET100, RNF170, POLR3B, POLR3A, WDR81, COA5, ZNF592, XPA, TRNT1 , (...)

View the complete list with 460 more genes
Specificity
1 %
Genes
4 %
PulmoGene Panel (64 Genes).

By Laboratory for Molecular Medicine Laboratory for Molecular Medicine (Partners HealthCare Personalized Medicine) in United States.

GDNF, ASCL1, BDNF, SFTPA1, SFTPA2, DNAI1, SFTPB, BMPR2, DNAH5, NME8, SFTPC, ABCA3, NKX2-1, DNAH11, DNAI2, DNAAF2, RSPH4A, RSPH9, LTBP4, DNAAF1 , (...)

View the complete list with 44 more genes
Specificity
5 %
Genes
11 %
Benign hereditary chorea.

By Molecular Diagnostics Lab Nemours Alfred I. duPont Hospital for Children in United States.

NKX2-1
Specificity
100 %
Genes
4 %
Benign Hereditary Chorea.

By Laboratorio di Neurogenetica Istituto di Farmacologia Traslazionale - CNR in Italy.

NKX2-1
Specificity
100 %
Genes
4 %
NKX2-1. Complete sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

NKX2-1
Specificity
100 %
Genes
4 %
Neonatal Respiratory Distress Del/Dup Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

COPA, NOTCH2, SFTPB, ABCA3, NKX2-1, CSF2RB, CSF2RA, TERT, TERC, MARS, DKC1, FLNA, SLC7A7, GATA2, FOXF1, JAG1
Specificity
7 %
Genes
4 %
Neonatal Respiratory Distress Seq + Del/ Dup Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

COPA, NOTCH2, SFTPB, ABCA3, NKX2-1, CSF2RB, CSF2RA, TERT, TERC, MARS, DKC1, FLNA, SLC7A7, GATA2, FOXF1, JAG1
Specificity
7 %
Genes
4 %
Neonatal Respiratory Distress Seq Analysis.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

COPA, NOTCH2, SFTPB, ABCA3, NKX2-1, CSF2RB, CSF2RA, TERT, TERC, MARS, DKC1, FLNA, SLC7A7, GATA2, FOXF1, JAG1
Specificity
7 %
Genes
4 %
Comprehensive Pulmonary-Vascular Del/Dup Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

HYDIN, DNAH6, COPA, EIF2AK4, NOTCH2, DNAI1, SFTPB, BMPR2, DNAH5, NME8, ABCA3, NKX2-1, DNAH11, KCNA5, DNAI2, DNAAF2, RSPH4A, RSPH9, DNAAF1, CCDC40 , (...)

View the complete list with 44 more genes
Specificity
2 %
Genes
4 %
Comprehensive Pulmonary-Vascular Seq + Del/Dup Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

HYDIN, DNAH6, COPA, EIF2AK4, NOTCH2, DNAI1, SFTPB, BMPR2, DNAH5, NME8, ABCA3, NKX2-1, DNAH11, KCNA5, DNAI2, DNAAF2, RSPH4A, RSPH9, DNAAF1, CCDC40 , (...)

View the complete list with 44 more genes
Specificity
2 %
Genes
4 %
Benign hereditary chorea (deletion/duplication analysis of NKX2-1 gene).

By CGC Genetics in Portugal.

NKX2-1
Specificity
100 %
Genes
4 %
Choreoathetosis and congenital hypothyroidism (sequence analysis of NKX2-1 gene).

By CGC Genetics in Portugal.

NKX2-1
Specificity
100 %
Genes
4 %
Congenital Hypothyroidism (Thyroid Dysgenesis) via NKX2-1/TTF1 Gene Sequencing with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

NKX2-1
Specificity
100 %
Genes
4 %
Mental retardation - different panels.

By Institute of Human Genetics Cologne University in Germany.

EEF1B2, UBR7, PARP1, CAPN10, SLC31A1, TRMT1, PGAP2, GMPPA, TANGO2, IMPA1, RALGDS, ZBTB40, KCNK9, SETD1A, HERC2, TM4SF20, AHDC1, CCDC88A, ACBD6, KDM5A , (...)

View the complete list with 847 more genes
Specificity
1 %
Genes
22 %
Neurogenetic Disorders - panels.

By MGZ Medical Genetics Center in Germany.

PITRM1, KLC4, PTCD1, VPS11, TXN2, STAT2, PODXL, PPT2, GTPBP2, SLC25A26, KCNA4, SLC25A42, FLRT1, CCDC115, TANGO2, LONP1, TRIT1, RMND1, VARS2, TARS2 , (...)

View the complete list with 577 more genes
Specificity
1 %
Genes
11 %
Chorea, hereditary benign.

By Centogene AG - the Rare Disease Company in Germany.

NKX2-1
Specificity
100 %
Genes
4 %
AllNeuro panel.

By Centogene AG - the Rare Disease Company in Germany.

FCGR2B, TNF, ALOX5AP, PRKCH, TLR5, TIRAP, NOS2, XBP1, KCNK18, AANAT, SNIP1, EIF4E, ZBTB18, ADAM10, YAP1, ICAM1, SNX3, CISH, TAS2R38, FRG1 , (...)

View the complete list with 1185 more genes
Specificity
1 %
Genes
29 %
Comprehensive pulmonary disease panel.

By Centogene AG - the Rare Disease Company in Germany.

GDNF, ASCL1, BDNF, NOP10, SFTPA1, SFTPA2, DNAI1, SFTPB, BMPR2, DNAH5, NME8, SFTPC, ABCA3, NKX2-1, DNAH11, DNAI2, DNAAF2, RSPH4A, RSPH9, LTBP4 , (...)

View the complete list with 46 more genes
Specificity
4 %
Genes
8 %
Ataxia and differential diagnoses Panel.

By CeGaT GmbH in Germany.

RPIA, POLH, NOP56, XPC, VWA3B, CWF19L1, WDR73, TMEM240, SNX14, CHCHD10, RNF170, POLR3B, POLR3A, WDR81, XPA, TRNT1, PMPCA, RUBCN, SLC9A1, STUB1 , (...)

View the complete list with 184 more genes
Specificity
1 %
Genes
4 %
Single gene testing NKX2-1.

By CeGaT GmbH in Germany.

NKX2-1
Specificity
100 %
Genes
4 %
Chorea, Hereditary benign: TITF1 (NKX2-1) gene sequence analysis.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

NKX2-1
Specificity
100 %
Genes
4 %
Interstitial Lung Disease Panel.

By Blueprint Genetics in Finland.

SLC34A2, ITGA3, SFTPA1, SFTPA2, SFTPB, SFTPC, ABCA3, NKX2-1, CSF2RB, CSF2RA, PARN, TERT, ELMOD2, TERC, DKC1, NF1, RTEL1, SLC7A7, TSC1, TSC2 , (...)

View the complete list with 5 more genes
Specificity
4 %
Genes
4 %
Neonatal Respiratory Distress - Surfactant Dysfunction Panel.

By Blueprint Genetics in Finland.

SFTPB, SFTPC, ABCA3, NKX2-1, FOXF1
Specificity
20 %
Genes
4 %
CHOREA, HEREDITARY BENIGN.

By Laboratorio de Genetica Clinica SL in Spain.

NKX2-1
Specificity
100 %
Genes
4 %
NKX2-1 Related Disorders: gene sequencing.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

NKX2-1
Specificity
100 %
Genes
4 %
Comprehensive Pulmonary Panel.

By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center in United States.

SFTPA1, SFTPA2, DNAI1, SFTPB, BMPR2, DNAH5, NME8, SFTPC, ABCA3, NKX2-1, DNAH11, KCNA5, DNAI2, DNAAF2, RSPH4A, RSPH9, LTBP4, DNAAF1, MUC5B, CCDC40 , (...)

View the complete list with 73 more genes
Specificity
2 %
Genes
4 %
Surfactant Dysfunction and Respiratory Distress in Premature Infants Panel.

By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center in United States.

SFTPB, SFTPC, ABCA3, NKX2-1, CSF2RB, CSF2RA, SLC7A7, FOXF1
Specificity
13 %
Genes
4 %
Neonatal Respiratory Distress NGS Panel.

By Johns Hopkins DNA Diagnostic Laboratory Johns Hopkins Hospital in United States.

SFTPB, SFTPC, ABCA3, NKX2-1, FOXF1
Specificity
20 %
Genes
4 %
Choreoathetosis, Hypothyroidism, and Neonatal Respiratory Distress.

By Johns Hopkins DNA Diagnostic Laboratory Johns Hopkins Hospital in United States.

NKX2-1
Specificity
100 %
Genes
4 %
Childhood Interstitial Lung Disease Panel.

By Johns Hopkins DNA Diagnostic Laboratory Johns Hopkins Hospital in United States.

SFTPC, ABCA3, NKX2-1
Specificity
34 %
Genes
4 %
NKX2-1 Sequencing.

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center in United States.

NKX2-1
Specificity
100 %
Genes
4 %
Basic Fibrosis Panel (12 Genes).

By Laboratory for Molecular Medicine Laboratory for Molecular Medicine (Partners HealthCare Personalized Medicine) in United States.

SFTPA1, SFTPA2, SFTPB, SFTPC, ABCA3, NKX2-1, MUC5B, CSF2RA, SFTPD, TERT, ELMOD2, TERC
Specificity
9 %
Genes
4 %
Pulmonary Fibrosis - Hermansky Pudlak Panel (21 Genes).

By Laboratory for Molecular Medicine Laboratory for Molecular Medicine (Partners HealthCare Personalized Medicine) in United States.

SFTPA1, SFTPA2, SFTPB, SFTPC, ABCA3, NKX2-1, MUC5B, CSF2RA, SFTPD, TERT, ELMOD2, TERC, BLOC1S6, AP3B1, HPS3, HPS4, HPS5, HPS6, BLOC1S3, HPS1 , (...)

View the complete list with 1 more genes
Specificity
5 %
Genes
4 %
Choreoathetosis, hypothyroidism and neonatal respiratory distress.

By Molecular Diagnostics Lab Nemours Alfred I. duPont Hospital for Children in United States.

NKX2-1
Specificity
100 %
Genes
4 %
NKX2-1 mutation analysis.

By Laboratory of genome diagnostics Academic Medical Center, University of Amsterdam in Netherlands.

NKX2-1
Specificity
100 %
Genes
4 %
Comprehensive Pulmonary-Vascular Seq Analysis.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

HYDIN, DNAH6, COPA, EIF2AK4, NOTCH2, DNAI1, SFTPB, BMPR2, DNAH5, NME8, ABCA3, NKX2-1, DNAH11, KCNA5, DNAI2, DNAAF2, RSPH4A, RSPH9, DNAAF1, CCDC40 , (...)

View the complete list with 45 more genes
Specificity
2 %
Genes
4 %
Benign hereditary chorea (sequence analysis of NKX2-1 gene).

By CGC Genetics in Portugal.

NKX2-1
Specificity
100 %
Genes
4 %
Pulmonary Fibrosis and Surfactant Dysfunction Disorders Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

SFTPA2, SFTPB, SFTPC, ABCA3, NKX2-1, CSF2RB, SFTPD, TERT, ELMOD2, TERC
Specificity
10 %
Genes
4 %
Interstitial Lung Disease Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

SLC34A2, ITGA3, SFTPA2, SFTPB, SFTPC, ABCA3, NKX2-1, CSF2RB, PARN, TERT, TERC, DKC1, NF1, RTEL1, SLC7A7, FLCN, TSC1, TSC2, TINF2, CFTR , (...)

View the complete list with 4 more genes
Specificity
5 %
Genes
4 %
Choreatic Movement Disorders Panel.

By CeGaT GmbH in Germany.

ARHGEF2, FRRS1L, RNF216, ADCY5, PRNP, PDE10A, FTL, JPH3, NKX2-1, GNAO1, KCNA1, TBP, ATXN7, ATXN3, ATXN2, C9orf72, ATM, ATXN1, GM2A, OPA3 , (...)

View the complete list with 1 more genes
Specificity
5 %
Genes
4 %
NKX2-1.

By Fulgent Genetics Fulgent Genetics in United States.

NKX2-1
Specificity
100 %
Genes
4 %
Comprehensive Pulmonology Panel.

By Blueprint Genetics in Finland.

SLC34A2, PIH1D3, SLC6A5, GLRA1, ITGA3, SFTPA1, SFTPA2, DNAI1, SFTPB, DNAH5, NME8, SFTPC, ABCA3, NKX2-1, DNAH11, DNAI2, DNAAF2, RSPH4A, RSPH9, LTBP4 , (...)

View the complete list with 46 more genes
Specificity
4 %
Genes
8 %
Benign familial chorea.

By Bioarray in Spain.

NKX2-1
Specificity
100 %
Genes
4 %
THYROID CARCINOMA, PAPILLARY.

By Laboratorio de Genetica Clinica SL in Spain.

NKX2-1
Specificity
100 %
Genes
4 %
Benign Hereditary Chorea , Sequencing TITF1 Gene.

By Reference Laboratory Genetics in Spain.

NKX2-1
Specificity
100 %
Genes
4 %
Congenital Hypothyroidism , Sequencing TITF1 (NKX2-1) Gene.

By Reference Laboratory Genetics in Spain.

NKX2-1
Specificity
100 %
Genes
4 %
Benign Hereditary Chorea , Deletions-Duplications (MLPA) TITF1 Gene.

By Reference Laboratory Genetics in Spain.

NKX2-1
Specificity
100 %
Genes
4 %
Pulmonary Surfactant Metabolism Dysfunction and Related Disorders, Panel Massive Sequencing (NGS) 6 Genes.

By Reference Laboratory Genetics in Spain.

SFTPB, SFTPC, ABCA3, NKX2-1, CSF2RB, CSF2RA
Specificity
17 %
Genes
4 %
Charcot-Marie-Tooth Hereditary Neuropathy Panel.

By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center in United States.

GAN, MED25, AARS, LRSAM1, TFG, HINT1, DNAJB2, DHTKD1, GNB4, SBF1, PDK3, TRIM2, PLEKHG5, COX6A1, MARS, MORC2, MME, PRPS1, IGHMBP2, DYNC1H1 , (...)

View the complete list with 34 more genes
Specificity
2 %
Genes
4 %
Charcot-Marie-Tooth (CMT) and Related Hereditary Neuropathies Panel Sequencing.

By ARUP Laboratories, Molecular Genetics and Genomics in United States.

HOXD10, ARHGEF10, NGF, RETREG1, PRNP, CCT5, SLC5A7, GAN, MED25, AARS, LRSAM1, TFG, HINT1, DNAJB2, DHTKD1, GNB4, SBF1, PDK3, TRIM2, PLEKHG5 , (...)

View the complete list with 58 more genes
Specificity
3 %
Genes
8 %
Hereditary spastic paraplegia AR, X-linked (NGS panel for 33 genes).

By CGC Genetics in Portugal.

AMPD2, ARL6IP1, AP4M1, AP4E1, AP4B1, AP4S1, ERLIN2, VPS37A, DDHD1, TECPR2, DDHD2, CYP2U1, GBA2, B4GALNT1, C19orf12, NT5C2, ENTPD1, TFG, SPG21, SPART , (...)

View the complete list with 13 more genes
Specificity
4 %
Genes
4 %
Hereditary spastic paraplegia (NGS panel for 43 genes).

By CGC Genetics in Portugal.

AMPD2, ARL6IP1, ZFYVE27, AP4M1, AP4E1, AP4B1, AP4S1, ERLIN2, VPS37A, DDHD1, TECPR2, DDHD2, CYP2U1, GBA2, B4GALNT1, C19orf12, NT5C2, ENTPD1, TFG, SPG21 , (...)

View the complete list with 23 more genes
Specificity
3 %
Genes
4 %
Complex Hereditary Spastic Paraplegia Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

DARS, ARSI, USP8, WDR48, DSTYK, UNC80, AMPD2, ARL6IP1, IBA57, CCT5, AP4M1, AP4E1, AP4B1, AP4S1, RAB3GAP2, ERLIN2, VPS37A, DDHD1, TECPR2, DDHD2 , (...)

View the complete list with 50 more genes
Specificity
2 %
Genes
4 %
Charcot-Marie-Tooth disease Deletion / Duplication panel.

By Connective Tissue Gene Tests in United States.

ATP1A1, MED25, AARS, LRSAM1, TFG, DHTKD1, GNB4, SBF1, PDK3, TRIM2, PLEKHG5, COX6A1, PRPS1, DYNC1H1, BSCL2, GJB1, LMNA, DNM2, YARS, HSPB1 , (...)

View the complete list with 23 more genes
Specificity
3 %
Genes
4 %
Charcot-Marie-Tooth disease NGS panel.

By Connective Tissue Gene Tests in United States.

ATP1A1, MED25, AARS, LRSAM1, TFG, DHTKD1, GNB4, SBF1, PDK3, TRIM2, PLEKHG5, COX6A1, PRPS1, DYNC1H1, BSCL2, GJB1, LMNA, DNM2, YARS, HSPB1 , (...)

View the complete list with 23 more genes
Specificity
3 %
Genes
4 %
Neuropathy.

By MGZ Medical Genetics Center in Germany.

KLHL13, MICAL1, SH3BP4, LARS, CLP1, DCAF8, ATL3, SCN11A, IFRD1, FAM126A, ARHGEF10, NGF, RETREG1, SCN10A, CHCHD10, SLC52A3, SLC52A2, AAAS, ABCA1, COX10 , (...)

View the complete list with 102 more genes
Specificity
2 %
Genes
8 %
Spinal Muscular Atrophy, Proximal Motor Neuropathy.

By MGZ Medical Genetics Center in Germany.

CLP1, SLC52A3, SLC52A2, TFG, LAS1L, IGHMBP2, DYNC1H1, BICD2, VAPB, SETX, LMNA, TRPV4, HEXA, MFN2
Specificity
8 %
Genes
4 %
Hereditary Spastic Paraplegias (HSP) and differential diagnoses Panel.

By CeGaT GmbH in Germany.

PRPH, ADD3, VPS54, KLC4, FLRT1, ARSI, ATP2B4, ARHGEF28, KANK1, HNRNPA1, HNRNPA2B1, AIMP1, FAM126A, STUB1, GRID2, SLC1A4, AMPD2, CCDC88C, ARL6IP1, IBA57 , (...)

View the complete list with 123 more genes
Specificity
1 %
Genes
4 %
Hereditary spastic paraplegia (HSP), autosomal recessive and X-linked Panel.

By CeGaT GmbH in Germany.

KLC4, SLC1A4, AMPD2, ARL6IP1, IBA57, CCT5, AP4M1, AP4E1, AP4B1, AP4S1, ERLIN2, VPS37A, DDHD1, TECPR2, DDHD2, CYP2U1, GBA2, B4GALNT1, C19orf12, NT5C2 , (...)

View the complete list with 24 more genes
Specificity
3 %
Genes
4 %
Charcot-Marie-Tooth Disease.

By Asper Biogene Asper Biogene LLC in Estonia.

ARHGEF10, NGF, SLC5A7, GAN, MED25, AARS, LRSAM1, TFG, HINT1, DNAJB2, DHTKD1, GNB4, SBF1, TRIM2, PLEKHG5, COX6A1, MARS, MORC2, PRPS1, SCN9A , (...)

View the complete list with 47 more genes
Specificity
2 %
Genes
4 %
Invitae Amyotrophic Lateral Sclerosis Panel.

By Invitae in United States.

CHCHD10, TBK1, TFG, UBQLN2, PFN1, VAPB, TARDBP, DCTN1, FUS, ALS2, SPG11, SOD1, OPTN
Specificity
8 %
Genes
4 %
Invitae Combined Hereditary Dementia and Amyotrophic Lateral Sclerosis Panel.

By Invitae in United States.

CHCHD10, PRNP, TBK1, TFG, UBQLN2, PFN1, VAPB, TARDBP, DCTN1, FUS, ALS2, SNCA, MAPT, PSEN2, SPG11, SOD1, GRN, VCP, OPTN, PSEN1 , (...)

View the complete list with 1 more genes
Specificity
5 %
Genes
4 %
Charcot-Marie-Tooth Neuropathy Panel.

By Blueprint Genetics in Finland.

ATAD3A, MCM3AP, PRDM12, DCAF8, ATL3, SCN11A, ARHGEF10, NGF, RETREG1, CHCHD10, SLC25A46, DST, COX10, CCT5, CTDP1, GAN, MED25, AARS, LRSAM1, TFG , (...)

View the complete list with 78 more genes
Specificity
3 %
Genes
8 %
Hereditary Spastic Paraplegia Panel.

By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center in United States.

ZFYVE27, AP4M1, AP4E1, AP4B1, AP4S1, RAB3GAP2, ERLIN2, VPS37A, ADAR, DDHD1, TECPR2, DDHD2, CYP2U1, GBA2, TUBB4A, B4GALNT1, UCHL1, C19orf12, KIF1C, NT5C2 , (...)

View the complete list with 59 more genes
Specificity
2 %
Genes
4 %
Charcot-Marie-Tooth (CMT) and Related Hereditary Neuropathies, PMP22 Deletion/Duplication with Reflex to Sequencing Panel.

By ARUP Laboratories, Molecular Genetics and Genomics in United States.

HOXD10, ARHGEF10, NGF, RETREG1, PRNP, CCT5, SLC5A7, GAN, MED25, AARS, LRSAM1, TFG, HINT1, DNAJB2, DHTKD1, GNB4, SBF1, PDK3, TRIM2, PLEKHG5 , (...)

View the complete list with 58 more genes
Specificity
3 %
Genes
8 %
Hereditary peripheral neuropathies, including Charcot-Marie-Tooth disease (NGS panel for 74 genes).

By CGC Genetics in Portugal.

DCAF8, ATL3, SCN11A, HOXD10, ARHGEF10, NGF, RETREG1, DST, CTDP1, GAN, MED25, AARS, LRSAM1, TFG, HINT1, DHTKD1, GNB4, SBF1, PDK3, TRIM2 , (...)

View the complete list with 54 more genes
Specificity
3 %
Genes
8 %
Hereditary Spastic Paraplegia Comprehensive Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

DARS, ARSI, USP8, WDR48, ZFR, ATP2B4, DSTYK, UNC80, AMPD2, ARL6IP1, IBA57, CCT5, ZFYVE27, AP4M1, AP4E1, AP4B1, AP4S1, RAB3GAP2, ERLIN2, VPS37A , (...)

View the complete list with 60 more genes
Specificity
2 %
Genes
4 %
Comprehensive Neuropathy Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

NGF, RETREG1, CCT5, SLC5A7, GAN, MED25, AARS, LRSAM1, TFG, HINT1, DNAJB2, DHTKD1, GNB4, SBF1, PDK3, TRIM2, PLEKHG5, COX6A1, MARS, LAS1L , (...)

View the complete list with 51 more genes
Specificity
3 %
Genes
8 %
TFG-Related Disorders via TFG Gene Sequencing with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

TFG
Specificity
100 %
Genes
4 %
Charcot-Marie-Tooth disease Comprehensive panel.

By Connective Tissue Gene Tests in United States.

ATP1A1, MED25, AARS, LRSAM1, TFG, DHTKD1, GNB4, SBF1, PDK3, TRIM2, PLEKHG5, COX6A1, PRPS1, DYNC1H1, BSCL2, GJB1, LMNA, DNM2, YARS, HSPB1 , (...)

View the complete list with 23 more genes
Specificity
3 %
Genes
4 %
Hereditary motor and sensory neuropathy, Okinawa type.

By Centogene AG - the Rare Disease Company in Germany.

TFG
Specificity
100 %
Genes
4 %
SPG57.

By Centogene AG - the Rare Disease Company in Germany.

TFG
Specificity
100 %
Genes
4 %
Charcot-Marie-Tooth and Sensory Neuropathies Panel.

By CeGaT GmbH in Germany.

DCAF8, ATL3, SCN11A, HOXD10, ARHGEF10, NGF, RETREG1, SCN10A, DST, CCT5, CTDP1, GAN, MED25, AARS, LRSAM1, TFG, HINT1, DHTKD1, GNB4, SBF1 , (...)

View the complete list with 64 more genes
Specificity
3 %
Genes
8 %
Invitae Comprehensive Neuropathies Panel.

By Invitae in United States.

FBXO38, ATL3, SCN11A, NGF, RETREG1, CHCHD10, SLC52A3, SLC52A2, DST, SLC5A7, GAN, MED25, AARS, LRSAM1, TFG, HINT1, DNAJB2, GNB4, PDK3, TRIM2 , (...)

View the complete list with 50 more genes
Specificity
3 %
Genes
8 %
Invitae Charcot-Marie-Tooth Disease Comprehensive Panel.

By Invitae in United States.

MED25, AARS, LRSAM1, TFG, HINT1, DNAJB2, GNB4, PDK3, TRIM2, PLEKHG5, MORC2, PRPS1, IGHMBP2, DYNC1H1, BSCL2, INF2, SPG11, GJB1, LMNA, DNM2 , (...)

View the complete list with 22 more genes
Specificity
3 %
Genes
4 %
Invitae Charcot-Marie-Tooth Disease Autosomal Dominant Panel.

By Invitae in United States.

AARS, LRSAM1, TFG, GNB4, MORC2, DYNC1H1, BSCL2, INF2, LMNA, DNM2, YARS, HSPB1, EGR2, RAB7A, LITAF, HSPB8, NEFL, PMP22, MPZ, TRPV4 , (...)

View the complete list with 4 more genes
Specificity
5 %
Genes
4 %
TFG.

By Fulgent Genetics Fulgent Genetics in United States.

TFG
Specificity
100 %
Genes
4 %
MitoMet®Plus aCGH Analysis.

By Baylor Miraca Genetics Laboratories in United States.

GSN, NEFH, SOD1, TEAD1, PHB, PLA2G2A, AKAP10, PNKD, PAX2, CPOX, ABCB7, TAZ, TIMM8A, GK, PDHA1, HCCS, NYX, FRMD7, OTC, RP2 , (...)

View the complete list with 617 more genes
Specificity
1 %
Genes
15 %
MetaboSeq Fatty Acid Oxidation Disorders Panel by next-generation sequencing (NGS).

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center in United States.

HADH, SLC25A20, SLC22A5, ETFDH, ETFA, ETFB, CPT1A, TAZ, GLUD1, HADHB, HMGCL, HADHA, HSD17B10, CPT2, PPARG, ACADVL, ACADS, ACADM, ACAD9
Specificity
6 %
Genes
4 %
Partial Lipodystrophy Deletion/Duplication Panel.

By Genetic Services Laboratory University of Chicago in United States.

PLIN1, CIDEC, TBC1D4, LIPE, PIK3R1, ADRA2A, AKT2, POLD1, PSMB8, ZMPSTE24, CAV1, LMNB2, LMNA, PPARG
Specificity
8 %
Genes
4 %
Partial Lipodystrophy Panel.

By Genetic Services Laboratory University of Chicago in United States.

PLIN1, CIDEC, TBC1D4, LIPE, PIK3R1, ADRA2A, AKT2, POLD1, PSMB8, ZMPSTE24, CAV1, LMNB2, LMNA, PPARG
Specificity
8 %
Genes
4 %
Lipodystrophies (NGS panel for 17 genes).

By CGC Genetics in Portugal.

PCYT1A, AGPAT2, PLIN1, CIDEC, TBC1D4, LIPE, PIK3R1, AKT2, PSMB8, ZMPSTE24, CAV1, LMNB2, BSCL2, LMNA, CAVIN1, FBN1, PPARG
Specificity
6 %
Genes
4 %
Lipodystrophies and progeroid syndromes (NGS panel for 25 genes).

By CGC Genetics in Portugal.

BANF1, SPRTN, PCYT1A, WRN, AGPAT2, KCNJ6, PLIN1, CIDEC, TBC1D4, LIPE, PIK3R1, ERCC8, AKT2, POLD1, ERCC6, PSMB8, ZMPSTE24, CAV1, LMNB2, BSCL2 , (...)

View the complete list with 5 more genes
Specificity
4 %
Genes
4 %
Lysosomal and peroxisomal diseases (NGS panel of 109 genes).

By CGC Genetics in Portugal.

SC5D, SIAE, IGF2R, EHHADH, FAR1, ABCD3, PMVK, ATP6AP1, MFF, ECM1, ACP2, VMA21, DNASE1, PEX11B, LAMTOR2, ATP6V0A4, IDH1, VIPAS39, TRIM37, GNPAT , (...)

View the complete list with 88 more genes
Specificity
1 %
Genes
4 %
Lipodystrophies (NGS panel for 17 genes).

By CGC Genetics in Portugal.

PCYT1A, AGPAT2, PLIN1, CIDEC, TBC1D4, LIPE, PIK3R1, AKT2, PSMB8, ZMPSTE24, CAV1, LMNB2, BSCL2, LMNA, CAVIN1, FBN1, PPARG
Specificity
6 %
Genes
4 %
Familial partial lipodystrophy (sequence analysis of PPARG gene).

By CGC Genetics in Portugal.

PPARG
Specificity
100 %
Genes
4 %
Lipodystrophies and progeroid syndromes (NGS panel for 25 genes).

By CGC Genetics in Portugal.

BANF1, SPRTN, PCYT1A, WRN, AGPAT2, KCNJ6, PLIN1, CIDEC, TBC1D4, LIPE, PIK3R1, ERCC8, AKT2, POLD1, ERCC6, PSMB8, ZMPSTE24, CAV1, LMNB2, BSCL2 , (...)

View the complete list with 5 more genes
Specificity
4 %
Genes
4 %
Diabetes Mellitus, Noninsulin-Dependent, with Acanthosis Nigricans and Hypertension.

By Laboratory for Molecular Diagnostics Center for Nephrology and Metabolic Disorders in Germany.

PPARG
Specificity
100 %
Genes
4 %
Familial partial lipodystrophy type 3.

By Laboratory for Molecular Diagnostics Center for Nephrology and Metabolic Disorders in Germany.

PPARG
Specificity
100 %
Genes
4 %
Familial Partial Lipodystrophy Type 3.

By Exeter Molecular Genetics Laboratory in United Kingdom.

PPARG
Specificity
100 %
Genes
4 %
Disorders of Fatty Acid Oxidation Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

FLAD1, DECR1, ECHS1, HADH, SLC25A20, SLC22A5, ETFDH, ETFA, ETFB, MLYCD, CPT1A, LPIN1, TAZ, HMGCS2, HADHB, ACADSB, HMGCL, HADHA, HSD17B10, CPT2 , (...)

View the complete list with 7 more genes
Specificity
4 %
Genes
4 %
Lipodystrophy - panel diagnostics.

By Institute of Human Genetics Cologne University in Germany.

PLIN1, CIDEC, AKT2, LMNA, PPARG
Specificity
20 %
Genes
4 %
Cardiovascular Diseases_General Panel.

By Health in Code in Spain.

CH25H, BMP10, TRIB1, TOPBP1, ISL1, GREM2, HAND2, SLC25A40, NNT, PPARA, MYOM1, LPA, SLC22A8, IRX3, KCNK17, PPP1R13L, PERP, FHOD3, FOXD4, SMAD1 , (...)

View the complete list with 360 more genes
Specificity
2 %
Genes
18 %
Insulin resistance, severe, digenic.

By Praxis fuer Humangenetik Wien in Austria.

PPARG
Specificity
100 %
Genes
4 %
Obesity, severe, susceptibility to,.

By Praxis fuer Humangenetik Wien in Austria.

PPARG
Specificity
100 %
Genes
4 %
Insulin resistance, severe, digenic.

By MedGene in Slovakia.

PPARG
Specificity
100 %
Genes
4 %
Lipodystrophy, familial partial, 3.

By MedGene in Slovakia.

PPARG
Specificity
100 %
Genes
4 %
Obesity, severe, susceptibility to,.

By MedGene in Slovakia.

PPARG
Specificity
100 %
Genes
4 %
Lipodystrophy, familial partial.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

PLIN1, CIDEC, LIPE, LMNA, PPARG
Specificity
20 %
Genes
4 %
Endocrine Disorders: Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

GDF9, KISS1, TAC3, FSHR, BMP15, NOBOX, FIGLA, PSMC3IP, NSMF, CYP19A1, AGPAT2, CIDEC, TBC1D4, INSR, EIF2AK3, GATA6, PTF1A, GLIS3, BLK, KLF11 , (...)

View the complete list with 37 more genes
Specificity
2 %
Genes
4 %
Lipodystrophy NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

AGPAT2, CIDEC, TBC1D4, AKT2, ZMPSTE24, CAV1, BSCL2, LMNA, CAVIN1, PPARG
Specificity
10 %
Genes
4 %
PPARG.

By Fulgent Genetics Fulgent Genetics in United States.

PPARG
Specificity
100 %
Genes
4 %
Monogenic Obesity Panel.

By Blueprint Genetics in Finland.

KSR2, ADCY3, MC3R, NR0B2, NTRK2, DYRK1B, SIM1, GNAS, SDCCAG8, WDPCP, MAGEL2, VPS13B, CUL4B, PHF6, MC4R, POMC, PCSK1, LEPR, LEP, ALMS1 , (...)

View the complete list with 16 more genes
Specificity
3 %
Genes
4 %
Comprehensive Metabolism Panel.

By Blueprint Genetics in Finland.

PRKAG3, NIPA2, GLUL, SLC6A9, SLC25A26, ADK, GMPPA, TANGO2, COQ5, COQ7, MOCOS, FLAD1, CTH, DPYS, UPB1, ALAD, ABCD3, STT3A, STT3B, NGLY1 , (...)

View the complete list with 414 more genes
Specificity
1 %
Genes
8 %
Fatty Acid Oxidation Syndrome Panel.

By Blueprint Genetics in Finland.

ECHS1, HADH, SLC25A20, SLC22A5, ETFDH, ETFA, ETFB, CPT1A, LPIN1, ALDH5A1, TAZ, HMGCS2, GLUD1, HADHB, ACADSB, ACAD8, HMGCL, HADHA, HSD17B10, CPT2 , (...)

View the complete list with 6 more genes
Specificity
4 %
Genes
4 %
Monogenic Diabetes NGS and Deletion/Duplication Panel.

By DDC Clinic Molecular Diagnostics Laboratory DDC Clinic, Center for Special Needs Children in United States.

G6PC2, INSR, EIF2AK3, NEUROG3, GLIS3, BLK, KLF11, PAX4, SLC2A2, HADH, FOXP3, HNF4A, PDX1, INS, KCNJ11, CEL, ABCC8, GLUD1, UCP2, GCK , (...)

View the complete list with 6 more genes
Specificity
4 %
Genes
4 %
PPARG Gene Sequencing and Deletion/Duplication Analysis.

By DDC Clinic Molecular Diagnostics Laboratory DDC Clinic, Center for Special Needs Children in United States.

PPARG
Specificity
100 %
Genes
4 %
LIPODYSTROPHY, FAMILIAL PARTIAL.

By Laboratorio de Genetica Clinica SL in Spain.

LMNA, PPARG
Specificity
50 %
Genes
4 %
Fatty Acid Oxidation Related Disorders , Panel Massive Sequencing (NGS) 19 Genes.

By Reference Laboratory Genetics in Spain.

HADH, SLC25A20, SLC22A5, ETFDH, ETFA, ETFB, CPT1A, TAZ, GLUD1, HADHB, HMGCL, HADHA, HSD17B10, CPT2, PPARG, ACADVL, ACADS, ACADM, ACAD9
Specificity
6 %
Genes
4 %
Severe Obesity (Susceptibility to) , Panel Massive Sequencing (NGS) 18 Genes.

By Reference Laboratory Genetics in Spain.

SDC3, GHRL, AGRP, ADRB3, ADRB2, MC3R, CARTPT, ENPP1, NR0B2, SIM1, MC4R, POMC, LEPR, LEP, PPARGC1B, UCP3, UCP1, PPARG
Specificity
6 %
Genes
4 %
PPARG Sequencing.

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center in United States.

PPARG
Specificity
100 %
Genes
4 %
MetaboSeq Fatty Acid Oxidation Disorders deletion/duplication panel.

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center in United States.

HADH, SLC25A20, SLC22A5, ETFDH, ETFA, ETFB, CPT1A, TAZ, HADHB, HMGCL, HADHA, HSD17B10, CPT2, PPARG, ACADVL, ACADS, ACADM, ACAD9
Specificity
6 %
Genes
4 %
PPARG Deletion/duplication analysis.

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center in United States.

PPARG
Specificity
100 %
Genes
4 %
Comprehensive Lipodystrophy Deletion/Duplication Panel.

By Genetic Services Laboratory University of Chicago in United States.

AGPAT2, KCNJ6, PLIN1, CIDEC, TBC1D4, LIPE, PIK3R1, ADRA2A, AKT2, POLD1, PSMB8, ZMPSTE24, CAV1, LMNB2, BSCL2, LMNA, CAVIN1, FBN1, PPARG
Specificity
6 %
Genes
4 %
Comprehensive Lipodystrophy Panel.

By Genetic Services Laboratory University of Chicago in United States.

AGPAT2, KCNJ6, PLIN1, CIDEC, TBC1D4, LIPE, PIK3R1, ADRA2A, AKT2, POLD1, PSMB8, ZMPSTE24, CAV1, LMNB2, BSCL2, LMNA, CAVIN1, FBN1, PPARG
Specificity
6 %
Genes
4 %
Obesity, PPARG-Related.

By Unity of Clinical Genetics and Functional Genomics University of Zaragoza. Faculty of Medicine. in Spain.

PPARG
Specificity
100 %
Genes
4 %
Obesity (sequence analysis of PPARG gene).

By CGC Genetics in Portugal.

PPARG
Specificity
100 %
Genes
4 %
Lysosomal and peroxisomal diseases (NGS panel of 109 genes).

By CGC Genetics in Portugal.

SC5D, SIAE, IGF2R, EHHADH, FAR1, ABCD3, PMVK, ATP6AP1, MFF, ECM1, ACP2, VMA21, DNASE1, PEX11B, LAMTOR2, ATP6V0A4, IDH1, VIPAS39, TRIM37, GNPAT , (...)

View the complete list with 88 more genes
Specificity
1 %
Genes
4 %
Familial partial lipodystrophy (sequence analysis of PPARG gene).

By CGC Genetics in Portugal.

PPARG
Specificity
100 %
Genes
4 %
Carotid intimal medial thickness 1.

By Laboratory for Molecular Diagnostics Center for Nephrology and Metabolic Disorders in Germany.

PPARG
Specificity
100 %
Genes
4 %
Lipodystrophy.

By Institute of Human Genetics Cologne University in Germany.

LMNA, PPARG
Specificity
50 %
Genes
4 %
Carotid intimal medial thickness type 1.

By Centogene AG - the Rare Disease Company in Germany.

PPARG
Specificity
100 %
Genes
4 %
Obesity, severe.

By Centogene AG - the Rare Disease Company in Germany.

PPARG
Specificity
100 %
Genes
4 %
Lipodystrophy, familial partial, type 3.

By Centogene AG - the Rare Disease Company in Germany.

PPARG
Specificity
100 %
Genes
4 %
Familial Partial Lipodystrophy type 3.

By DNAbiolab Cretan Center for Research and Development of Applications on Genetics and Molecular Biology in Greece.

PPARG
Specificity
100 %
Genes
4 %
Fatty Acid Oxidation Disorder.

By Asper Biogene Asper Biogene LLC in Estonia.

HADH, SLC25A20, SLC22A5, ETFDH, ETFA, ETFB, CPT1A, TAZ, HMGCS2, GLUD1, HADHB, HMGCL, HADHA, HSD17B10, CPT2, PPARG, ACADVL, ACADS, ACADM, ACAD9
Specificity
5 %
Genes
4 %
Mixed hyperlipidemias.

By Health in Code in Spain.

INSIG2, AGPAT2, PLIN1, CIDEC, INSR, AKT2, ZMPSTE24, CAV1, BSCL2, LMNA, LEP, CAVIN1, PPARG
Specificity
8 %
Genes
4 %
Dyslipidemias / Early atherosclerosis.

By Health in Code in Spain.

CH25H, TRIB1, SLC25A40, PPARA, LPA, SLC22A8, CYP3A5, LRP6, INSIG2, CYP3A4, SAR1B, MYLIP, SLCO1B1, PLTP, LIPC, APOC3, AGPAT2, PLIN1, CIDEC, TBC1D4 , (...)

View the complete list with 64 more genes
Specificity
2 %
Genes
4 %
Carotid intimal medial thickness 1.

By Praxis fuer Humangenetik Wien in Austria.

PPARG
Specificity
100 %
Genes
4 %
Lipodystrophy, familial partial, 3.

By Praxis fuer Humangenetik Wien in Austria.

PPARG
Specificity
100 %
Genes
4 %
Carotid intimal medial thickness 1.

By MedGene in Slovakia.

PPARG
Specificity
100 %
Genes
4 %
Endocrine Disorders: Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

GDF9, KISS1, TAC3, FSHR, BMP15, NOBOX, FIGLA, PSMC3IP, NSMF, CYP19A1, AGPAT2, CIDEC, TBC1D4, INSR, EIF2AK3, GATA6, PTF1A, GLIS3, BLK, KLF11 , (...)

View the complete list with 37 more genes
Specificity
2 %
Genes
4 %
Comprehensive Monogenic Diabetes Panel.

By Blueprint Genetics in Finland.

ZFP57, INSR, EIF2AK3, GATA6, PTF1A, NEUROG3, GLIS3, BLK, KLF11, PAX4, RFX6, SLC2A2, HADH, FOXP3, HNF4A, PDX1, INS, KCNJ11, ABCC8, GLUD1 , (...)

View the complete list with 8 more genes
Specificity
4 %
Genes
4 %
Congenital and Familial Lipodystrophy Panel.

By Blueprint Genetics in Finland.

AGPAT2, PLIN1, TBC1D4, LIPE, AKT2, ZMPSTE24, CAV1, BSCL2, LMNA, CAVIN1, PPARG
Specificity
10 %
Genes
4 %
Genitourinary Tumors Gene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

PBRM1, CDKN1A, KMT2C, RXRA, ERBB2, PIK3R1, AKT1, AKT3, FBXW7, STAG2, EGFR, AKT2, PIK3CA, BAP1, ERBB3, TERT, KDM6A, MTOR, MED12, ERCC2 , (...)

View the complete list with 24 more genes
Specificity
10 %
Genes
15 %
Lipodystrophy Related Disorders , Panel Massive Sequencing (NGS) 10 Genes.

By Reference Laboratory Genetics in Spain.

AGPAT2, PLIN1, CIDEC, ZMPSTE24, CAV1, LMNB2, BSCL2, LMNA, CAVIN1, PPARG
Specificity
10 %
Genes
4 %
BRAF Sequence Analysis.

By Baylor Miraca Genetics Laboratories in United States.

BRAF
Specificity
100 %
Genes
4 %
BRAF Sequence Analysis (Prenatal Diagnosis).

By Baylor Miraca Genetics Laboratories in United States.

BRAF
Specificity
100 %
Genes
4 %
PreSeek Non-invasive Prenatal Gene Sequencing Screen.

By Baylor Miraca Genetics Laboratories in United States.

NSD1, NIPBL, TSC1, SMC1A, SMC3, SYNGAP1, CBL, RAD21, TSC2, MAP2K2, RIT1, HDAC8, SOS2, FGFR2, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS , (...)

View the complete list with 10 more genes
Specificity
14 %
Genes
15 %
Syndromic Autism Panel.

By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center in United States.

NLGN3, NLGN4X, CTNNB1, UBE3C, ARID1B, TMEM231, TBR1, HOXA1, CHD8, AP1S2, CACNA1C, EHMT1, FOXP1, FOXP2, KIRREL3, LAMC3, MED12, MID1, NTNG1, ADNP , (...)

View the complete list with 63 more genes
Specificity
2 %
Genes
4 %
Non-immune Hydrops Panel.

By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center in United States.

PTH1R, SEC23B, CDAN1, CCBE1, CANT1, CHRNG, NEU1, UROS, PKLR, FOXP3, SOX18, RASA1, MVK, RPS24, RPS17, RPL5, RPL11, CLCNKA, RPS10, RPS26 , (...)

View the complete list with 67 more genes
Specificity
5 %
Genes
15 %
Comprehensive Cardiac Panel.

By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center in United States.

DTNA, MYL3, MYL2, DSC2, CSRP3, ACTN2, RBM20, MYOZ2, JPH2, GATAD1, TNNT2, TPM1, RANGRF, MYPN, JUP, DSG2, NEXN, PLN, PRKAG2, MYH6 , (...)

View the complete list with 87 more genes
Specificity
4 %
Genes
15 %
Leopard Syndrome.

By Center for Human Genetics, Inc in United States.

BRAF
Specificity
100 %
Genes
4 %
Cardiomyopathy Panel.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

TMPO, TXNRD2, OBSCN, CTF1, VCL, DTNA, MYL3, MYL2, DSC2, CSRP3, ACTN2, RBM20, MYOZ2, JPH2, GATAD1, TNNT2, TPM1, MYPN, JUP, DSG2 , (...)

View the complete list with 92 more genes
Specificity
4 %
Genes
15 %
Autsim Panel.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

NR1I3, AVPR1A, BDNF, SLC6A4, AUTS2, DOCK4, GABRG1, GNA14, IMMP2L, KATNAL2, KCTD13, KLHL3, NEGR1, PDE10A, PIP5K1B, PON3, SATB2, SMG6, SOX5, ST7 , (...)

View the complete list with 87 more genes
Specificity
1 %
Genes
4 %
BRAF-Cardiofaciocutaneous syndrome.

By Genetics Laboratory University of Oklahoma Health Sciences Center in United States.

BRAF
Specificity
100 %
Genes
4 %
Noonan Spectrum Panel.

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center in United States.

SPRED1, NF1, CBL, MAP2K2, RIT1, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS, HRAS, BRAF, RAF1
Specificity
29 %
Genes
15 %
Noonan Syndrome Sequencing Panel.

By Genetic Services Laboratory University of Chicago in United States.

NF1, CBL, MAP2K2, RIT1, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS, HRAS, BRAF, RAF1
Specificity
31 %
Genes
15 %
Noonan Spectrum Disorders Panel, Sequencing, 15 Genes.

By ARUP Laboratories, Molecular Genetics and Genomics in United States.

SPRED1, RAB40AL, KAT6B, CBL, MAP2K2, RIT1, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS, HRAS, BRAF, RAF1
Specificity
27 %
Genes
15 %
Noonan Spectrum Disorders Panel.

By GeneDx in United States.

CBL, MAP2K2, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS, HRAS, BRAF, RAF1
Specificity
37 %
Genes
15 %
Comprehensive Cardiomyopathy Panel.

By GeneDx in United States.

MT-TL2, MT-TM, MT-TD, MT-TQ, MT-TH, MT-TI, MT-TG, TMPO, MT-ND5, VCL, DTNA, MYL3, MYL2, DSC2, CSRP3, ACTN2, RBM20, MYOZ2, JPH2, GATAD1 , (...)

View the complete list with 56 more genes
Specificity
6 %
Genes
15 %
BRAF-Related LEOPARD Syndrome.

By Molecular Diagnostics Lab Nemours Alfred I. duPont Hospital for Children in United States.

BRAF
Specificity
100 %
Genes
4 %
Autism/Intellectual Disability/Multiple Anomalies.

By Human Genetics Laboratory, Munroe-Meyer Institute University of Nebraska Medical Center in United States.

ERCC8, RPGRIP1L, AVPR1A, BDNF, SLC6A4, ERCC6, SPRED1, RPS6KA3, NLGN3, NLGN4X, HOXA1, AP1S2, CACNA1C, EHMT1, FOXP1, FOXP2, MED12, MID1, SHANK2, SHANK3 , (...)

View the complete list with 69 more genes
Specificity
5 %
Genes
15 %
Lynch Syndrome Paired Testing.

By Ambry Genetics in United States.

NRAS, KRAS, BRAF, MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
38 %
Genes
11 %
TumorNext-Lynch+CancerNext.

By Ambry Genetics in United States.

HOXB13, DICER1, POLE, GREM1, POLD1, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2 , (...)

View the complete list with 17 more genes
Specificity
9 %
Genes
11 %
Lymphedema NGS Multi-Gene Panel (36 Genes).

By Laboratory of genome diagnostics Academic Medical Center, University of Amsterdam in Netherlands.

CDK19, ITGA9, PEPD, TUBGCP6, GJA1, FLT4, PTPN14, KIF11, VEGFC, ABCC9, NAGA, SPRED1, CCBE1, SOX18, FAT4, FOXC2, HGF, RELN, GATA2, MET , (...)

View the complete list with 16 more genes
Specificity
12 %
Genes
15 %
BRAF Exon 15 Sequencing.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

BRAF
Specificity
100 %
Genes
4 %
BRAF-Related Cardiofaciocutaneous Syndrome.

By CGC Genetics in Portugal.

BRAF
Specificity
100 %
Genes
4 %
Noonan syndrome and rasopathies (NGS panel for 13 genes).

By CGC Genetics in Portugal.

SPRED1, NF1, CBL, MAP2K2, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS, HRAS, BRAF, RAF1
Specificity
31 %
Genes
15 %
Non-NF1 RASopathy Next Generation Sequencing and Deletion/Duplication.

By Medical Genomics Laboratory Department of Genetics UAB in United States.

RASA2, SPRED1, CBL, MAP2K2, RIT1, SOS2, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS, HRAS, BRAF, RAF1
Specificity
27 %
Genes
15 %
RASopathy Next Generation Sequencing and Deletion/Duplication.

By Medical Genomics Laboratory Department of Genetics UAB in United States.

SPRED1, NF1, CBL, MAP2K2, RIT1, SOS2, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS, HRAS, BRAF, RAF1
Specificity
27 %
Genes
15 %
Comprehensive Cardiology Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

ZBTB17, SREBF2, TRIM63, ZHX3, KLF10, TBX3, CALR3, MIB1, CAVIN4, CREB3L3, APOA4, GJA5, NPPA, GPIHBP1, APOC2, LMF1, LPL, APOA5, LDLRAP1, CETP , (...)

View the complete list with 144 more genes
Specificity
3 %
Genes
15 %
Fetal Concerns Sequencing Panel Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

GLE1, CHRNG, KAT6B, PEX12, PEX10, PEX26, PEX6, KCNQ1, SCN5A, KCNH2, CHRND, CHRNA1, MUSK, KLHL40, RAPSN, SUMF1, SLC17A5, PEX1, DOK7, CBL , (...)

View the complete list with 20 more genes
Specificity
10 %
Genes
15 %
Autism Spectrum Disorders Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

MBD6, WDFY3, DGAT2L6, CDC42BPB, SYN2, STXBP5, KAT2B, TNRC6B, TCF20, KMT5B, MYO9B, CSMD1, NAA15, DSCAM, DISC1, EFR3A, CTTNBP2, CNTN6, CTNND2, ASH1L , (...)

View the complete list with 87 more genes
Specificity
2 %
Genes
8 %
Noonan spectrum disorder NGS panel.

By Connective Tissue Gene Tests in United States.

PPP1CB, A2ML1, RRAS, RASA2, NSUN2, CABIN1, SPRED1, LZTR1, ACTG1, ACTB, NF1, NF2, CBL, MAP2K2, RIT1, SOS2, SOS1, SHOC2, PTPN11, NRAS , (...)

View the complete list with 5 more genes
Specificity
16 %
Genes
15 %
Noonan syndrome core Deletion / Duplication panel.

By Connective Tissue Gene Tests in United States.

LZTR1, CBL, MAP2K2, RIT1, SOS2, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS, HRAS, BRAF, RAF1
Specificity
29 %
Genes
15 %
Noonan syndrome core Comprehensive panel.

By Connective Tissue Gene Tests in United States.

LZTR1, CBL, MAP2K2, RIT1, SOS2, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS, HRAS, BRAF, RAF1
Specificity
29 %
Genes
15 %
Lynch Syndrome.

By MGZ Medical Genetics Center in Germany.

KRAS, BRAF, MLH1, MSH6, PMS2, MSH2
Specificity
34 %
Genes
8 %
Heart Diseases - panels.

By MGZ Medical Genetics Center in Germany.

TLL1, NKX2-6, NR2F2, MED13L, TAB2, SMAD6, TBX20, GATA5, ADAMTSL4, ZFPM2, NOTCH2, CFC1, GATA6, CRELD1, CITED2, GATA4, GDF1, GJA1, TBX5, VCL , (...)

View the complete list with 137 more genes
Specificity
3 %
Genes
15 %
Mental Retardation and Dysmorphology - panels.

By MGZ Medical Genetics Center in Germany.

GATAD2B, CUL7, SPECC1L, IRF6, CCNQ, ROR2, CCND2, HEPACAM, TBC1D7, KPTN, WNT5A, SRCAP, UBR1, C2CD3, TCTN3, NOTCH2, PACS1, EPG5, ERCC8, AKT1 , (...)

View the complete list with 323 more genes
Specificity
2 %
Genes
15 %
Syndromal Diseases - panels.

By MGZ Medical Genetics Center in Germany.

PACS1, EPG5, ERCC8, AKT1, AKT3, PIK3R2, INSR, IDH1, ALX1, GNAQ, PIK3CA, CPLANE1, KIF7, GNAS, TRIM37, EFTUD2, EFNB1, EP300, TBX5, SALL4 , (...)

View the complete list with 322 more genes
Specificity
2 %
Genes
15 %
Congenital heart defects panel.

By Genome Diagnostics Laboratory University Medical Center Utrecht in Netherlands.

GJC1, TBX20, CFC1, ACVR2B, CRELD1, LEFTY2, GATA4, GDF1, ZIC3, GJA1, TBX5, MYH6, NKX2-5, ACTC1, MYH11, FOXH1, NODAL, MYBPC3, LDB3, MYH7 , (...)

View the complete list with 14 more genes
Specificity
12 %
Genes
15 %
Cardiofaciocutaneous syndrome.

By Centogene AG - the Rare Disease Company in Germany.

BRAF
Specificity
100 %
Genes
4 %
RASopathies Panel.

By CeGaT GmbH in Germany.

CCND2, AKT3, PIK3R2, PIK3CA, STAMBP, A2ML1, RRAS, RASA2, SPRED1, RASA1, NF1, CBL, MAP2K2, RIT1, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS , (...)

View the complete list with 3 more genes
Specificity
18 %
Genes
15 %
RASopathies Panel.

By CeGaT GmbH in Germany.

CCND2, AKT3, PIK3R2, PIK3CA, STAMBP, A2ML1, RRAS, RASA2, SPRED1, RASA1, NF1, CBL, MAP2K2, RIT1, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS , (...)

View the complete list with 3 more genes
Specificity
18 %
Genes
15 %
Basal ganglia calcification Panel.

By CeGaT GmbH in Germany.

XPR1, PDGFB, PDGFRB, TBCE, ERCC8, SLC20A2, TREM2, CTC1, ADAR, IFIH1, ERCC6, GATA3, GFAP, TREX1, RNASEH2B, RNASEH2C, RNASEH2A, SAMHD1, COL4A1, FOLR1 , (...)

View the complete list with 7 more genes
Specificity
4 %
Genes
4 %
BRAF-Related Noonan Syndrome.

By Innovagenomics Innovagenomics S.L in Spain.

BRAF
Specificity
100 %
Genes
4 %
Inherited Cardiovascular Diseases and Sudden Death Panel.

By Health in Code in Spain.

FHOD3, FOXD4, SMAD1, TRIM63, KLF10, LRP6, CALR3, MIB1, TBX20, CAVIN4, APOC3, ADAMTSL4, KCNE5, CTNNA3, SCN10A, OBSL1, ANK3, AGPAT2, GJA5, NPPA , (...)

View the complete list with 193 more genes
Specificity
2 %
Genes
15 %
Cardiomyopathies Panel.

By Health in Code in Spain.

FHOD3, FOXD4, TRIM63, KLF10, CALR3, MIB1, TBX20, CAVIN4, CTNNA3, OBSL1, AGPAT2, GJA5, GATA6, CRELD1, GATA4, TMPO, TXNRD2, FHL2, CTF1, GJA1 , (...)

View the complete list with 129 more genes
Specificity
3 %
Genes
15 %
Hypertrophic Cardiomyopathy Extended Panel.

By Health in Code in Spain.

FHOD3, TRIM63, KLF10, CALR3, CAVIN4, OBSL1, AGPAT2, FHL2, CTF1, VCL, MYL3, MYL2, ACTN2, MYOZ2, JPH2, TNNT2, TPM1, MYPN, NEXN, PLN , (...)

View the complete list with 70 more genes
Specificity
5 %
Genes
15 %
Arrhythmia General Panel.

By Health in Code in Spain.

GREM2, NNT, MYOM1, IRX3, KCNK17, PPP1R13L, PERP, FHOD3, FOXD4, NKX2-6, MRPL44, KCND2, COA6, TRIM63, KLF10, PKP4, TNNI3K, CALM3, CALR3, MIB1 , (...)

View the complete list with 198 more genes
Specificity
2 %
Genes
15 %
Congenital heart diseases Panel.

By Health in Code in Spain.

ISL1, HAND2, IRX4, MCTP2, NKX2-6, MED13L, TNNI3K, TAB2, SMAD6, TFAP2B, MIB1, TBX20, GATA5, ZFPM2, NOTCH2, GJA5, TDGF1, CFC1, PDGFRA, GATA6 , (...)

View the complete list with 56 more genes
Specificity
6 %
Genes
15 %
RASopathies Panel.

By Health in Code in Spain.

A2ML1, RRAS, RASA2, SPRED1, LZTR1, NF1, MAP2K2, RIT1, SOS2, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS, HRAS, BRAF, RAF1
Specificity
23 %
Genes
15 %
Noonan syndrome 7.

By Praxis fuer Humangenetik Wien in Austria.

BRAF
Specificity
100 %
Genes
4 %
CRANEO-FACIAL-CUTANEOUS SYNDROME.

By Hereditary Cancer Group - Genetic Diagnostic Unit Germans Trias I Pujol Research Institute in Spain.

MAP2K2, SOS1, MAP2K1, KRAS, BRAF
Specificity
40 %
Genes
8 %
qChip.

By Quantitative Genomic Medicine Laboratories, SL in Spain.

SEM1, IGF2, CBFB, TRAPPC10, FBXW11, TBX3, HDAC4, TRPS1, STS, HOXD13, LMNB1, MID2, IRF6, MNX1, SIM1, DISP1, MYCN, GATA4, ZIC3, VEGFA , (...)

View the complete list with 106 more genes
Specificity
2 %
Genes
8 %
Invitae Congenital Heart Defects and Heterotaxy Panel.

By Invitae in United States.

MEIS2, NKX2-6, NR2F2, MED13L, ANKS6, ZNF423, NOTCH2, CFAP53, ACVR2B, LEFTY2, GATA4, GDF1, NEK8, ZIC3, GJA1, TBX5, NKX2-5, ACTC1, DNAI1, DNAH5 , (...)

View the complete list with 62 more genes
Specificity
5 %
Genes
15 %
Invitae Congenital Heart Disease Panel.

By Invitae in United States.

HAND1, MEIS2, NKX2-6, NR2F2, MED13L, SMAD6, ZFPM2, GATA6, ACVR2B, CRELD1, LEFTY2, GATA4, GDF1, ZIC3, GJA1, TBX5, MYH6, NKX2-5, ACTC1, NOTCH1 , (...)

View the complete list with 22 more genes
Specificity
10 %
Genes
15 %
Invitae Noonan Syndrome Panel.

By Invitae in United States.

A2ML1, RRAS, CBL, MAP2K2, RIT1, SOS2, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS, BRAF, RAF1
Specificity
22 %
Genes
11 %
Cardio-Facio-Cutaneous syndrome: BRAF gene sequence analysis.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

BRAF
Specificity
100 %
Genes
4 %
Noonan syndrome 7: BRAF gene sequence analysis.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

BRAF
Specificity
100 %
Genes
4 %
ONCOLOGY, PANEL.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

POLH, XPC, HOXB13, XPA, ERCC5, AIP, ELANE, PDGFRA, GREM1, ERCC4, CDKN1B, XRCC2, FANCD2, FANCI, FANCL, SLX4, FANCE, FANCF, FANCG, FANCA , (...)

View the complete list with 60 more genes
Specificity
3 %
Genes
8 %
Noonan Syndrome and Related Disorders: Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

SPRED1, CBL, MAP2K2, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS, HRAS, BRAF, RAF1
Specificity
34 %
Genes
15 %
Melanoma: Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

WRN, GNAQ, PIK3CA, BAP1, KIT, CDKN2A, CDK4, NRAS, MAP2K1, KRAS, BRAF, RB1, PTEN
Specificity
24 %
Genes
11 %
Autism Spectrum Disorders: Tier 2 Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

NR1I3, SMARCB1, MAGEL2, UBE2A, AFF2, NLGN3, NLGN4X, AP1S2, CACNA1C, EHMT1, FOXP1, FOXP2, MED12, MID1, PTCHD1, VPS13B, ZEB2, RAB39B, CASK, OPHN1 , (...)

View the complete list with 39 more genes
Specificity
2 %
Genes
4 %
Cardiomyopathy: Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

VCL, DTNA, MYL3, MYL2, DSC2, CSRP3, ACTN2, RBM20, MYOZ2, JPH2, GATAD1, TNNT2, TPM1, MYPN, JUP, DSG2, NEXN, PLN, PRKAG2, MYH6 , (...)

View the complete list with 45 more genes
Specificity
7 %
Genes
15 %
Comprehensive Cardiovascular: Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

TMPO, FHL2, VCL, DTNA, MYL3, MYL2, DSC2, CSRP3, ACTN2, RBM20, MYOZ2, JPH2, GATAD1, TNNT2, TPM1, RANGRF, MYPN, JUP, DSG2, NEXN , (...)

View the complete list with 86 more genes
Specificity
4 %
Genes
15 %
Noonan Syndrome NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

CBL, MAP2K2, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS, HRAS, BRAF, RAF1
Specificity
37 %
Genes
15 %
Epilepsy NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

EFHC2, CELSR1, GPHN, SLC6A5, GLRA1, GLRB, SCN10A, BUB1B, MAPK10, COL18A1, ACY1, MED17, SNAP29, LIG4, NHEJ1, SLC46A1, ARL13B, RPGRIP1L, PGK1, SCN4B , (...)

View the complete list with 323 more genes
Specificity
2 %
Genes
15 %
Thyroid Cancer NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

SDHD, NRAS, KRAS, HRAS, BRAF, SDHB, RET, TP53, PTEN, MUTYH
Specificity
50 %
Genes
18 %
BRAF Full Gene Sequencing.

By Fulgent Genetics Fulgent Genetics in United States.

BRAF
Specificity
100 %
Genes
4 %
Cardio-Facio-Cutaneous Syndrome NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

MAP2K2, SOS1, MAP2K1, KRAS, BRAF
Specificity
40 %
Genes
8 %
BRAF.

By Fulgent Genetics Fulgent Genetics in United States.

BRAF
Specificity
100 %
Genes
4 %
Comprehensive Epilepsy NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

RANGAP1, EFHC2, CELSR1, NIPA2, UBR5, VDAC1, BRD2, RBFOX3, KPNA7, CNTN2, ARHGEF15, PIK3AP1, FASN, RYR3, GABBR2, HCN2, TNK2, SRGAP2, GPHN, SLC12A5 , (...)

View the complete list with 427 more genes
Specificity
1 %
Genes
15 %
Hereditary Leukemia Panel.

By Blueprint Genetics in Finland.

DDX41, SAMD9L, ETV6, IKZF1, SRP72, FANCA, TERT, TERC, DKC1, NF1, CEBPA, SBDS, PAX5, GATA2, CDKN2A, NBN, ATM, CBL, MAP2K2, RIT1 , (...)

View the complete list with 19 more genes
Specificity
13 %
Genes
18 %
Comprehensive Hematology Panel.

By Blueprint Genetics in Finland.

ARPC1B, MRTFA, GINS1, DCLRE1B, ERCC6L2, MTHFD1, AP3D1, SMARCD2, WDR1, LMAN1, MCFD2, RPS29, MECOM, TMPRSS6, F13B, SERPINC1, DHFR, F13A1, TF, F12 , (...)

View the complete list with 219 more genes
Specificity
3 %
Genes
18 %
Bone Marrow Failure Syndrome Panel.

By Blueprint Genetics in Finland.

ERCC6L2, SMARCD2, RPS29, DDX41, SAMD9L, SAMD9, DNAJC21, PGM3, ACD, JAGN1, WIPF1, CXCR4, RAC2, LAMTOR2, GFI1, RBM8A, VPS45, G6PC3, RPL15, ITK , (...)

View the complete list with 102 more genes
Specificity
5 %
Genes
18 %
Comprehensive Cardiology Panel.

By Blueprint Genetics in Finland.

PLEKHM2, PPA2, LRRC10, FBXO32, MYBPHL, CDH2, HAND1, FOXD4, TECRL, RMND1, GTPBP3, MYL4, TNNI3K, TAB2, CALM3, CALR3, ALPK3, TBX20, GATA5, RBCK1 , (...)

View the complete list with 165 more genes
Specificity
3 %
Genes
15 %
Comprehensive Growth Disorders / Skeletal Dysplasias and Disorders Panel.

By Blueprint Genetics in Finland.

IRS1, CKAP2L, LONP1, NANS, EXTL3, DLL4, TBX4, KIF22, ADAMTS17, ACAN, PAPSS2, NOG, ENAM, TBX6, DVL1, LTBP3, XYLT1, IHH, IGFALS, BHLHA9 , (...)

View the complete list with 288 more genes
Specificity
2 %
Genes
15 %
Noonan Syndrome Panel.

By Insight Medical Genetics in United States.

CBL, MAP2K2, RIT1, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS, HRAS, BRAF, RAF1
Specificity
34 %
Genes
15 %
BRAF Mutation by RT-PCR.

By Cancer Genetics, Inc. Cancer Genetics, Inc. in United States.

BRAF
Specificity
100 %
Genes
4 %
BRAF Mutation Analysis (cobas®).

By Cancer Genetics, Inc. Cancer Genetics, Inc. in United States.

BRAF
Specificity
100 %
Genes
4 %
Focus::Myeloid™ NGS Panel.

By Cancer Genetics, Inc. Cancer Genetics, Inc. in United States.

CBLC, BCORL1, CBLB, CSF3R, CUX1, ETV6, FBXW7, IDH1, IKZF1, MYD88, PDGFRA, SF3B1, SRSF2, STAG2, TET2, U2AF1, ZRSR2, ABL1, JAK2, NPM1 , (...)

View the complete list with 34 more genes
Specificity
10 %
Genes
18 %
Focus::MDS™ NGS Panel.

By Cancer Genetics, Inc. Cancer Genetics, Inc. in United States.

ETV6, IDH1, SF3B1, SRSF2, STAG2, TET2, U2AF1, ZRSR2, JAK2, FLT3, ASXL1, KMT2A, KDM6A, EZH2, DNMT3A, SETBP1, CEBPA, CBL, PTPN11, NRAS , (...)

View the complete list with 7 more genes
Specificity
15 %
Genes
15 %
Focus::CLL™ NGS Panel.

By Cancer Genetics, Inc. Cancer Genetics, Inc. in United States.

XPO1, TRAF2, PIM1, HIST1H1B, HIST1H1E, IKZF3, IRF4, BIRC3, PLCG2, CARD11, POT1, MYD88, SF3B1, NOTCH1, ZMYM3, MED12, BTK, CDKN2A, ATM, NRAS , (...)

View the complete list with 5 more genes
Specificity
12 %
Genes
11 %
Noonan syndrome type 7.

By Bioarray in Spain.

BRAF
Specificity
100 %
Genes
4 %
Hypertrophic Cardiomyopathy Gene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

MYL3, MYL2, CSRP3, ACTN2, MYOZ2, TNNT2, TPM1, NEXN, PLN, PRKAG2, MYH6, TNNI3, TNNC1, MYLK2, ACTC1, LAMP2, MYBPC3, MYH7, MAP2K2, RIT1 , (...)

View the complete list with 11 more genes
Specificity
13 %
Genes
15 %
Noonan Syndrome Panel.

By DDC Clinic Molecular Diagnostics Laboratory DDC Clinic, Center for Special Needs Children in United States.

CBL, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS, BRAF, RAF1
Specificity
34 %
Genes
11 %
Circulo Lung.

By Circulogene Theranostics in United States.

BRAF
Specificity
100 %
Genes
4 %
Circulo Melanoma.

By Circulogene Theranostics in United States.

BRAF
Specificity
100 %
Genes
4 %
Circulo Ovarian.

By Circulogene Theranostics in United States.

BRAF
Specificity
100 %
Genes
4 %
Circulo GIST.

By Circulogene Theranostics in United States.

BRAF
Specificity
100 %
Genes
4 %
Circulo Breast.

By Circulogene Theranostics in United States.

BRAF
Specificity
100 %
Genes
4 %
Circulo Thyroid.

By Circulogene Theranostics in United States.

BRAF
Specificity
100 %
Genes
4 %
Circulo Gastric.

By Circulogene Theranostics in United States.

BRAF
Specificity
100 %
Genes
4 %
LEOPARD SYNDROME.

By Laboratorio de Genetica Clinica SL in Spain.

PTPN11, BRAF, RAF1
Specificity
34 %
Genes
4 %
Cardiofaciocutaneous Syndrome Type 1, Sequencing BRAF Gene.

By Reference Laboratory Genetics in Spain.

BRAF
Specificity
100 %
Genes
4 %
Noonan Syndrome Type 7 , Sequencing BRAF Gene.

By Reference Laboratory Genetics in Spain.

BRAF
Specificity
100 %
Genes
4 %
Noonan Syndrome and Related Disorders , Panel Massive Sequencing (NGS) 13 Genes.

By Reference Laboratory Genetics in Spain.

SPRED1, CBL, MAP2K2, RIT1, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, HRAS, BRAF, RAF1
Specificity
25 %
Genes
11 %
Autism Spectrum Disorders (Expanded Panel) , Panel Massive Sequencing (NGS) 77 Genes.

By Reference Laboratory Genetics in Spain.

BDNF, SLC6A4, AUTS2, KLHL3, PDE10A, SATB2, SOX5, DPP6, SLC9A9, SNRPN, RPL10, NLGN3, NLGN4X, HOXA1, CHD8, AP1S2, CACNA1C, EHMT1, FOXP1, FOXP2 , (...)

View the complete list with 57 more genes
Specificity
2 %
Genes
4 %
Glioma (Susceptibility to Somatic) , Panel Massive Sequencing (NGS) 12 Genes.

By Reference Laboratory Genetics in Spain.

ERBB2, IDH1, EGFR, PIK3CA, LGI1, BRAF, PRKN, IDH2, RB1, TP53, PTEN, BRCA2
Specificity
9 %
Genes
4 %
Cardio-facio-cutaneous syndrome.

By Labor Dr. Wisplinghoff in Germany.

MAP2K2, KRAS, BRAF
Specificity
67 %
Genes
8 %
Phosphorus Pan Cardiomyopathy Including Rasopathies Panel.

By Phosphorus Diagnostics LLC in United States.

VCL, MYL3, MYL2, DSC2, CSRP3, ACTN2, RBM20, TNNT2, TPM1, JUP, DSG2, PLN, PRKAG2, TNNI3, TNNC1, TGFB3, ACTC1, RYR2, PKP2, ABCC9 , (...)

View the complete list with 49 more genes
Specificity
6 %
Genes
15 %
Phosphorus Pan Arrhythmia and Cardiomyopathy Including Rasopathies Panel.

By Phosphorus Diagnostics LLC in United States.

CALM3, SCN10A, VCL, MYL3, MYL2, DSC2, CSRP3, ACTN2, RBM20, TNNT2, TPM1, JUP, DSG2, PLN, PRKAG2, TNNI3, TNNC1, TGFB3, ACTC1, SCN4B , (...)

View the complete list with 67 more genes
Specificity
5 %
Genes
15 %
Phosphorus Hypertrophic Cardiomyopathy Including Rasopathies Panel.

By Phosphorus Diagnostics LLC in United States.

VCL, MYL3, MYL2, CSRP3, ACTN2, TNNT2, TPM1, PLN, PRKAG2, TNNI3, TNNC1, ACTC1, A2ML1, RRAS, SPRED1, LAMP2, RASA1, CACNA1C, TCAP, MYBPC3 , (...)

View the complete list with 25 more genes
Specificity
9 %
Genes
15 %
Melanoma: Gene Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

WRN, BAP1, KIT, CDKN2A, CDK4, NRAS, BRAF, RB1, TP53, PTEN, BRCA2
Specificity
19 %
Genes
8 %
BRAF Sequence Analysis (Familial Mutation/Variant Analysis).

By Baylor Miraca Genetics Laboratories in United States.

BRAF
Specificity
100 %
Genes
4 %
NGS RASopathy Panel.

By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center in United States.

A2ML1, RRAS, RASA2, NSUN2, CABIN1, SPRED1, KAT6B, LZTR1, NF1, NF2, CBL, MAP2K2, RIT1, SOS2, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS , (...)

View the complete list with 3 more genes
Specificity
18 %
Genes
15 %
Cardiofaciocutaneous Syndrome.

By Center for Human Genetics, Inc in United States.

MAP2K2, MAP2K1, KRAS, BRAF
Specificity
50 %
Genes
8 %
Cardio-facio-cutaneous syndrome.

By Center for Human Genetics, Inc in United States.

MAP2K2, MAP2K1, KRAS, BRAF
Specificity
50 %
Genes
8 %
Costello Syndrome.

By Center for Human Genetics, Inc in United States.

KRAS, HRAS, BRAF
Specificity
100 %
Genes
11 %
Noonan Syndrome 11-Gene Sequencing Panel.

By Center for Human Genetics, Inc in United States.

LZTR1, CBL, RIT1, SOS2, SOS1, SHOC2, PTPN11, NRAS, KRAS, BRAF, RAF1
Specificity
28 %
Genes
11 %
Rasopathy NextGen Panel.

By Children's Hospital Colorado Molecular Genetics Laboratory Children's Hospital Colorado in United States.

PPP1CB, A2ML1, RRAS, RASA2, SPRED1, LZTR1, ACTG1, ACTB, CBL, MAP2K2, RIT1, SOS2, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS, HRAS, BRAF , (...)

View the complete list with 1 more genes
Specificity
20 %
Genes
15 %
BRAF hotspot muatation analysis.

By Clinical Molecular Diagnostic Laboratory City of Hope National Medical Center in United States.

BRAF
Specificity
100 %
Genes
4 %
Noonan Syndrome Panel.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

SPRED1, CBL, MAP2K2, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS, HRAS, BRAF, RAF1
Specificity
34 %
Genes
15 %
MyeloidDx by NGS.

By Molecular Genetics Diagnostic Laboratory Detroit Medical Center University Laboratories in United States.

BCORL1, CBLB, CSF3R, CUX1, ETV6, FBXW7, IDH1, IKZF1, MYD88, PDGFRA, SF3B1, SRSF2, STAG2, TET2, U2AF1, ZRSR2, ABL1, JAK2, NPM1, FLT3 , (...)

View the complete list with 33 more genes
Specificity
10 %
Genes
18 %
MyeloidDx by NGS.

By Molecular Genetics Diagnostic Laboratory Detroit Medical Center University Laboratories in United States.

TET2-AS1, CBLC, BCORL1, CBLB, CSF3R, CUX1, ETV6, FBXW7, IDH1, IKZF1, MYD88, PDGFRA, SF3B1, SRSF2, STAG2, U2AF1, ZRSR2, ABL1, JAK2, NPM1 , (...)

View the complete list with 33 more genes
Specificity
10 %
Genes
18 %
Prenatal Noonan Spectrum Panel.

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center in United States.

MAP2K2, RIT1, SOS1, PTPN11, NRAS, MAP2K1, KRAS, HRAS, BRAF, RAF1
Specificity
40 %
Genes
15 %
Noonan Syndrome Deletion/Duplication Panel.

By Genetic Services Laboratory University of Chicago in United States.

NF1, CBL, MAP2K2, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS, HRAS, BRAF, RAF1
Specificity
34 %
Genes
15 %
Expanded RASopathy Panel (14 Genes).

By Laboratory for Molecular Medicine Laboratory for Molecular Medicine (Partners HealthCare Personalized Medicine) in United States.

SPRED1, NF1, CBL, MAP2K2, RIT1, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS, HRAS, BRAF, RAF1
Specificity
29 %
Genes
15 %
BRAF-Related Cardiofaciocutaneous Syndrome.

By Molecular Diagnostics Lab Nemours Alfred I. duPont Hospital for Children in United States.

BRAF
Specificity
100 %
Genes
4 %
Noonan syndrome/RASopathy Disorders Panel.

By Human Genetics Laboratory, Munroe-Meyer Institute University of Nebraska Medical Center in United States.

CBL, MAP2K2, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS, HRAS, BRAF, RAF1
Specificity
37 %
Genes
15 %
TumorNext-Lynch+ColoNext.

By Ambry Genetics in United States.

POLE, GREM1, POLD1, SMAD4, BMPR1A, CHEK2, STK11, CDH1, NRAS, KRAS, BRAF, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC
Specificity
15 %
Genes
11 %
TumorNext-Lynch.

By Ambry Genetics in United States.

NRAS, KRAS, BRAF, MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
38 %
Genes
11 %
Noonan Spectrum Panel - PTPN11, RAF1, SOS1, KRAS, BRAF, HRAS, NRAS, CBL, SHOC2, MAP2K1, MAP2K2, and SPRED1 Next Generation Sequence Analysis.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

SPRED1, CBL, MAP2K2, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS, HRAS, BRAF, RAF1
Specificity
34 %
Genes
15 %
Noonan Syndrome Seq Analysis.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

SPRED1, CBL, MAP2K2, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS, HRAS, BRAF, RAF1
Specificity
34 %
Genes
15 %
Cardiofaciocutaneous syndrome (sequence analysis of BRAF gene).

By CGC Genetics in Portugal.

BRAF
Specificity
100 %
Genes
4 %
Detection of V600E mutations on BRAF gene.

By CGC Genetics in Portugal.

BRAF
Specificity
100 %
Genes
4 %
Noonan Spectrum Disorders/Rasopathies Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

MAP3K8, SPRY1, A2ML1, RRAS, RASA2, KAT6B, LZTR1, NF1, CBL, MAP2K2, RIT1, SOS2, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS, HRAS, BRAF , (...)

View the complete list with 1 more genes
Specificity
20 %
Genes
15 %
Pan Cardiomyopathy Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

CALR3, MIB1, CAVIN4, TMPO, FHL2, DPP6, VCL, DTNA, MYL3, MYL2, DSC2, CSRP3, ACTN2, RBM20, MYOZ2, JPH2, GATAD1, TNNT2, TPM1, MYPN , (...)

View the complete list with 62 more genes
Specificity
5 %
Genes
15 %
BRAF-Related Disorders via BRAF Gene Sequencing with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

BRAF
Specificity
100 %
Genes
4 %
Noonan spectrum disorder Comprehensive panel.

By Connective Tissue Gene Tests in United States.

PPP1CB, A2ML1, RRAS, RASA2, NSUN2, CABIN1, SPRED1, LZTR1, ACTG1, ACTB, NF1, NF2, CBL, MAP2K2, RIT1, SOS2, SOS1, SHOC2, PTPN11, NRAS , (...)

View the complete list with 5 more genes
Specificity
16 %
Genes
15 %
Noonan spectrum disorder Deletion / Duplication panel.

By Connective Tissue Gene Tests in United States.

PPP1CB, A2ML1, RRAS, RASA2, NSUN2, CABIN1, SPRED1, LZTR1, ACTG1, ACTB, NF1, NF2, CBL, MAP2K2, RIT1, SOS2, SOS1, SHOC2, PTPN11, NRAS , (...)

View the complete list with 5 more genes
Specificity
16 %
Genes
15 %
Noonan syndrome core NGS panel.

By Connective Tissue Gene Tests in United States.

LZTR1, CBL, MAP2K2, RIT1, SOS2, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS, HRAS, BRAF, RAF1
Specificity
29 %
Genes
15 %
Hypertrophic cardiomyopathy - different panels.

By Institute of Human Genetics Cologne University in Germany.

AGPAT2, MYL3, MYL2, CSRP3, TNNT2, TPM1, PLN, PRKAG2, TNNI3, ACTC1, LAMP2, LZTR1, ACTA1, MYBPC3, FHL1, BSCL2, MYH7, DES, TTN, NF1 , (...)

View the complete list with 45 more genes
Specificity
7 %
Genes
15 %
Noonan syndrome - different panels.

By Institute of Human Genetics Cologne University in Germany.

A2ML1, RRAS, RASA2, LZTR1, RIT1, SOS2, SOS1, PTPN11, NRAS, MAP2K1, KRAS, BRAF, RAF1
Specificity
24 %
Genes
11 %
Colorectal adenocarcinoma, somatic mutation sequencing panel.

By Molecular Diagnostics Laboratory University Health Network in Canada.

PIK3CA, NRAS, KRAS, BRAF
Specificity
75 %
Genes
11 %
Custom solid tumor gene sequencing panel.

By Molecular Diagnostics Laboratory University Health Network in Canada.

RAC1, RICTOR, EIF1AX, HOXD8, ERBB4, CDKN2B, ERBB2, DDB2, CCND1, XPC, KDR, ERCC5, PDGFRB, CDK6, AKT1, GNA11, PDGFRA, SF3B1, EGFR, GNAQ , (...)

View the complete list with 25 more genes
Specificity
14 %
Genes
22 %
Melanoma, somatic mutation sequencing panel.

By Molecular Diagnostics Laboratory University Health Network in Canada.

GNA11, GNAQ, KIT, NRAS, BRAF
Specificity
40 %
Genes
8 %
RASopathies.

By MGZ Medical Genetics Center in Germany.

RRAS, RASA2, SPRED1, NF1, CBL, MAP2K2, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS, HRAS, BRAF, RAF1
Specificity
27 %
Genes
15 %
Cardiofaciocutaneous Syndrome Panel.

By FirmaLab in United States.

MAP2K2, KRAS, BRAF
Specificity
67 %
Genes
8 %
Myeloid Tumor Panel.

By Centogene AG - the Rare Disease Company in Germany.

CBLC, BCORL1, CBLB, CSF3R, CUX1, ETV6, FBXW7, IDH1, IKZF1, MYD88, PDGFRA, SF3B1, SRSF2, STAG2, TET2, U2AF1, ZRSR2, ABL1, JAK2, NPM1 , (...)

View the complete list with 34 more genes
Specificity
10 %
Genes
18 %
BRAF, selective sequencing of exon 15.

By Centogene AG - the Rare Disease Company in Germany.

BRAF
Specificity
100 %
Genes
4 %
LEOPARD syndrome 3.

By Centogene AG - the Rare Disease Company in Germany.

BRAF
Specificity
100 %
Genes
4 %
Adenocarcinoma of lung, somatic.

By Centogene AG - the Rare Disease Company in Germany.

BRAF
Specificity
100 %
Genes
4 %
Noonan syndrome type 7.

By Centogene AG - the Rare Disease Company in Germany.

BRAF
Specificity
100 %
Genes
4 %
Lung cancer.

By Centogene AG - the Rare Disease Company in Germany.

BRAF
Specificity
100 %
Genes
4 %
LEOPARD syndrome.

By bio.logis Center for Human Genetics Diagnosticum in Germany.

PTPN11, BRAF, RAF1
Specificity
34 %
Genes
4 %
Noonan syndrome.

By bio.logis Center for Human Genetics Diagnosticum in Germany.

SOS1, PTPN11, KRAS, BRAF, RAF1
Specificity
40 %
Genes
8 %
RASopathies Panel.

By CeGaT GmbH in Germany.

CCND2, AKT3, PIK3R2, PIK3CA, STAMBP, A2ML1, RRAS, RASA2, SPRED1, RASA1, NF1, CBL, MAP2K2, RIT1, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS , (...)

View the complete list with 3 more genes
Specificity
18 %
Genes
15 %
Noonan Syndrome.

By Laboratory of Human Genetics GENOMED Health Care Center in Poland.

SOS1, PTPN11, NRAS, MAP2K1, KRAS, BRAF, RAF1
Specificity
43 %
Genes
11 %
BRAF-Related Cardiofaciocutaneous Syndrome.

By Innovagenomics Innovagenomics S.L in Spain.

BRAF
Specificity
100 %
Genes
4 %
Adenocarcinoma of lung, somatic (BRAF).

By MVZ Dortmund Dr. Eberhard & Partner in Germany.

BRAF
Specificity
100 %
Genes
4 %
Noonan Syndrome.

By Asper Biogene Asper Biogene LLC in Estonia.

SPRED1, KAT6B, CBL, MAP2K2, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS, HRAS, BRAF, RAF1
Specificity
31 %
Genes
15 %
Autism Spectrum Disorders.

By Asper Biogene Asper Biogene LLC in Estonia.

EN2, PDE8B, AVPR1A, SLC6A4, SLC9A9, MAGEL2, RPL10, NLGN4X, HOXA1, CACNA1C, EHMT1, FOXP1, FOXP2, MED12, MID1, NTNG1, ADNP, PTCHD1, SHANK3, VPS13B , (...)

View the complete list with 32 more genes
Specificity
2 %
Genes
4 %
Rasopathies SANGER Panel.

By Health in Code in Spain.

MAP2K2, MAP2K1, KRAS, BRAF
Specificity
50 %
Genes
8 %
Dilated Cardiomyopathy Panel.

By Health in Code in Spain.

FHOD3, FOXD4, TBX20, CAVIN4, GATA6, GATA4, TMPO, TXNRD2, FHL2, CTF1, VCL, MYL3, MYL2, DSC2, CSRP3, ACTN2, RBM20, GATAD1, TNNT2, TPM1 , (...)

View the complete list with 61 more genes
Specificity
2 %
Genes
4 %
Ventricular Arrythmia & Sudden Death Panel with Structural Heart Disease.

By Health in Code in Spain.

FHOD3, TRIM63, KLF10, CALR3, CAVIN4, KCNE5, CTNNA3, SCN10A, OBSL1, ANK3, AGPAT2, GJA5, NPPA, GATA6, GATA4, FHL2, CTF1, GJA1, TBX5, VCL , (...)

View the complete list with 121 more genes
Specificity
3 %
Genes
15 %
Rasopathies NGS Panel.

By Health in Code in Spain.

SPRED1, CBL, MAP2K2, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS, HRAS, BRAF, RAF1
Specificity
34 %
Genes
15 %
Congenital Heart Diseases Panel.

By Health in Code in Spain.

TBX20, GJA5, GATA6, CRELD1, GATA4, GJA1, TBX5, DTNA, NEXN, MYH6, TNNI3, ANKRD1, NKX2-5, ACTC1, KCNJ8, MYH11, ACTA2, SMAD3, NOTCH1, TBX1 , (...)

View the complete list with 19 more genes
Specificity
11 %
Genes
15 %
Hypertrophic cardiomyopathy extended panel.

By Health in Code in Spain.

MYOM1, FHOD3, MRPL44, COA6, TRIM63, KLF10, CALR3, CAVIN4, COA5, OBSL1, AGPAT2, OBSCN, FHL2, VCL, MYL3, MYL2, CSRP3, ACTN2, MYOZ2, JPH2 , (...)

View the complete list with 84 more genes
Specificity
4 %
Genes
15 %
Cardiomyopathies General Panel.

By Health in Code in Spain.

NNT, MYOM1, PPP1R13L, PERP, FHOD3, FOXD4, MRPL44, COA6, TRIM63, KLF10, PKP4, TNNI3K, CALR3, MIB1, TBX20, CAVIN4, CHRM2, GATA5, CTNNA3, COA5 , (...)

View the complete list with 153 more genes
Specificity
3 %
Genes
15 %
Cardiofaciocutaneous syndrome.

By Praxis fuer Humangenetik Wien in Austria.

BRAF
Specificity
100 %
Genes
4 %
LEOPARD syndrome 3.

By Praxis fuer Humangenetik Wien in Austria.

BRAF
Specificity
100 %
Genes
4 %
RASOPATHY-RELATED SYNDROME.

By Hereditary Cancer Group - Genetic Diagnostic Unit Germans Trias I Pujol Research Institute in Spain.

A2ML1, RRAS, RASA2, SPRED1, LZTR1, NF1, CBL, MAP2K2, RIT1, SOS2, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS, HRAS, BRAF, RAF1
Specificity
22 %
Genes
15 %
NOONAN SYNDROME.

By Hereditary Cancer Group - Genetic Diagnostic Unit Germans Trias I Pujol Research Institute in Spain.

A2ML1, RRAS, RASA2, LZTR1, NF1, CBL, RIT1, SOS2, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS, BRAF, RAF1
Specificity
19 %
Genes
11 %
Cardiofaciocutaneous syndrome.

By MedGene in Slovakia.

BRAF
Specificity
100 %
Genes
4 %
LEOPARD syndrome 3.

By MedGene in Slovakia.

BRAF
Specificity
100 %
Genes
4 %
Noonan syndrome 7.

By MedGene in Slovakia.

BRAF
Specificity
100 %
Genes
4 %
Invitae Cardio-Facio-Cutaneous Syndrome Panel.

By Invitae in United States.

MAP2K2, SOS1, SHOC2, MAP2K1, KRAS, BRAF
Specificity
34 %
Genes
8 %
Invitae Noonan Syndrome with Multiple Lentigines Panel.

By Invitae in United States.

PTPN11, BRAF, RAF1
Specificity
34 %
Genes
4 %
Invitae RASopathies Comprehensive Panel.

By Invitae in United States.

A2ML1, RRAS, SPRED1, RASA1, NF1, CBL, MAP2K2, RIT1, SOS2, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS, HRAS, BRAF, RAF1
Specificity
23 %
Genes
15 %
NOONAN, LEOPARD, COSTELLO and CARDIOFACIOCUTANEOUS SYNDROME.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

PRKCB, PIK3CG, LRP1, CRKL, PIK3CB, MAPK1, GAB2, CRK, SPRY2, IL2, PRKCH, RAC1, ERBB2, SRC, IL2RA, SRCAP, PIK3R1, PIK3CD, AKT1, PIK3R2 , (...)

View the complete list with 24 more genes
Specificity
10 %
Genes
15 %
BRAF-Related Disorders: BRAF Gene Sequencing.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

BRAF
Specificity
100 %
Genes
4 %
BRAF Gene Deletion/Duplication.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

BRAF
Specificity
100 %
Genes
4 %
Autism Spectrum Disorders: Tier 2 Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

NR1I3, SMARCB1, MAGEL2, UBE2A, AFF2, NLGN3, NLGN4X, CHD8, AP1S2, CACNA1C, EHMT1, FOXP1, FOXP2, MED12, MID1, PTCHD1, VPS13B, ZEB2, RAB39B, CASK , (...)

View the complete list with 42 more genes
Specificity
2 %
Genes
4 %
Comprehensive Cardiovascular: Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

CTNNA3, GJA5, NPPA, TMPO, FHL2, VCL, DTNA, MYL3, MYL2, DSC2, CSRP3, ACTN2, RBM20, MYOZ2, JPH2, GATAD1, TNNT2, TPM1, RANGRF, MYPN , (...)

View the complete list with 97 more genes
Specificity
4 %
Genes
15 %
Cardiomyopathy: Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

VCL, DTNA, MYL3, MYL2, DSC2, CSRP3, ACTN2, RBM20, MYOZ2, JPH2, GATAD1, TNNT2, TPM1, MYPN, JUP, DSG2, NEXN, PLN, PRKAG2, MYH6 , (...)

View the complete list with 42 more genes
Specificity
7 %
Genes
15 %
Noonan Syndrome and Related Conditions Profile.

By Integrated Genetics Westborough Integrated Genetics in United States.

MAP2K2, SOS1, SHOC2, PTPN11, MAP2K1, KRAS, HRAS, BRAF, RAF1
Specificity
34 %
Genes
11 %
Autism NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

AVPR1A, BDNF, SLC6A4, AUTS2, DOCK4, GABRG1, GNA14, IMMP2L, KATNAL2, KCTD13, KLHL3, NEGR1, PDE10A, PIP5K1B, PON3, SATB2, SMG6, SOX5, ST7, STK3 , (...)

View the complete list with 80 more genes
Specificity
1 %
Genes
4 %
Hypertrophic Cardiomyopathy NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

TMPO, CTF1, VCL, DTNA, MYL3, MYL2, DSC2, CSRP3, ACTN2, RBM20, MYOZ2, JPH2, GATAD1, TNNT2, TPM1, MYPN, JUP, DSG2, NEXN, PLN , (...)

View the complete list with 43 more genes
Specificity
7 %
Genes
15 %
Cardiomyopathy Panel.

By Blueprint Genetics in Finland.

PLEKHM2, PPA2, LRRC10, FBXO32, MYBPHL, CDH2, HAND1, FOXD4, RMND1, GTPBP3, MYL4, TNNI3K, TAB2, CALR3, ALPK3, TBX20, RBCK1, CTNNA3, EPG5, XK , (...)

View the complete list with 135 more genes
Specificity
3 %
Genes
15 %
Comprehensive Short Stature Syndrome Panel.

By Blueprint Genetics in Finland.

IRS1, IGFALS, IGF1R, TBX3, IGF1, POC1A, LARP7, CCDC8, OBSL1, XRCC4, RNU4ATAC, ORC4, ORC6, CDT1, CDC6, ORC1, CDC45, CEP63, CUL7, RTTN , (...)

View the complete list with 55 more genes
Specificity
6 %
Genes
15 %
Noonan Syndrome Panel.

By Blueprint Genetics in Finland.

PPP1CB, RRAS, RASA2, NSUN2, SPRED1, LZTR1, ACTG1, ACTB, NF1, CBL, MAP2K2, RIT1, SOS2, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS, HRAS , (...)

View the complete list with 2 more genes
Specificity
19 %
Genes
15 %
Hypertrophic Cardiomyopathy (HCM) Panel.

By Blueprint Genetics in Finland.

ALPK3, EPG5, APOA1, MYL3, MYL2, CSRP3, ACTN2, JPH2, TNNT2, TPM1, PRKAG2, TNNI3, ACTC1, ABCC9, LAMP2, ACTA1, MYBPC3, FHL1, BAG3, FLNC , (...)

View the complete list with 18 more genes
Specificity
6 %
Genes
8 %
Genetic Study of Hypertrophic Cardiomyopathy Panel (2 panels: 57 genes or 18 genes).

By HeartGenetics, Genetics and Biotechnology, SA in Portugal.

MYL3, MYL2, CSRP3, TNNT2, TPM1, TNNI3, TNNC1, ACTC1, LAMP2, TCAP, MYBPC3, FHL1, LDB3, FLNC, MYH7, BRAF, CRYAB
Specificity
6 %
Genes
4 %
Anti-EGFR antibody therapy response in metastatic colorectal Carcinoma.

By HeartGenetics, Genetics and Biotechnology, SA in Portugal.

NRAS, KRAS, BRAF
Specificity
100 %
Genes
11 %
BRAF Mutation Analysis.

By Cancer Genetics, Inc. Cancer Genetics, Inc. in United States.

BRAF
Specificity
100 %
Genes
4 %
Focus::Myeloid™ NGS Panel.

By Cancer Genetics, Inc. Cancer Genetics, Inc. in United States.

CBLC, CBLB, CSF3R, ETV6, FBXW7, IDH1, IKZF1, MYD88, PDGFRA, SF3B1, SRSF2, STAG2, TET2, U2AF1, ABL1, JAK2, NPM1, FLT3, GNAS, CALR , (...)

View the complete list with 30 more genes
Specificity
10 %
Genes
18 %
Focus::AML™ NGS Panel.

By Cancer Genetics, Inc. Cancer Genetics, Inc. in United States.

BCORL1, CSF3R, ETV6, IDH1, SF3B1, SRSF2, STAG2, TET2, U2AF1, ZRSR2, ABL1, JAK2, NPM1, FLT3, CALR, ASXL1, KIT, KMT2A, KDM6A, EZH2 , (...)

View the complete list with 17 more genes
Specificity
11 %
Genes
15 %
Focus::DLBCL&FL™ NGS Panel.

By Cancer Genetics, Inc. Cancer Genetics, Inc. in United States.

FOXO1, SGK1, STAT6, SYK, SOCS1, PIM1, PRDM1, IKZF3, IRF4, BCL10, GNAI2, GNA13, MYC, BCL6, CDKN2B, BCL2, CD79B, CD79A, B2M, PLCG2 , (...)

View the complete list with 24 more genes
Specificity
5 %
Genes
8 %
Focus::Lymphoma™ NGS Panel.

By Cancer Genetics, Inc. Cancer Genetics, Inc. in United States.

FOXO1, SGK1, STAT6, SYK, SOCS1, PIM1, PRDM1, IKZF3, CCND3, IRF4, BCL10, IRF8, KMT2C, GNAI2, GNA13, MYC, BCL6, CDKN2B, BCL2, CCND1 , (...)

View the complete list with 29 more genes
Specificity
5 %
Genes
8 %
CardioGene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

TMPO, FHL2, CTF1, VCL, DTNA, MYL3, MYL2, DSC2, CSRP3, ACTN2, RBM20, MYOZ2, GATAD1, TNNT2, TPM1, JUP, DSG2, NEXN, PLN, PRKAG2 , (...)

View the complete list with 60 more genes
Specificity
5 %
Genes
15 %
Cardiomyopathy Gene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

TMPO, FHL2, CTF1, VCL, DTNA, MYL3, MYL2, DSC2, CSRP3, ACTN2, RBM20, MYOZ2, GATAD1, TNNT2, TPM1, JUP, DSG2, NEXN, PLN, PRKAG2 , (...)

View the complete list with 39 more genes
Specificity
7 %
Genes
15 %
Hematopoietic Disorders Gene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

TSLP, FGFR4, TET1, BIRC3, PDGFRB, NOTCH2, IL7R, CSF3R, ETV6, FBXW7, IDH1, PDGFRA, SF3B1, SRSF2, STAG2, TET2, U2AF1, ZRSR2, ABL1, JAK2 , (...)

View the complete list with 34 more genes
Specificity
8 %
Genes
15 %
CNS Tumor Gene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

H3F3A, KLF4, TRAF7, HIST1H3B, DAXX, FUBP1, MYB, MYBL1, CIC, MYC, SMO, MN1, ERBB2, NTRK2, PIK3R1, AKT1, IDH1, PDGFRA, EGFR, PIK3CA , (...)

View the complete list with 28 more genes
Specificity
7 %
Genes
11 %
Breast Tumors Gene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

RAD54B, ESR2, ESR1, RAC1, ERBB4, ERBB2, KDR, CDK6, PIK3R1, AKT1, FBXW7, IDH1, EGFR, PIK3CA, FANCA, KIT, ERBB3, GATA3, FGFR1, BRIP1 , (...)

View the complete list with 22 more genes
Specificity
10 %
Genes
15 %
Gynecologic Tumors Gene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

ERBB4, PPP2R1A, FAT1, SMO, ERBB2, CDK12, CCND1, KDR, PIK3R1, AKT1, AKT3, PIK3R2, POLE, FBXW7, ABL1, EGFR, AKT2, POLD1, PIK3CA, JAK3 , (...)

View the complete list with 30 more genes
Specificity
8 %
Genes
15 %
Cardiofaciocutaneous Syndrome Panel.

By DDC Clinic Molecular Diagnostics Laboratory DDC Clinic, Center for Special Needs Children in United States.

MAP2K2, MAP2K1, KRAS, BRAF
Specificity
50 %
Genes
8 %
Noonan Syndrome and related disorders (RASopathies) Panel.

By DDC Clinic Molecular Diagnostics Laboratory DDC Clinic, Center for Special Needs Children in United States.

CBL, MAP2K2, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS, HRAS, BRAF, RAF1
Specificity
37 %
Genes
15 %
BRAF Gene Sequencing and Deletion/Duplication Analysis.

By DDC Clinic Molecular Diagnostics Laboratory DDC Clinic, Center for Special Needs Children in United States.

BRAF
Specificity
100 %
Genes
4 %
Exome.

By DNA CONSULT GENETICA E BIOTECNOLOGIA LTDA. in Brazil.

IPW, SMNDC1, GEMIN2, HERC2, ATXN8, CYP2C9, IL1RN, CCDC88C, VKORC1, CYP2D6, CYP2C19, F8, F9, MAGEL2, SOX9, RPL10, PTCHD1, SEMA3E, SHANK2, KCND3 , (...)

View the complete list with 46 more genes
Specificity
7 %
Genes
15 %
Cardiomyopathy Exome Panel.

By Northwest Clinical Genomics Laboratory University of Washington in United States.

CAVIN4, CHRM2, TMPO, FHL2, VCL, DTNA, MYL3, MYL2, DSC2, CSRP3, ACTN2, RBM20, MYOZ2, JPH2, GATAD1, TNNT2, MYPN, JUP, DSG2, NEXN , (...)

View the complete list with 55 more genes
Specificity
6 %
Genes
15 %
Circulo Colorectal.

By Circulogene Theranostics in United States.

BRAF
Specificity
100 %
Genes
4 %
LUNG ADENOCARCINOMA.

By Laboratorio de Genetica Clinica SL in Spain.

BRAF
Specificity
100 %
Genes
4 %
CARDIOFACIOCUTANEOUS SYNDROME.

By Laboratorio de Genetica Clinica SL in Spain.

MAP2K2, MAP2K1, KRAS, BRAF
Specificity
50 %
Genes
8 %
NOONAN SYNDROME.

By Laboratorio de Genetica Clinica SL in Spain.

SOS1, PTPN11, NRAS, MAP2K1, KRAS, BRAF, RAF1
Specificity
43 %
Genes
11 %
Cardiofaciocutaneous Syndrome , Panel Massive Sequencing (NGS) 6 Genes.

By Reference Laboratory Genetics in Spain.

MAP2K2, SOS1, SHOC2, MAP2K1, KRAS, BRAF
Specificity
34 %
Genes
8 %
LEOPARD Syndrome, Panel Massive Sequencing (NGS) PTPN11, RAF1, BRAF Genes.

By Reference Laboratory Genetics in Spain.

PTPN11, BRAF, RAF1
Specificity
34 %
Genes
4 %
Phosphorus Pan Arrhythmia and Cardiomyopathy Including Rasopathies and Recessive Pediatric Syndromes Panel.

By Phosphorus Diagnostics LLC in United States.

CALM3, SCN10A, VCL, MYL3, MYL2, DSC2, CSRP3, ACTN2, RBM20, TNNT2, TPM1, JUP, DSG2, PLN, PRKAG2, TNNI3, TNNC1, TGFB3, ACTC1, SCN4B , (...)

View the complete list with 75 more genes
Specificity
5 %
Genes
15 %
Phosphorus Pan Cardiomyopathy Including Rasopathies and Recessive Pediatric Syndromes Panel.

By Phosphorus Diagnostics LLC in United States.

VCL, MYL3, MYL2, DSC2, CSRP3, ACTN2, RBM20, TNNT2, TPM1, JUP, DSG2, PLN, PRKAG2, TNNI3, TNNC1, TGFB3, ACTC1, RYR2, PKP2, ABCC9 , (...)

View the complete list with 57 more genes
Specificity
6 %
Genes
15 %
Phosphorus Hypertrophic Cardiomyopathy Including Rasopathies and Recessive Pediatric Syndromes Panel.

By Phosphorus Diagnostics LLC in United States.

VCL, ACTN2, TNNT2, TPM1, PLN, PRKAG2, TNNI3, TNNC1, ACTC1, A2ML1, RRAS, SPRED1, LAMP2, RASA1, CACNA1C, TCAP, FHL1, BAG3, LDB3, FLNC , (...)

View the complete list with 29 more genes
Specificity
9 %
Genes
15 %
CEN4GEN Colorectal cancer: Extended Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

MIER3, TCERG1, ATP6V0D2, ACVR1B, PTPN12, GALNT17, MAP2K4, MAP7, FZD3, MYO1B, CDC27, TCF7L2, BAX, DCC, ERBB2, MSH3, GPC6, PIK3R1, AKT1, FBXW7 , (...)

View the complete list with 18 more genes
Specificity
8 %
Genes
11 %
CEN4GEN Ovarian cancer: Extended gene sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

KREMEN1, USP16, MAS1L, CSMD3, FAT3, GABRA6, CCNE1, PPP2R1A, ERBB2, CDK12, PIK3R1, AKT1, CBLC, PDGFRA, EGFR, PIK3CA, KIT, ARID1A, CTNNB1, NF1 , (...)

View the complete list with 12 more genes
Specificity
10 %
Genes
11 %
CEN4GEN Comprehensive Solid tumors (somatic genetic testing): Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

ESR1, SMO, ERBB2, AKT1, IDH1, PDGFRA, EGFR, PIK3CA, KIT, MTOR, CTNNB1, MET, CDKN2A, STK11, PTCH1, ATM, MAP2K2, FGFR2, NRAS, KRAS , (...)

View the complete list with 12 more genes
Specificity
16 %
Genes
18 %
KRAS Sequence Analysis.

By Baylor Miraca Genetics Laboratories in United States.

KRAS
Specificity
100 %
Genes
4 %
Juvenile Myelomonocytic Leukemia.

By UCSF Molecular Diagnostics Laboratory University of California, San Francisco in United States.

SH2B3, JAK3, ASXL1, SETBP1, NF1, CBL, PTPN11, NRAS, KRAS
Specificity
23 %
Genes
8 %
KRAS related Noonan syndrome.

By Genetics Laboratory University of Oklahoma Health Sciences Center in United States.

KRAS
Specificity
100 %
Genes
4 %
Autoimmune Lymphoproliferative Syndrome Panel by next-generation sequencing (NGS).

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center in United States.

FADD, ITK, CASP10, FASLG, FAS, MAGT1, NRAS, KRAS, CASP8
Specificity
23 %
Genes
8 %
Autoimmune Lymphoproliferative Syndrome Deletion/Duplication Panel.

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center in United States.

FADD, ITK, CASP10, FASLG, FAS, MAGT1, NRAS, KRAS, CASP8
Specificity
23 %
Genes
8 %
TumorNext-Lynch+OvaNext.

By Ambry Genetics in United States.

DICER1, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, NRAS, KRAS, TP53, PTEN, MUTYH , (...)

View the complete list with 7 more genes
Specificity
8 %
Genes
8 %
KRAS gene sequence.

By Ambry Genetics in United States.

KRAS
Specificity
100 %
Genes
4 %
PTPN11, SOS1, RAF1, KRAS, BRAF, NRAS, HRAS, SPRED1, SHOC2, CBL, MAP2K1, MAP2K2. NextGeneDx.Complete sequencing by NGS.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

SPRED1, CBL, MAP2K2, SOS1, SHOC2, PTPN11, NRAS, MAP2K1, KRAS, HRAS, RAF1
Specificity
28 %
Genes
11 %
Noonan Syndrome and Cardiofaciocutaneous Syndrome - KRAS Sequence Analysis.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

KRAS
Specificity
100 %
Genes
4 %
KRAS-Related Noonan Syndrome.

By ChildLab Molecular Genetics Laboratory Nationwide Children's Hospital in United States.

KRAS
Specificity
100 %
Genes
4 %
Noonan syndrome (sequence analysis of KRAS gene).

By CGC Genetics in Portugal.

KRAS
Specificity
100 %
Genes
4 %
KRAS-Related Disorders via the KRAS Gene.

By PreventionGenetics PreventionGenetics in United States.

KRAS
Specificity
100 %
Genes
4 %
Noonan Syndrome.

By MGZ Medical Genetics Center in Germany.

RRAS, RASA2, CBL, SOS1, SHOC2, PTPN11, NRAS, KRAS, RAF1
Specificity
23 %
Genes
8 %
KRAS Sequencing.

By FirmaLab in United States.

KRAS
Specificity
100 %
Genes
4 %
ALPS/autoimmunity panel.

By Genome Diagnostics Laboratory University Medical Center Utrecht in Netherlands.

ITCH, IL2RA, FADD, LRBA, CASP10, FASLG, FAS, FOXP3, NRAS, KRAS, AIRE, CASP8
Specificity
17 %
Genes
8 %
Noonan syndrome type 3.

By Centogene AG - the Rare Disease Company in Germany.

KRAS
Specificity
100 %
Genes
4 %
Gastric cancer, somatic.

By Centogene AG - the Rare Disease Company in Germany.

KRAS
Specificity
100 %
Genes
4 %
Lung cancer, somatic.

By Centogene AG - the Rare Disease Company in Germany.

KRAS
Specificity
100 %
Genes
4 %
Pancreatic carcinoma, somatic.

By Centogene AG - the Rare Disease Company in Germany.

KRAS
Specificity
100 %
Genes
4 %
Single gene testing KRAS.

By CeGaT GmbH in Germany.

KRAS
Specificity
100 %
Genes
4 %
Noonan Syndrome.

By Laboratory of Human Genetics GENOMED Health Care Center in Poland.

SOS1, PTPN11, KRAS, RAF1
Specificity
25 %
Genes
4 %
Breast and Ovarian Cancer.

By Asper Biogene Asper Biogene LLC in Estonia.

CHD1, RAD51, XRCC2, FANCD2, FANCE, FANCF, FANCG, FANCA, RAD51D, BARD1, RAD51C, BRIP1, CHEK2, STK11, PALB2, NBN, MRE11, ATM, KRAS, FANCC , (...)

View the complete list with 9 more genes
Specificity
4 %
Genes
4 %
NGS HemeOnc Panel.

By BloodCenter of Wisconsin Diagnostic Laboratories BloodCenter of Wisconsin, part of Versiti in United States.

CSF3R, ETV6, IDH1, SF3B1, SRSF2, TET2, U2AF1, ABL1, JAK2, NPM1, FLT3, SH2B3, ASXL1, KIT, EZH2, DNMT3A, SETBP1, PHF6, MPL, CEBPA , (...)

View the complete list with 9 more genes
Specificity
11 %
Genes
11 %
Cardiofaciocutaneous syndrome.

By MedGene in Slovakia.

KRAS
Specificity
100 %
Genes
4 %
Noonan syndrome 3.

By MedGene in Slovakia.

KRAS
Specificity
100 %
Genes
4 %
COLON, BREAST AND OVARIAN CANCER.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

MLH3, AXIN2, XRCC2, NF1, RAD51D, PMS1, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, KRAS , (...)

View the complete list with 11 more genes
Specificity
4 %
Genes
4 %
KRAS Gene Deletion/Duplication.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

KRAS
Specificity
100 %
Genes
4 %
Proportionate Short Stature/Small for Gestational Age: Sequencing and Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

SHOX2, IGF1R, IGF1, TBCE, WRN, CUL7, ROR2, SRCAP, SMARCAL1, STAT5B, INSR, TRIM37, EP300, THRB, LHX3, ERCC6, KDM6A, GLI2, SOX3, RPS6KA3 , (...)

View the complete list with 25 more genes
Specificity
3 %
Genes
4 %
Intellectual Disability NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

AQP7, TPH2, AFP, XIST, SNIP1, ZBTB24, GLUL, DIP2B, KCNK9, UPB1, CEP57, FTO, ZBTB16, TMCO1, IRX5, AGT, IGF1R, MRAP, HDAC4, IGF1 , (...)

View the complete list with 372 more genes
Specificity
1 %
Genes
4 %
KRAS Full Gene Analysis.

By Fulgent Genetics Fulgent Genetics in United States.

KRAS
Specificity
100 %
Genes
4 %
Primary Immunodeficiency Panel.

By Blueprint Genetics in Finland.

BCL11B, OTULIN, IRF2BP2, RASGRP1, CARMIL2, ZNF341, TFRC, POLE2, HYOU1, JAK1, ARPC1B, BACH2, LAT, MRTFA, MSN, GINS1, CD59, ADAM17, BCL10, IRF8 , (...)

View the complete list with 255 more genes
Specificity
1 %
Genes
8 %
KRAS Mutation Analysis.

By Cancer Genetics, Inc. Cancer Genetics, Inc. in United States.

KRAS
Specificity
100 %
Genes
4 %
Severe Congenital Neutropenia Gene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

CXCR2, JAGN1, CXCR4, LAMTOR2, GFI1, VPS45, G6PC3, ELANE, CSF3R, RAB27A, USB1, LYST, VPS13B, WAS, SBDS, GATA2, NRAS, KRAS, TCIRG1, TAZ , (...)

View the complete list with 4 more genes
Specificity
9 %
Genes
8 %
Head & Neck Tumors Gene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

RHOA, BCL2L1, PIK3C2B, MCL1, KMT2C, NFE2L2, RAC1, FAT1, AFF3, ERBB2, CCND1, NOTCH2, PIK3R1, AKT1, AKT3, FBXW7, EGFR, AKT2, PIK3CA, GATA4 , (...)

View the complete list with 21 more genes
Specificity
8 %
Genes
11 %
Circulo Breast.

By Circulogene Theranostics in United States.

KRAS
Specificity
100 %
Genes
4 %
Circulo Colorectal.

By Circulogene Theranostics in United States.

KRAS
Specificity
100 %
Genes
4 %
Circulo Ovarian.

By Circulogene Theranostics in United States.

KRAS
Specificity
100 %
Genes
4 %
Circulo Melanoma.

By Circulogene Theranostics in United States.

KRAS
Specificity
100 %
Genes
4 %
Circulo Thyroid.

By Circulogene Theranostics in United States.

KRAS
Specificity
100 %
Genes
4 %
Circulo Hematological.

By Circulogene Theranostics in United States.

KRAS
Specificity
100 %
Genes
4 %
Circulo Pancreatic.

By Circulogene Theranostics in United States.

KRAS
Specificity
100 %
Genes
4 %
Circulo Gastric.

By Circulogene Theranostics in United States.

KRAS
Specificity
100 %
Genes
4 %
LEUKEMIA, ACUTE MYELOGENOUS.

By Laboratorio de Genetica Clinica SL in Spain.

NPM1, KRAS
Specificity
50 %
Genes
4 %
PANCREATIC CARCINOMA.

By Laboratorio de Genetica Clinica SL in Spain.

KRAS
Specificity
100 %
Genes
4 %
Cardiofaciocutaneous Syndrome Type 2, Sequencing KRAS Gene.

By Reference Laboratory Genetics in Spain.

KRAS
Specificity
100 %
Genes
4 %
KRAS Sequence Analysis (Familial Mutation/Variant Analysis).

By Baylor Miraca Genetics Laboratories in United States.

KRAS
Specificity
100 %
Genes
4 %
KRAS Sequence Analysis (Prenatal Diagnosis).

By Baylor Miraca Genetics Laboratories in United States.

KRAS
Specificity
100 %
Genes
4 %
KRAS/RAF1/SOS1 DNA Sequencing Evaluation.

By Athena Diagnostics Inc in United States.

SOS1, KRAS, RAF1
Specificity
34 %
Genes
4 %
KRAS DNA Sequencing Test.

By Athena Diagnostics Inc in United States.

KRAS
Specificity
100 %
Genes
4 %
Noonan syndrome 3 (KRAS).

By Center for Human Genetics, Inc in United States.

KRAS
Specificity
100 %
Genes
4 %
KRAS Mutation Analysis.

By Molecular Genetics Diagnostic Laboratory Detroit Medical Center University Laboratories in United States.

KRAS
Specificity
100 %
Genes
4 %
KRAS Deletion/duplication analysis.

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center in United States.

KRAS
Specificity
100 %
Genes
4 %
KRAS Sequencing.

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center in United States.

KRAS
Specificity
100 %
Genes
4 %
KRAS Molecular Genetic Testing.

By Michigan State University Clinical Genetics Laboratory Michigan State University in United States.

KRAS
Specificity
100 %
Genes
4 %
KRAS-Related Noonan Syndrome.

By Molecular Diagnostics Lab Nemours Alfred I. duPont Hospital for Children in United States.

KRAS
Specificity
100 %
Genes
4 %
Noonan Syndrome Panel.

By Ambry Genetics in United States.

SOS1, PTPN11, KRAS, RAF1
Specificity
25 %
Genes
4 %
KRAS. Complete sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

KRAS
Specificity
100 %
Genes
4 %
PTPN11, RAF1, SOS1, KRAS, BRAF. NextGeneDx.Complete sequencing by NGS.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

SOS1, PTPN11, KRAS, RAF1
Specificity
25 %
Genes
4 %
KRAS-Related Noonan Syndrome.

By Unity of Clinical Genetics and Functional Genomics University of Zaragoza. Faculty of Medicine. in Spain.

KRAS
Specificity
100 %
Genes
4 %
KRAS gene (sequence analysis).

By CGC Genetics in Portugal.

KRAS
Specificity
100 %
Genes
4 %
Detection of frequent mutations on KRAS gene.

By CGC Genetics in Portugal.

KRAS
Specificity
100 %
Genes
4 %
Noonan syndrome (NGS panel for 5 genes).

By CGC Genetics in Portugal.

SOS1, PTPN11, NRAS, KRAS, RAF1
Specificity
40 %
Genes
8 %
Peripheral Nerve Sheath Tumor NGS panel.

By Medical Genomics Laboratory Department of Genetics UAB in United States.

SMARCB1, LZTR1, NF1, NF2, PTPN11, KRAS
Specificity
17 %
Genes
4 %
Hypertrophic Cardiomyopathy Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

VCL, MYL3, MYL2, CSRP3, ACTN2, MYOZ2, JPH2, TNNT2, TPM1, MYPN, NEXN, PLN, PRKAG2, MYH6, TNNI3, TNNC1, ANKRD1, MYLK2, ACTC1, RYR2 , (...)

View the complete list with 18 more genes
Specificity
3 %
Genes
4 %
Autoimmune Lymphoproliferative Syndrome/ALPS Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

PRKCD, CTLA4, FADD, LRBA, PIK3CD, ITK, CASP10, FASLG, XIAP, FAS, SH2D1A, MAGT1, NRAS, KRAS, STAT3, CASP8
Specificity
13 %
Genes
8 %
Noonan Syndrome Sequential Panel.

By FirmaLab in United States.

SOS1, PTPN11, KRAS, RAF1
Specificity
25 %
Genes
4 %
Breast cancer, somatic.

By Centogene AG - the Rare Disease Company in Germany.

KRAS
Specificity
100 %
Genes
4 %
Bladder cancer, somatic.

By Centogene AG - the Rare Disease Company in Germany.

KRAS
Specificity
100 %
Genes
4 %
Cardiofaciocutaneous syndrome.

By Centogene AG - the Rare Disease Company in Germany.

KRAS
Specificity
100 %
Genes
4 %
Bladder cancer, somatic (KRAS).

By MVZ Dortmund Dr. Eberhard & Partner in Germany.

KRAS
Specificity
100 %
Genes
4 %
Cardiofaciocutaneous syndrome 2 (KRAS).

By MVZ Dortmund Dr. Eberhard & Partner in Germany.

KRAS
Specificity
100 %
Genes
4 %
KRAS gene sequencing.

By Health in Code in Spain.

KRAS
Specificity
100 %
Genes
4 %
Hypertrophic cardiomyopathy with suspected Noonan Syndrome.

By Health in Code in Spain.

PTPN11, KRAS
Specificity
50 %
Genes
4 %
Primary lymphedema and Hydrops fetalis.

By Center for Human Genetics Cliniques Universitaires Saint Luc in Belgium.

EPHB4, ITGA9, GJA1, FLT4, PTPN14, KIF11, VEGFC, CCBE1, SOX18, RASA1, FAT4, PIEZO1, FOXC2, HGF, GATA2, SOS1, PTPN11, NRAS, KRAS, IKBKG , (...)

View the complete list with 3 more genes
Specificity
14 %
Genes
11 %
Cardiofaciocutaneous syndrome.

By Praxis fuer Humangenetik Wien in Austria.

KRAS
Specificity
100 %
Genes
4 %
Noonan syndrome 3.

By Praxis fuer Humangenetik Wien in Austria.

KRAS
Specificity
100 %
Genes
4 %
KRAS: KRAS gene sequence analysis.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

KRAS
Specificity
100 %
Genes
4 %
Noonan syndrome 3: KRAS gene sequence analysis.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

KRAS
Specificity
100 %
Genes
4 %
KRAS Full Gene Sequencing.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

KRAS
Specificity
100 %
Genes
4 %
Short Stature NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

EP300, FGD1, NIPBL, SMC1A, SOS1, PTPN11, KRAS, DHCR7, CREBBP, RAF1
Specificity
10 %
Genes
4 %
KRAS.

By Fulgent Genetics Fulgent Genetics in United States.

KRAS
Specificity
100 %
Genes
4 %
BREASTON-EXTENDED.

By PentaCoreLab in Hungary.

DIRAS3, ERBB2, RAD51, BARD1, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, ATM, KRAS, TP53, BRCA2, BRCA1
Specificity
7 %
Genes
4 %
KRAS Mutation by PCR.

By Cancer Genetics, Inc. Cancer Genetics, Inc. in United States.

KRAS
Specificity
100 %
Genes
4 %
V-KI-RAS2 Kirsten rat sarcoma viral oncogene Homolog V-KI-RAS-2.

By Bioarray in Spain.

KRAS
Specificity
100 %
Genes
4 %
Lung and colon cancer.

By Bioarray in Spain.

KRAS
Specificity
100 %
Genes
4 %
Nevus Gene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

GNA11, GNAQ, PIK3CA, NRAS, KRAS, HRAS, FGFR3
Specificity
43 %
Genes
11 %
KRAS Gene Sequencing and Deletion/Duplication Analysis.

By DDC Clinic Molecular Diagnostics Laboratory DDC Clinic, Center for Special Needs Children in United States.

KRAS
Specificity
100 %
Genes
4 %
Circulo Lung.

By Circulogene Theranostics in United States.

KRAS
Specificity
100 %
Genes
4 %
LUNG CANCER, SQUAMOUS CELL.

By Laboratorio de Genetica Clinica SL in Spain.

KRAS
Specificity
100 %
Genes
4 %
BLADDER CANCER.

By Laboratorio de Genetica Clinica SL in Spain.

KRAS
Specificity
100 %
Genes
4 %
Noonan Syndrome Type 3, Sequencing KRAS Gene.

By Reference Laboratory Genetics in Spain.

KRAS
Specificity
100 %
Genes
4 %
Familial Pancreatic Cancer , Panel Massive Sequencing (NGS) 16 Genes.

By Reference Laboratory Genetics in Spain.

MLH3, TGFBR2, SMAD4, CDKN2A, STK11, PALB2, KRAS, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, APC, BRCA2, BRCA1
Specificity
7 %
Genes
4 %
Juvenile Myelomonocytic Leukemia , Panel Massive Sequencing (NGS) 5 Genes.

By Reference Laboratory Genetics in Spain.

NF1, CBL, PTPN11, NRAS, KRAS
Specificity
40 %
Genes
8 %
Acute Myeloid Leukemia (Susceptibility to) , Panel Massive Sequencing (NGS) 21 Genes.

By Reference Laboratory Genetics in Spain.

SH3GL1, LPP, CBFB, PICALM, IDH1, JAK2, NPM1, FLT3, ASXL1, KIT, TERT, TERC, DNMT3A, CEBPA, GATA2, NSD1, KRAS, IDH2, WT1, TP53 , (...)

View the complete list with 1 more genes
Specificity
5 %
Genes
4 %
Autosomic Autoimmune Lymphoproliferative Syndrome , Panel Massive Sequencing (NGS) 10 Genes.

By Reference Laboratory Genetics in Spain.

CTLA4, FADD, ITK, CASP10, FASLG, FAS, MAGT1, NRAS, KRAS, CASP8
Specificity
20 %
Genes
8 %
Thrombocytopenia Sequencing Panel.

By Genetic Services Laboratory University of Chicago in United States.

GP9, TUBB1, ACTN1, FLI1, FYB1, PRKACG, RUNX1T1, SLFN14, CFHR4, SRC, RBM8A, GP1BB, ETV6, ITGA2B, ITGB3, GFI1B, HOXA11, NBEAL2, GP1BA, ABCG8 , (...)

View the complete list with 23 more genes
Specificity
3 %
Genes
4 %
Comprehensive Hereditary Cancer Panel.

By Genetic Services Laboratory University of Chicago in United States.

DDX41, SAMD9L, SAMD9, POLE, ETV6, IKZF1, POLD1, SRP72, BAP1, TERT, TERC, NF1, RTEL1, CEBPA, PAX5, GATA2, BRIP1, SMAD4, BMPR1A, MAX , (...)

View the complete list with 34 more genes
Specificity
4 %
Genes
8 %
Thrombocytopenia Deletion/Duplication Panel.

By Genetic Services Laboratory University of Chicago in United States.

CFHR4, SRC, RBM8A, GP1BB, ETV6, ITGA2B, ITGB3, GFI1B, HOXA11, NBEAL2, GP1BA, ABCG8, ABCG5, ADAMTS13, DGKE, CFHR3, CFHR1, THBD, C3, CD46 , (...)

View the complete list with 23 more genes
Specificity
3 %
Genes
4 %
Hereditary Myeloid Malignancy and Inherited Bone Marrow Failure Panel.

By Genetic Services Laboratory University of Chicago in United States.

RAD51, UBE2T, SAMD9L, SAMD9, NAF1, POT1, DNAJC21, ACD, CXCR4, GFI1, RBM8A, RPL26, VPS45, G6PC3, RPL15, ELANE, CSF3R, ETV6, IKZF1, USB1 , (...)

View the complete list with 59 more genes
Specificity
2 %
Genes
4 %
RT-PCR t(12;21)(TEL/AML1).

By CGC Genetics in Portugal.

ETV6, RUNX1
Specificity
50 %
Genes
4 %
RT-PCR t(5;12) (TEL/PDGFRb).

By CGC Genetics in Portugal.

PDGFRB, ETV6
Specificity
50 %
Genes
4 %
TEL/AML1 fusion gene quantification.

By CGC Genetics in Portugal.

ETV6, RUNX1
Specificity
50 %
Genes
4 %
RT-PCR t(12;22) (TEL/MN1).

By CGC Genetics in Portugal.

MN1, ETV6
Specificity
50 %
Genes
4 %
Thrombocytopenia type 5.

By Centogene AG - the Rare Disease Company in Germany.

ETV6
Specificity
100 %
Genes
4 %
Platelets, Coagulation disorders Panel.

By CeGaT GmbH in Germany.

SERPINC1, F13A1, DSG1, F12, F10, PDGFRB, ETV6, TET2, SERPINE1, ADAMTS13, F8, VWF, F11, ENTPD1, VHL, F5, F2
Specificity
6 %
Genes
4 %
Thrombocytopenia Panel.

By Blueprint Genetics in Finland.

ARPC1B, MECOM, GP9, TUBB1, ACTN1, FLI1, FYB1, PRKACG, SLFN14, SRC, WIPF1, RBM8A, GP1BB, ETV6, MASTL, ITGA2B, ITGB3, GFI1B, HOXA11, ITGA2 , (...)

View the complete list with 14 more genes
Specificity
3 %
Genes
4 %
Hereditary Cancer Comprehensive Panel.

By NeoGenomics Laboratories NeoGenomics Laboratories, Inc. in United States.

TP53BP1, KLLN, CHEK1, GEN1, MYH15, MYH1, MYH13, MYH4, PPM1D, HOXB13, MYH10, GALNT12, RAD51, AKT1, POLE, ABRAXAS1, ETV6, GREM1, POLD1, PIK3CA , (...)

View the complete list with 53 more genes
Specificity
5 %
Genes
11 %
Inherited Bone Marrow Failure Panel.

By NeoGenomics Laboratories NeoGenomics Laboratories, Inc. in United States.

TERF1, TERF2, DDX41, POT1, TERF2IP, ACD, GFI1, RPL26, G6PC3, RPL15, ELANE, CSF3R, ETV6, RPS7, THPO, SRP72, ERCC4, XRCC2, FANCD2, FANCI , (...)

View the complete list with 38 more genes
Specificity
2 %
Genes
4 %
ETV6 Sequencing.

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center in United States.

ETV6
Specificity
100 %
Genes
4 %
Hereditary Leukemia and Breast Cancer Panel.

By Genetic Services Laboratory University of Chicago in United States.

DDX41, SAMD9L, SAMD9, ETV6, IKZF1, SRP72, TERT, TERC, NF1, RTEL1, CEBPA, PAX5, GATA2, CHEK2, CDH1, PALB2, NBN, ATM, CBL, PTPN11 , (...)

View the complete list with 11 more genes
Specificity
4 %
Genes
4 %
Tier 1: Familial Myelodysplastic Syndrome/Acute Leukemia (MDS/AL).

By Genetic Services Laboratory University of Chicago in United States.

DDX41, SAMD9L, SAMD9, ETV6, IKZF1, SRP72, TERT, TERC, RTEL1, CEBPA, PAX5, GATA2, ANKRD26, TP53, RUNX1
Specificity
7 %
Genes
4 %
Detection by FISH of t(12;21) ETV6/AML1.

By CGC Genetics in Portugal.

ETV6, RUNX1
Specificity
50 %
Genes
4 %
Hereditary Myelodysplastic Syndrome (MDS) /Acute Myeloid Leukemia (AML) Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

DDX41, SAMD9L, ETV6, SRP72, TERT, TERC, CEBPA, GATA2, ANKRD26, TP53, RUNX1
Specificity
10 %
Genes
4 %
Thrombocytopenia Sequencing Panel with CNV Detection - Expanded.

By PreventionGenetics PreventionGenetics in United States.

MECOM, GP9, TUBB1, ACTN1, FLI1, FYB1, PRKACG, RBM8A, GP1BB, ETV6, MASTL, ITGA2B, ITGB3, CD36, GFI1B, HOXA11, NBEAL2, GP1BA, ABCG8, ABCG5 , (...)

View the complete list with 9 more genes
Specificity
4 %
Genes
4 %
Hereditary Thrombocytopenia and Hematologic Malignancy via the ETV6 Gene.

By PreventionGenetics PreventionGenetics in United States.

ETV6
Specificity
100 %
Genes
4 %
Thrombocytopenia NGS Panel.

By Connective Tissue Gene Tests in United States.

MECOM, TUBB1, FLI1, FYB1, PRKACG, SLFN14, SRC, WIPF1, RBM8A, ETV6, MASTL, ITGA2B, ITGB3, HOXA11, NBEAL2, TBXAS1, ADAMTS13, LYST, GATA1, MYH9 , (...)

View the complete list with 8 more genes
Specificity
4 %
Genes
4 %
Thrombocytopenia Deletion / Duplication Panel.

By Connective Tissue Gene Tests in United States.

MECOM, TUBB1, FLI1, FYB1, PRKACG, SLFN14, SRC, WIPF1, RBM8A, ETV6, MASTL, ITGA2B, ITGB3, HOXA11, NBEAL2, TBXAS1, ADAMTS13, LYST, GATA1, MYH9 , (...)

View the complete list with 8 more genes
Specificity
4 %
Genes
4 %
Thrombocytopenia Comprehensive Panel.

By Connective Tissue Gene Tests in United States.

MECOM, TUBB1, FLI1, FYB1, PRKACG, SLFN14, SRC, WIPF1, RBM8A, ETV6, MASTL, ITGA2B, ITGB3, HOXA11, NBEAL2, TBXAS1, ADAMTS13, LYST, GATA1, MYH9 , (...)

View the complete list with 8 more genes
Specificity
4 %
Genes
4 %
Fluorescent in situ Hybridization - Hematopathology.

By Hartford Hospital Laboratory - Molecular Genetics and Cytogenetics Hartford Hospital-Hartford-CT-USA in United States.

ABI1, DLEU1, CRLF2, CDKN2C, CKS1B, MECOM, MYC, BCL6, PBX1, TCF3, RARA, CBFB, PML, BCL2, PDGFRB, RUNX1T1, BCR, ETV6, PDGFRA, ABL1 , (...)

View the complete list with 9 more genes
Specificity
4 %
Genes
4 %
ETV6.

By Fulgent Genetics Fulgent Genetics in United States.

ETV6
Specificity
100 %
Genes
4 %
Onco microarray for ALL.

By Pittsburgh Cytogenetics Laboratory University of Pittsburgh Medical Center in United States.

BTG1, EBF1, PDGFRB, ETV6, IKZF1, JAK2, PAX5, CDKN2A, RB1, TP53
Specificity
10 %
Genes
4 %
Bleeding Disorder/Coagulopathy Panel.

By Blueprint Genetics in Finland.

LMAN1, MCFD2, MECOM, SERPINC1, F13A1, F12, F10, GP9, TUBB1, ACTN1, FLI1, FYB1, PRKACG, SLFN14, SRC, F7, VKORC1, PROC, PROS1, RBM8A , (...)

View the complete list with 42 more genes
Specificity
2 %
Genes
4 %
NTRK3.

By Fulgent Genetics Fulgent Genetics in United States.

NTRK3
Specificity
100 %
Genes
4 %
HRAS Sequence Analysis (Prenatal Diagnosis).

By Baylor Miraca Genetics Laboratories in United States.

HRAS
Specificity
100 %
Genes
4 %
Costello syndrome.

By Genetics Laboratory University of Oklahoma Health Sciences Center in United States.

HRAS
Specificity
100 %
Genes
4 %
Congenital Myopathy Sequencing Panel.

By Genetic Services Laboratory University of Chicago in United States.

HACD1, LMOD3, SPEG, STAC3, MYF6, KLHL41, COL12A1, CHKB, BIN1, MTM1, TNNT1, TPM2, CFL2, CNTN1, KBTBD13, MEGF10, CCDC78, ACTA1, TPM3, KLHL40 , (...)

View the complete list with 8 more genes
Specificity
4 %
Genes
4 %
Congenital Myopathy Deletion/Duplication Panel.

By Genetic Services Laboratory University of Chicago in United States.

HACD1, LMOD3, SPEG, STAC3, MYF6, KLHL41, COL12A1, CHKB, BIN1, MTM1, TNNT1, TPM2, CFL2, CNTN1, KBTBD13, MEGF10, CCDC78, ACTA1, TPM3, KLHL40 , (...)

View the complete list with 8 more genes
Specificity
4 %
Genes
4 %
Costello Syndrome.

By Molecular Diagnostics Lab Nemours Alfred I. duPont Hospital for Children in United States.

HRAS
Specificity
100 %
Genes
4 %
HRAS. Complete sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

HRAS
Specificity
100 %
Genes
4 %
Costello Syndrome.

By Unity of Clinical Genetics and Functional Genomics University of Zaragoza. Faculty of Medicine. in Spain.

HRAS
Specificity
100 %
Genes
4 %
Costello Syndrome via the HRAS Gene.

By PreventionGenetics PreventionGenetics in United States.

HRAS
Specificity
100 %
Genes
4 %
Hereditary kidney disorders - different panels.

By Institute of Human Genetics Cologne University in Germany.

CLDN10, TMEM260, KANK3, SLC6A20, MAGEC1, TBC1D1, SLC41A1, SLC36A2, SLC22A10, KCNMB1, NRIP1, MAGED2, DYNC2LI1, IFT52, RMND1, MAPKBP1, MOCOS, SLC26A1, PDE3A, FN1 , (...)

View the complete list with 391 more genes
Specificity
1 %
Genes
8 %
Nevus sebaceous, HRAS related, somatic.

By Centogene AG - the Rare Disease Company in Germany.

HRAS
Specificity
100 %
Genes
4 %
Bladder cancer, HRAS related, somatic.

By Centogene AG - the Rare Disease Company in Germany.

HRAS
Specificity
100 %
Genes
4 %
Thyroid carcinoma, follicular, HRAS related, somatic.

By Centogene AG - the Rare Disease Company in Germany.

HRAS
Specificity
100 %
Genes
4 %
Costello syndrome (HRAS).

By MVZ Dortmund Dr. Eberhard & Partner in Germany.

HRAS
Specificity
100 %
Genes
4 %
Costello syndrome (HRAS).

By MVZ Dortmund Dr. Eberhard & Partner in Germany.

HRAS
Specificity
100 %
Genes
4 %
Aortic Valvular Diseases Panel.

By Health in Code in Spain.

ADAMTSL4, PRKG1, NKX2-5, TGFB3, KCNJ8, MYH11, SLC2A10, ACTA2, FBN2, MYLK, SKI, TGFBR2, TGFBR1, SMAD3, NOTCH1, TGFB2, FLNA, SMAD4, PTPN11, PLOD1 , (...)

View the complete list with 10 more genes
Specificity
4 %
Genes
4 %
Skeletal Myopathy Panel.

By Health in Code in Spain.

CAVIN4, MYL3, MYL2, PRKAG2, TNNI3, KCNE3, LAMP2, CACNA1C, LAMA2, KCNJ2, SGCD, TCAP, EMD, TMEM43, ACTA1, FHL1, BAG3, BSCL2, LDB3, MYOT , (...)

View the complete list with 26 more genes
Specificity
3 %
Genes
4 %
Aortic diseases Panel.

By Health in Code in Spain.

GATA5, ADAMTSL4, B3GAT3, PRKG1, NKX2-5, TGFB3, EFEMP2, KCNJ8, MYH11, SLC2A10, ACTA2, FBN2, MYLK, SKI, TGFBR2, TGFBR1, SMAD3, NOTCH1, TGFB2, ZDHHC9 , (...)

View the complete list with 15 more genes
Specificity
3 %
Genes
4 %
Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic.

By Praxis fuer Humangenetik Wien in Austria.

HRAS
Specificity
100 %
Genes
4 %
Congenital myopathy with excess of muscle spindles.

By MedGene in Slovakia.

HRAS
Specificity
100 %
Genes
4 %
Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic.

By MedGene in Slovakia.

HRAS
Specificity
100 %
Genes
4 %
Invitae Pediatric Hematologic Malignancies Panel.

By Invitae in United States.

TERT, TERC, NF1, CEBPA, GATA2, NBN, ATM, HRAS, BLM, TP53, RUNX1, MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
7 %
Genes
4 %
Invitae Myelodysplastic Syndrome/Leukemia Panel.

By Invitae in United States.

TERT, TERC, NF1, CEBPA, GATA2, NBN, ATM, HRAS, BLM, TP53, RUNX1, MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
7 %
Genes
4 %
Invitae Costello Syndrome Test.

By Invitae in United States.

HRAS
Specificity
100 %
Genes
4 %
Costello syndrome: HRAS gene sequence analysis (exon 2).

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

HRAS
Specificity
100 %
Genes
4 %
Costello Syndrome: HRAS Gene Sequencing.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

HRAS
Specificity
100 %
Genes
4 %
Lysosomal Disorders NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

ACY1, SLC46A1, PGK1, GNPTG, DYM, ANTXR2, ADAMTSL2, CTSC, HYAL1, NAGA, LAMP2, NEU1, PEX5, PEX12, PEX10, PEX26, PEX16, PEX3, PEX13, PEX19 , (...)

View the complete list with 86 more genes
Specificity
1 %
Genes
4 %
Sarcoma Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

DICER1, WRN, PDGFRA, KIT, NF1, PRKAR1A, SDHD, CDKN1C, SUFU, PTCH1, NBN, HRAS, BLM, SDHA, SDHB, FH, SDHC, RB1, TP53, RECQL4 , (...)

View the complete list with 6 more genes
Specificity
4 %
Genes
4 %
Lysosomal Disorders and Mucopolysaccharidosis Panel.

By Blueprint Genetics in Finland.

ACY1, MAN1B1, SLC46A1, PGK1, GNPTG, DYM, ANTXR2, ADAMTSL2, CTSC, HYAL1, NAGA, LAMP2, NEU1, PEX5, PEX12, PEX10, PEX26, PEX16, PEX3, PEX13 , (...)

View the complete list with 82 more genes
Specificity
1 %
Genes
4 %
COSTELLO SYNDROME.

By Laboratorio de Genetica Clinica SL in Spain.

HRAS
Specificity
100 %
Genes
4 %
Costello Syndrome, Sequencing HRAS Gene.

By Reference Laboratory Genetics in Spain.

HRAS
Specificity
100 %
Genes
4 %
Hereditary Sarcoma (Susceptibility to) , Panel Massive Sequencing (NGS) 25 Genes.

By Reference Laboratory Genetics in Spain.

DICER1, WRN, KIT, NF1, PRKAR1A, SDHD, CDKN1C, SUFU, PTCH1, NBN, HRAS, BLM, SDHB, FH, SDHC, SDHAF2, RB1, TP53, RECQL4, MLH1 , (...)

View the complete list with 5 more genes
Specificity
4 %
Genes
4 %
Costello syndrome.

By Labor Dr. Wisplinghoff in Germany.

HRAS
Specificity
100 %
Genes
4 %
Phosphorus Leukemia including Fanconi Anemia Genes Panel.

By Phosphorus Diagnostics LLC in United States.

ERCC4, XRCC2, FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, TERT, TERC, DKC1, FANCB, NF1, RAD51C, CEBPA, GATA2, BRIP1 , (...)

View the complete list with 15 more genes
Specificity
3 %
Genes
4 %
HRAS Sequence Analysis.

By Baylor Miraca Genetics Laboratories in United States.

HRAS
Specificity
100 %
Genes
4 %
HRAS Sequence Analysis (Familial Mutation/Variant Analysis).

By Baylor Miraca Genetics Laboratories in United States.

HRAS
Specificity
100 %
Genes
4 %
Lysosomal Storage Disease Panel.

By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center in United States.

DYM, ANTXR2, ADAMTSL2, CTSC, HYAL1, NAGA, LAMP2, NEU1, PEX5, PEX12, PEX10, PEX26, PEX16, PEX3, PEX13, PEX19, PEX14, FUCA1, PEX6, COL11A2 , (...)

View the complete list with 55 more genes
Specificity
2 %
Genes
4 %
Neuromuscular Disorders Sequencing Panel.

By Genetic Services Laboratory University of Chicago in United States.

ALG14, LRP4, PREPL, SYT2, HACD1, COL13A1, ORAI1, STIM1, GMPPB, LMOD3, SPEG, STAC3, POMK, HNRNPDL, TNPO3, MYF6, LIMS2, KLHL41, COL12A1, MYL2 , (...)

View the complete list with 91 more genes
Specificity
1 %
Genes
4 %
HRAS Gene Sequencing.

By GeneDx in United States.

HRAS
Specificity
100 %
Genes
4 %
HRAS. Sequencing of the exon 2.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

HRAS
Specificity
100 %
Genes
4 %
Costello Syndrome - HRAS Sequence Analysis.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

HRAS
Specificity
100 %
Genes
4 %
Costello syndrome.

By ChildLab Molecular Genetics Laboratory Nationwide Children's Hospital in United States.

HRAS
Specificity
100 %
Genes
4 %
Costello syndrome (sequence analysis of HRAS gene).

By CGC Genetics in Portugal.

HRAS
Specificity
100 %
Genes
4 %
Costello syndrome.

By Centogene AG - the Rare Disease Company in Germany.

HRAS
Specificity
100 %
Genes
4 %
Single gene testing HRAS.

By CeGaT GmbH in Germany.

HRAS
Specificity
100 %
Genes
4 %
Costello syndrome (HRAS).

By MVZ Dortmund Dr. Eberhard & Partner in Germany.

HRAS
Specificity
100 %
Genes
4 %
HRAS gene sequencing.

By Health in Code in Spain.

HRAS
Specificity
100 %
Genes
4 %
Skeletal myopathy Panel.

By Health in Code in Spain.

CAVIN4, XK, SPEG, TOR1AIP1, MYL3, MYL2, PRKAG2, TNNI3, KCNE3, LAMP2, CACNA1C, LAMA2, KCNJ2, SGCD, TCAP, EMD, SYNE2, TMEM43, SYNE1, ACTA1 , (...)

View the complete list with 37 more genes
Specificity
2 %
Genes
4 %
Congenital myopathy with excess of muscle spindles.

By Praxis fuer Humangenetik Wien in Austria.

HRAS
Specificity
100 %
Genes
4 %
Costello syndrome.

By Praxis fuer Humangenetik Wien in Austria.

HRAS
Specificity
100 %
Genes
4 %
COSTELLO SYNDROME.

By Hereditary Cancer Group - Genetic Diagnostic Unit Germans Trias I Pujol Research Institute in Spain.

HRAS
Specificity
100 %
Genes
4 %
Costello syndrome.

By MedGene in Slovakia.

HRAS
Specificity
100 %
Genes
4 %
Invitae Sarcoma Panel.

By Invitae in United States.

DICER1, WRN, PDGFRA, KIT, NF1, PRKAR1A, SDHD, CDKN1C, SUFU, PTCH1, NBN, HRAS, BLM, SDHA, SDHB, FH, SDHC, RB1, TP53, RECQL4 , (...)

View the complete list with 6 more genes
Specificity
4 %
Genes
4 %
Costello syndrome: HRAS gene sequence analysis.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

HRAS
Specificity
100 %
Genes
4 %
Costello Syndrome: HRAS Gene Deletion/Duplication.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

HRAS
Specificity
100 %
Genes
4 %
Hereditary Cancer NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

RBM15, EXO1, XRCC3, PICALM, ROBO2, MSH3, DDB2, XPC, HOXB13, CYLD, GALNT12, BUB1B, RAD51, XPA, ERCC5, DICER1, EGLN1, WRN, PRKDC, AIP , (...)

View the complete list with 92 more genes
Specificity
2 %
Genes
8 %
HRAS.

By Fulgent Genetics Fulgent Genetics in United States.

HRAS
Specificity
100 %
Genes
4 %
Hematologic Malignancy Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

TERT, TERC, NF1, CEBPA, GATA2, NBN, ATM, HRAS, BLM, TP53, RUNX1, MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
7 %
Genes
4 %
Congenital Structural Heart Disease Panel.

By Blueprint Genetics in Finland.

CDK13, HAND1, TLL1, PRKD1, MEIS2, NKX2-6, NR2F2, NAA15, CHD4, TGDS, ADAMTS17, TAB2, TFAP2B, TBX20, ADAMTS10, EIF2AK4, GATA5, ZFPM2, NOTCH2, GJA5 , (...)

View the complete list with 42 more genes
Specificity
2 %
Genes
4 %
Costello syndrome.

By Bioarray in Spain.

HRAS
Specificity
100 %
Genes
4 %
HRAS Gene Sequencing and Deletion/Duplication Analysis.

By DDC Clinic Molecular Diagnostics Laboratory DDC Clinic, Center for Special Needs Children in United States.

HRAS
Specificity
100 %
Genes
4 %
Circulo Colorectal.

By Circulogene Theranostics in United States.

HRAS
Specificity
100 %
Genes
4 %
Circulo Melanoma.

By Circulogene Theranostics in United States.

HRAS
Specificity
100 %
Genes
4 %
Circulo Thyroid.

By Circulogene Theranostics in United States.

HRAS
Specificity
100 %
Genes
4 %
Otogenetics Hereditary Cancers.

By Otogenetics in United States.

PALLD, RAD51, NF1, NTRK1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, MET, CDKN2A, CDK4, STK11, CDH1, PALB2, PTCH1, NBN , (...)

View the complete list with 19 more genes
Specificity
8 %
Genes
11 %
Costello Syndrome, Sequencing Exon 2 HRAS Gene.

By Reference Laboratory Genetics in Spain.

HRAS
Specificity
100 %
Genes
4 %
Phosphorus Leukemia Panel.

By Phosphorus Diagnostics LLC in United States.

TERT, TERC, DKC1, NF1, CEBPA, GATA2, NBN, ATM, TINF2, HRAS, BLM, TP53, RUNX1, MLH1, MSH6, PMS2, MSH2, EPCAM
Specificity
6 %
Genes
4 %
ERC1.

By Fulgent Genetics Fulgent Genetics in United States.

ERC1
Specificity
100 %
Genes
4 %
Hereditary Endocrine Cancer Panel.

By Baylor Miraca Genetics Laboratories in United States.

CDC73, PRKAR1A, MAX, SDHD, TSHR, SDHA, MEN1, TMEM127, SDHB, SDHC, RET, SDHAF2, TP53, PTEN, VHL
Specificity
7 %
Genes
4 %
MEN2 (RET) DNA Sequencing Test.

By Athena Diagnostics Inc in United States.

RET
Specificity
100 %
Genes
4 %
Pheochromocytoma Evaluation.

By Athena Diagnostics Inc in United States.

SDHB, RET, VHL
Specificity
34 %
Genes
4 %
Multiple endocrine neoplasia, type 2.

By Center for Human Genetics, Inc in United States.

RET
Specificity
100 %
Genes
4 %
Hirschprungs Disease (RET mutations).

By Clinical Molecular Genetics Laboratory Johns Hopkins All Children's Hospital in United States.

RET
Specificity
100 %
Genes
4 %
Multiple Endocrine Neoplasia.

By Molecular Pathology Laboratory Ohio State University in United States.

RET
Specificity
100 %
Genes
4 %
Multiple Endocrine Neoplasia Type 2.

By DNA Diagnostic Laboratory Henry Ford Hospital in United States.

RET
Specificity
100 %
Genes
4 %
Multiple Endocrine Neoplasia Type 2: MEN2A, Sequencing.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

RET
Specificity
100 %
Genes
4 %
Multiple Endocrine Neoplasia Type 2: MEN2B Sequencing.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

RET
Specificity
100 %
Genes
4 %
Inherited Cancer Panel.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

CDKN1B, BAP1, XRCC2, MITF, NF1, RAD51D, BARD1, RAD51C, CDC73, PRKAR1A, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2, MET, FLCN, CDKN2A, CDK4 , (...)

View the complete list with 29 more genes
Specificity
3 %
Genes
4 %
VistaSeq Endrocrine Cancer Panel.

By Molecular Diagnostic Laboratory LabCorp in United States.

NF1, CDC73, PRKAR1A, MAX, SDHD, MEN1, TMEM127, SDHB, SDHC, RET, TP53, PTEN, VHL
Specificity
8 %
Genes
4 %
Multiple Endocrine Neoplasia Type 2.

By Genetics Laboratory University of Oklahoma Health Sciences Center in United States.

RET
Specificity
100 %
Genes
4 %
Hyperparathyroidism Deletion/Duplication Panel.

By Genetic Services Laboratory University of Chicago in United States.

AP2S1, GNA11, CDKN1B, PTH1R, CASR, CDC73, MEN1, RET
Specificity
13 %
Genes
4 %
Multiple Endocrine Neoplasia Type 2.

By Service de Génétique Gustave Roussy in France.

RET
Specificity
100 %
Genes
4 %
Central Hypoventilation Syndrome Panel (6 Genes).

By Laboratory for Molecular Medicine Laboratory for Molecular Medicine (Partners HealthCare Personalized Medicine) in United States.

GDNF, ASCL1, BDNF, EDN3, PHOX2B, RET
Specificity
17 %
Genes
4 %
Hereditary Cancer Panel - Endocrine/Paraganglioma-Pheochromocytoma17.

By Human Genetics Laboratory, Munroe-Meyer Institute University of Nebraska Medical Center in United States.

NF1, CDC73, PRKAR1A, MAX, SDHD, TSC1, TSC2, SDHA, MEN1, TMEM127, SDHB, SDHC, RET, SDHAF2, TP53, PTEN, VHL
Specificity
6 %
Genes
4 %
RET gene sequence.

By Ambry Genetics in United States.

RET
Specificity
100 %
Genes
4 %
RET. Sequencing of the exons 5, 8, 13, 14 and 16.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

RET
Specificity
100 %
Genes
4 %
RET. Complete sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

RET
Specificity
100 %
Genes
4 %
RET. Sequencing of the exons 10 and 11.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

RET
Specificity
100 %
Genes
4 %
RET. Sequencing of the exons 10 and 11.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

RET
Specificity
100 %
Genes
4 %
RET. Complete sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

RET
Specificity
100 %
Genes
4 %
RET. Sequencing of the exons 13, 14, 15 and 16.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

RET
Specificity
100 %
Genes
4 %
RET. Complete sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

RET
Specificity
100 %
Genes
4 %
Multiple Endocrine Neoplasia MEN2A - RET Proto-oncogene Known Point Mutation Analysis.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

RET
Specificity
100 %
Genes
4 %
Hereditary Paraganglioma/Pheochromocytoma Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

NF1, MAX, SDHD, SDHA, MEN1, TMEM127, SDHB, FH, SDHC, RET, SDHAF2, VHL
Specificity
9 %
Genes
4 %
Hereditary Endocrine Cancer Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

CDKN1B, CDC73, PRKAR1A, MAX, SDHD, SDHA, MEN1, TMEM127, SDHB, SDHC, RET, SDHAF2, TP53, PTEN, VHL
Specificity
7 %
Genes
4 %
RET-Related Pheochromocytoma.

By CGC Genetics in Portugal.

RET
Specificity
100 %
Genes
4 %
Hirschsprung Disease (exons 2, 7, 15 and 19 of RET gene).

By CGC Genetics in Portugal.

RET
Specificity
100 %
Genes
4 %
Hirschsprung Disease (sequence analysis of RET gene).

By CGC Genetics in Portugal.

RET
Specificity
100 %
Genes
4 %
Medullary thyroid carcinoma (sequence analysis of RET gene).

By CGC Genetics in Portugal.

RET
Specificity
100 %
Genes
4 %
Multiple endocrine neoplasia type 2A (frequent mutations of RET gene, exons 5, 8, 10, 11, 13, 14, 15 and 16).

By CGC Genetics in Portugal.

RET
Specificity
100 %
Genes
4 %
Familial medullary thyroid carcinoma (frequent mutations on RET gene).

By CGC Genetics in Portugal.

RET
Specificity
100 %
Genes
4 %
Pheochromocytoma (frequent mutations on RET gene).

By CGC Genetics in Portugal.

RET
Specificity
100 %
Genes
4 %
Multiple Endocrine Neoplasia type 2B (sequence analysis of RET gene).

By CGC Genetics in Portugal.

RET
Specificity
100 %
Genes
4 %
Multiple endocrine neoplasia type 2A (sequence analysis of RET gene).

By CGC Genetics in Portugal.

RET
Specificity
100 %
Genes
4 %
Hereditary amyloidosis (NGS panel of 19 genes).

By CGC Genetics in Portugal.

OSMR, IL31RA, LYZ, CST3, B2M, APOA2, TACSTD2, F10, TNFRSF1A, FGA, APOA1, PRNP, MEFV, NLRP3, GSN, RET, TGFBI, APP, TTR
Specificity
6 %
Genes
4 %
Pheochromocytoma and paraganglioma (NGS panel for 16 genes).

By CGC Genetics in Portugal.

GDNF, EGLN1, NF1, PRKAR1A, MAX, SDHD, SDHA, MEN1, TMEM127, SDHB, FH, SDHC, KIF1B, RET, SDHAF2, VHL
Specificity
7 %
Genes
4 %
Multiple endocrine neoplasia 2.

By Laboratory of Genetics HUSLAB in Finland.

RET
Specificity
100 %
Genes
4 %
RET-Related Pheochromocytoma.

By Exeter Molecular Genetics Laboratory in United Kingdom.

RET
Specificity
100 %
Genes
4 %
RET - Related Familial medullary thyroid carcinoma.

By Exeter Molecular Genetics Laboratory in United Kingdom.

RET
Specificity
100 %
Genes
4 %
Multiple Endocrine Neoplasia Type 2B.

By Exeter Molecular Genetics Laboratory in United Kingdom.

RET
Specificity
100 %
Genes
4 %
Multiple Endocrine Neoplasia Type 2.

By Molecular Genetics, Function and Therapy Cyprus Institute of Neurology and Genetics in Cyprus.

RET
Specificity
100 %
Genes
4 %
Multiple Endocrine Neoplasia Type 2A (MEN2A) and Familial Medullary Thyroid Carcinoma (FMTC) via the RET Gene - Tier 2.

By PreventionGenetics PreventionGenetics in United States.

RET
Specificity
100 %
Genes
4 %
Congenital Abnormalities of the Kidney and Urinary Tract (CAKUT) Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

DSTYK, CHD1L, HOXA4, HOXB6, CDC5L, GREB1L, BMP7, SIX2, TRAP1, UPK3A, AGTR1, TBX18, FGF20, ITGA8, PBX1, ROBO2, AGT, SOX17, HPSE2, LIFR , (...)

View the complete list with 29 more genes
Specificity
3 %
Genes
4 %
Hirschsprung Disease (Non-syndromic) Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

NRTN, ECE1, GDNF, EDNRB, EDN3, RET
Specificity
17 %
Genes
4 %
Multiple Endocrine Neoplasia Type 2B (MEN2B) via the RET Gene, Exons 15-16.

By PreventionGenetics PreventionGenetics in United States.

RET
Specificity
100 %
Genes
4 %
Hirschsprung Disease (HSCR) via the RET Gene.

By PreventionGenetics PreventionGenetics in United States.

RET
Specificity
100 %
Genes
4 %
Congenital Central Hypoventilation Syndrome (CCHS) Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

BMP2, ASCL1, BDNF, EDN3, PHOX2B, PHOX2A, RET
Specificity
15 %
Genes
4 %
Endocrine tumours.

By Institute of Human Genetics Cologne University in Germany.

CDKN1B, MAX, SDHD, SDHA, MEN1, TMEM127, SDHB, SDHC, RET, SDHAF2, VHL
Specificity
10 %
Genes
4 %
Thyroid Cancer.

By MGZ Medical Genetics Center in Germany.

DICER1, CHEK2, FLCN, SDHD, STK11, ATM, MEN1, SDHB, SDHC, RET, PTEN, MUTYH, APC
Specificity
8 %
Genes
4 %
Multiple Endocrine Neoplasia Type 2.

By Bioscientia GmbH Center for Human Genetics in Germany.

RET
Specificity
100 %
Genes
4 %
Multiple Endocrine Neoplasia II.

By Synlab MVZ Humane Genetik München Synlab MVZ Humane Genetik München in Germany.

RET
Specificity
100 %
Genes
4 %
MEN2A.

By Genome Diagnostics Laboratory University Medical Center Utrecht in Netherlands.

RET
Specificity
100 %
Genes
4 %
Medullary thyroid carcinoma, somatic.

By Centogene AG - the Rare Disease Company in Germany.

RET
Specificity
100 %
Genes
4 %
Multiple endocrine neoplasia type IIA.

By Centogene AG - the Rare Disease Company in Germany.

RET
Specificity
100 %
Genes
4 %
Pheochromocytoma and Paraganglioma Panel.

By CeGaT GmbH in Germany.

CDKN1B, NF1, PRKAR1A, MAX, SDHD, SDHA, MEN1, TMEM127, SDHB, SDHC, RET, SDHAF2, VHL
Specificity
8 %
Genes
4 %
Multiple Endocrine Neoplasia.

By Laboratory of Human Genetics GENOMED Health Care Center in Poland.

MEN1, RET
Specificity
50 %
Genes
4 %
Multiple endocrine neoplasia type II, RET.

By GGA - Galil Genetic Analysis in Israel.

RET
Specificity
100 %
Genes
4 %
Multiple Endocrine Neoplasia type 2.

By Molecular Genetics and Cytogenetics, Clinical Laboratory Service Faculty of Medicine, Pontificia Universidad Católica de Chile in Chile.

RET
Specificity
100 %
Genes
4 %
Thyroid Cancer.

By Asper Biogene Asper Biogene LLC in Estonia.

DICER1, CDC73, PRKAR1A, SDHD, MEN1, SDHB, RET, TP53, PTEN, APC
Specificity
10 %
Genes
4 %
Hermansky-Pudlak Syndrome/Oculocutaneous Albinism/Pigmentation panel.

By Molecular Vision Laboratory in United States.

SLC38A8, MLPH, RAB27A, MYO5A, KIT, LYST, BLOC1S6, LRMDA, SLC24A5, MITF, SOX10, SNAI2, EDNRB, PAX3, EDN3, AP3B1, HPS3, HPS4, HPS5, HPS6 , (...)

View the complete list with 9 more genes
Specificity
4 %
Genes
4 %
Medullary thyroid carcinoma.

By Praxis fuer Humangenetik Wien in Austria.

RET
Specificity
100 %
Genes
4 %
Multiple endocrine Neoplasia 2B.

By Praxis fuer Humangenetik Wien in Austria.

RET
Specificity
100 %
Genes
4 %
Pheochromocytoma.

By Praxis fuer Humangenetik Wien in Austria.

RET
Specificity
100 %
Genes
4 %
CARCINOMA MEDULAR DE TIROIDES.

By GENETIX Centro de Investigación en Genética Humana y Reproductiva in Colombia.

RET
Specificity
100 %
Genes
4 %
Multiple endocrine neoplasia (MEN) 2B (screening RET proto-oncogene).

By Molecular Diagnosis Centre National University Hospital in Singapore.

RET
Specificity
100 %
Genes
4 %
Inherited Cancer Screen.

By Counsyl in United States.

POLE, GREM1, POLD1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, MRE11, ATM, SDHA , (...)

View the complete list with 16 more genes
Specificity
3 %
Genes
4 %
qCancer Risk Expanded.

By Quantitative Genomic Medicine Laboratories, SL in Spain.

POLE, POLD1, MITF, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2, MET, FLCN, SDHD, CDKN2A, CDK4, STK11, CDH1 , (...)

View the complete list with 25 more genes
Specificity
3 %
Genes
4 %
Medullary thyroid carcinoma.

By MedGene in Slovakia.

RET
Specificity
100 %
Genes
4 %
Multiple endocrine Neoplasia 2A.

By MedGene in Slovakia.

RET
Specificity
100 %
Genes
4 %
Multiple endocrine Neoplasia 2B.

By MedGene in Slovakia.

RET
Specificity
100 %
Genes
4 %
Renal agenesis.

By MedGene in Slovakia.

RET
Specificity
100 %
Genes
4 %
Invitae Multiple Endocrine Neoplasia Type 2 Test.

By Invitae in United States.

RET
Specificity
100 %
Genes
4 %
Invitae Hyperparathyroidism Panel.

By Invitae in United States.

CDKN1B, CASR, CDC73, MEN1, RET
Specificity
20 %
Genes
4 %
Hirschsprung disease: RET gene sequence analysis.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

RET
Specificity
100 %
Genes
4 %
Renal Agenesis: RET gene sequence analysis.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

RET
Specificity
100 %
Genes
4 %
Multiple endocrine Neoplasia type 2A (MEN2A): RET gene sequence (exons 10, 11, 13, 14).

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

RET
Specificity
100 %
Genes
4 %
Multiple endocrine Neoplasia type 2A (MEN2A): RET gene sequence analysis (exons 10, 11).

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

RET
Specificity
100 %
Genes
4 %
Multiple endocrine Neoplasia type 2B (MEN2B): RET gene sequence analysis (exons 15, 16).

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

RET
Specificity
100 %
Genes
4 %
Multiple endocrine Neoplasia type 2 (MEN2): RET gene sequence analysis (remaining exons: 1-9, 12, 17-20).

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

RET
Specificity
100 %
Genes
4 %
Multiple Endocrine Neoplasia Type 2: RET gene sequence analysis.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

RET
Specificity
100 %
Genes
4 %
Multiple Endocrine Neoplasia Type 2: RET Full Gene Sequencing.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

RET
Specificity
100 %
Genes
4 %
Multiple Endocrine Neoplasia Type 2: RET Gene Deletion/Duplication.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

RET
Specificity
100 %
Genes
4 %
Early Onset Inflammatory Bowel Disease: Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

IL2RA, ICOS, TTC37, IL10RA, LRBA, STXBP2, XIAP, CD40LG, AICDA, NCF4, NCF2, SH2D1A, MEFV, FOXP3, MVK, BTK, WAS, DCLRE1C, CYBB, CYBA , (...)

View the complete list with 6 more genes
Specificity
4 %
Genes
4 %
Pulmonary Disease: Comprehensive Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

GDNF, ASCL1, BDNF, DNAI1, SFTPB, BMPR2, DNAH5, NME8, SFTPC, ABCA3, DNAH11, DNAI2, DNAAF2, RSPH4A, RSPH9, LTBP4, DNAAF1, MUC5B, CCDC40, DNAL1 , (...)

View the complete list with 33 more genes
Specificity
2 %
Genes
4 %
Endocrine Cancer: Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

MXD1, AIP, CDKN1B, CDC73, PRKAR1A, SDHD, MEN1, TMEM127, SDHB, SDHC, RET, SDHAF2, TP53, PTEN, VHL
Specificity
7 %
Genes
4 %
Early Onset Inflammatory Bowel Disease: Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

IL2RA, ICOS, TTC37, IL10RA, LRBA, STXBP2, XIAP, CD40LG, AICDA, NCF4, NCF2, SH2D1A, MEFV, FOXP3, MVK, BTK, WAS, DCLRE1C, CYBB, CYBA , (...)

View the complete list with 6 more genes
Specificity
4 %
Genes
4 %
Paraganglioma-Pheochromocytomas NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

EGLN1, NF1, MAX, SDHD, SDHA, TMEM127, SDHB, SDHC, KIF1B, RET, SDHAF2, VHL
Specificity
9 %
Genes
4 %
Hirschsprung Disease NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

ECE1, GDNF, EDNRB, EDN3, RET
Specificity
20 %
Genes
4 %
Focus Cancer Panel - 40 Genes.

By Fulgent Genetics Fulgent Genetics in United States.

RAD51, AXIN2, POLE, BAP1, KIT, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, MET, CDKN2A, CDK4, STK11, CDH1, PALB2 , (...)

View the complete list with 20 more genes
Specificity
3 %
Genes
4 %
Thyroid Cancer Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

DICER1, PRKAR1A, CHEK2, RET, TP53, PTEN, APC
Specificity
15 %
Genes
4 %
Paraganglioma-Pheochromocytoma Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

NF1, MAX, SDHD, SDHA, TMEM127, SDHB, FH, SDHC, RET, SDHAF2, VHL
Specificity
10 %
Genes
4 %
RET Sequencing and Deletion/Duplication.

By Quest Diagnostics Nichols Institute San Juan Capistrano in United States.

RET
Specificity
100 %
Genes
4 %
MyVantage(TM) Hereditary Comprehensive Cancer Panel.

By Quest Diagnostics Nichols Institute San Juan Capistrano in United States.

POLE, POLD1, NF1, RAD51D, BARD1, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, SDHD, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM, MEN1, SDHB , (...)

View the complete list with 14 more genes
Specificity
3 %
Genes
4 %
KidneySeq - 264 Genes.

By Iowa Institute of Human Genetics University of Iowa in United States.

FN1, FAN1, DSTYK, CHD1L, SIX2, ARHGAP24, NUP107, NUP93, NUP205, FAT1, XPO5, SGPL1, TRAP1, UPK3A, AGTR1, TBX18, EHHADH, ANLN, FGF20, KCTD1 , (...)

View the complete list with 232 more genes
Specificity
1 %
Genes
4 %
Hereditary Endocrine Cancer Panel.

By Blueprint Genetics in Finland.

DICER1, WRN, AIP, CDKN1B, NF1, CDC73, PRKAR1A, MAX, MET, SDHD, SDHA, MEN1, TMEM127, SDHB, FH, SDHC, RET, SDHAF2, TP53, PTEN , (...)

View the complete list with 2 more genes
Specificity
5 %
Genes
4 %
Multiple endocrine neoplasia type 2B.

By Bioarray in Spain.

RET
Specificity
100 %
Genes
4 %
Multiple endocrine neoplasia type 2A.

By Bioarray in Spain.

RET
Specificity
100 %
Genes
4 %
Rapid microarray (CGH and SNP).

By Allele Diagnostics Allele Diagnostics in United States.

CRK, SEM1, IGF2, FBXW4, YWHAE, TBX3, HDAC4, TRPS1, STS, GRIK2, FLI1, PREPL, MAMLD1, ARSE, IRF6, CCNQ, MNX1, NFIA, EDA, XK , (...)

View the complete list with 153 more genes
Specificity
1 %
Genes
4 %
High-Resolution Rapid Microarray (CGH and SNP).

By Allele Diagnostics Allele Diagnostics in United States.

CRK, SEM1, IGF2, FBXW4, YWHAE, TBX3, HDAC4, TRPS1, STS, GRIK2, FLI1, PREPL, MAMLD1, ARSE, IRF6, CCNQ, MNX1, NFIA, EDA, XK , (...)

View the complete list with 153 more genes
Specificity
1 %
Genes
4 %
iGene Cancer Panel.

By ApolloGen, Inc. in United States.

NF1, RAD51C, BRIP1, SMAD4, BMPR1A, CDKN2A, STK11, CDH1, PALB2, PTCH1, NBN, ATM, MEN1, RET, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2 , (...)

View the complete list with 5 more genes
Specificity
4 %
Genes
4 %
Multiple Endocrine Neoplasia, Type 2 panel.

By National Taiwan University Hospital A1 Center National Taiwan University Hospital in Taiwan.

RET
Specificity
100 %
Genes
4 %
Medullary Thyroid Cancer (MTC) Genetic Test.

By National Taiwan University Hospital A1 Center National Taiwan University Hospital in Taiwan.

RET
Specificity
100 %
Genes
4 %
Hereditary Thyroid Cancer - RET Gene Analysis.

By GeneKor MSA in Greece.

RET
Specificity
100 %
Genes
4 %
HYPOVENTILATION SYNDROME, CONGENITAL CENTRAL (ONDINE SYNDROME).

By Laboratorio de Genetica Clinica SL in Spain.

GDNF, ASCL1, BDNF, EDN3, PHOX2B, RET
Specificity
17 %
Genes
4 %
THYROID CARCINOMA, MEDULLARY.

By Laboratorio de Genetica Clinica SL in Spain.

RET
Specificity
100 %
Genes
4 %
Renal Agenesis, Sequencing RET Gene.

By Reference Laboratory Genetics in Spain.

RET
Specificity
100 %
Genes
4 %
Multiple Endocrine Neoplasia Type 2A , Sequencing RET Gene.

By Reference Laboratory Genetics in Spain.

RET
Specificity
100 %
Genes
4 %
Hirschsprung Disease, Sequencing RET Gene.

By Reference Laboratory Genetics in Spain.

RET
Specificity
100 %
Genes
4 %
Multiple Endocrine Neoplasia Type 2B, Sequencing Exons (15,16) RET Gene.

By Reference Laboratory Genetics in Spain.

RET
Specificity
100 %
Genes
4 %
Hereditary Pheochromocytoma-Paraganglioma Syndrome , Panel Massive Sequencing (NGS) 11 Genes.

By Reference Laboratory Genetics in Spain.

NF1, MAX, SDHD, SDHA, MEN1, TMEM127, SDHB, SDHC, RET, SDHAF2, VHL
Specificity
10 %
Genes
4 %
Cardiology Genetic Panel (Full) , Panel Massive Sequencing (NGS) 96 Genes.

By Reference Laboratory Genetics in Spain.

ECE1, CTNNA3, CACNA1G, GJA5, NPPA, NUP155, SLC6A4, GJA1, DPP6, VCL, MYL3, MYL2, DSC2, CSRP3, ACTN2, RBM20, MYOZ2, JPH2, TNNT2, TPM1 , (...)

View the complete list with 75 more genes
Specificity
2 %
Genes
4 %
CEN4GEN Gastric cancer: Extended gene sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

WNK2, ADGRB3, SSTR1, TRRAP, LRP1B, LPAR2, GPR78, ATP4A, CCNE1, TRIO, DCC, MYC, ERBB2, PRKDC, FBXW7, PIK3CA, SPEG, NOTCH1, CTNNB1, S1PR2 , (...)

View the complete list with 9 more genes
Specificity
4 %
Genes
4 %
Endocrine Cancer: gene sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

AIP, CDKN1B, CDC73, PRKAR1A, MAX, SDHD, MEN1, TMEM127, SDHB, SDHC, RET, SDHAF2, TP53, PTEN, VHL
Specificity
7 %
Genes
4 %
Multiple Endocrine Neoplasia Type 2: RET Gene Sequencing.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

RET
Specificity
100 %
Genes
4 %
Hereditary Paraganglioma/Pheochromocytoma Panel.

By Baylor Miraca Genetics Laboratories in United States.

MAX, SDHD, SDHA, TMEM127, SDHB, SDHC, RET, SDHAF2, VHL
Specificity
12 %
Genes
4 %
Multiple Endocrine Neoplasia Type 2.

By Clinical Molecular Genetics Laboratory Johns Hopkins All Children's Hospital in United States.

RET
Specificity
100 %
Genes
4 %
Multiple Endocrine Neoplasia Type 2: FMTC Sequencing.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

RET
Specificity
100 %
Genes
4 %
Hereditary Pheochromocytoma and Paraganglioma Panel.

By Genetic Services Laboratory University of Chicago in United States.

EGLN1, EPAS1, NF1, MAX, SDHD, SDHA, MEN1, TMEM127, SDHB, SDHC, KIF1B, RET, SDHAF2, VHL
Specificity
8 %
Genes
4 %
Hyperparathyroidism Sequencing Panel.

By Genetic Services Laboratory University of Chicago in United States.

AP2S1, GNA11, CDKN1B, PTH1R, CASR, CDC73, MEN1, RET
Specificity
13 %
Genes
4 %
Hereditary Thyroid Cancer Panel.

By Genetic Services Laboratory University of Chicago in United States.

DICER1, SRGAP1, WRN, AKT1, PIK3CA, PRKAR1A, CHEK2, SDHD, SDHB, RET, TP53, PTEN, APC
Specificity
8 %
Genes
4 %
Multiple Endorine Neoplasia Type 2.

By Molecular Genetics Laboratory - Diagnostics Genetics LabPLUS - Auckland City Hospital in New Zealand.

RET
Specificity
100 %
Genes
4 %
Multiple Endoctine Neoplasia Type 2 (RET).

By Molecular Genetics Laboratory London Health Sciences Centre in Canada.

RET
Specificity
100 %
Genes
4 %
Multiple Endocrine Neoplasia (MEN2), RET Gene Mutations by Sequencing.

By ARUP Laboratories, Molecular Genetics and Genomics in United States.

RET
Specificity
100 %
Genes
4 %
RET Select Exons Sequencing (HSCR).

By GeneDx in United States.

RET
Specificity
100 %
Genes
4 %
RET Remaining Exons Sequencing (HSCR).

By GeneDx in United States.

RET
Specificity
100 %
Genes
4 %
RET Remaining Exons Sequencing (MEN2B).

By GeneDx in United States.

RET
Specificity
100 %
Genes
4 %
RET Select Exons Sequencing (MEN2B).

By GeneDx in United States.

RET
Specificity
100 %
Genes
4 %
PGL/PCC (Paraganglioma/Pheochromocytoma) Panel.

By GeneDx in United States.

NF1, MAX, SDHD, SDHA, MEN1, TMEM127, SDHB, FH, SDHC, RET, SDHAF2, VHL
Specificity
9 %
Genes
4 %
CancerNext-Expanded.

By Ambry Genetics in United States.

HOXB13, GALNT12, DICER1, POT1, POLE, GREM1, POLD1, CDKN1B, BAP1, XRCC2, SMARCB1, SMARCA4, SMARCE1, MITF, NF1, RAD51D, BARD1, RAD51C, PRKAR1A, BRIP1 , (...)

View the complete list with 44 more genes
Specificity
2 %
Genes
4 %
PGLNext.

By Ambry Genetics in United States.

NF1, MAX, SDHD, SDHA, MEN1, TMEM127, SDHB, FH, SDHC, RET, SDHAF2, VHL
Specificity
9 %
Genes
4 %
RET. Detection of the mutations p.Met918Thr and p.Ala883Phe by sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

RET
Specificity
100 %
Genes
4 %
Multiple Endocrine Neoplasia MEN2A - RET Proto-oncogene Full Sequence Analysis.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

RET
Specificity
100 %
Genes
4 %
RET-Related Hirschsprung Disease.

By CGC Genetics in Portugal.

RET
Specificity
100 %
Genes
4 %
RET-Related Renal Adysplasia.

By CGC Genetics in Portugal.

RET
Specificity
100 %
Genes
4 %
Multiple endocrine neoplasia type 2A (frequent mutations of RET gene, exons 2, 10, 11 and 13 to 16).

By CGC Genetics in Portugal.

RET
Specificity
100 %
Genes
4 %
OncoRisk (NGS panel for 48 genes).

By CGC Genetics in Portugal.

EXT1, EXT2, FANCA, FANCB, NF1, RAD51C, CDC73, PRKAR1A, CEBPA, BRIP1, SMAD4, BMPR1A, MAX, CHEK2, MET, FLCN, SDHD, CDKN1C, CDKN2A, CDK4 , (...)

View the complete list with 28 more genes
Specificity
3 %
Genes
4 %
Pheochromocytoma (sequence analysis of RET gene).

By CGC Genetics in Portugal.

RET
Specificity
100 %
Genes
4 %
Pheochromocytoma and paraganglioma (NGS panel for 16 genes).

By CGC Genetics in Portugal.

GDNF, EGLN1, NF1, PRKAR1A, MAX, SDHD, SDHA, MEN1, TMEM127, SDHB, FH, SDHC, KIF1B, RET, SDHAF2, VHL
Specificity
7 %
Genes
4 %
Hereditary amyloidosis (NGS panel of 19 genes).

By CGC Genetics in Portugal.

OSMR, IL31RA, LYZ, CST3, B2M, APOA2, TACSTD2, F10, TNFRSF1A, FGA, APOA1, PRNP, MEFV, NLRP3, GSN, RET, TGFBI, APP, TTR
Specificity
6 %
Genes
4 %
Multiple endocrine neoplasia type 2A (sequence analysis of RET gene).

By CGC Genetics in Portugal.

RET
Specificity
100 %
Genes
4 %
Multiple Endocrine Neoplasia type 2B (sequence analysis of RET gene).

By CGC Genetics in Portugal.

RET
Specificity
100 %
Genes
4 %
RET-Related Hirschsprung Disease.

By Exeter Molecular Genetics Laboratory in United Kingdom.

RET
Specificity
100 %
Genes
4 %
Multiple Endocrine Neoplasia Type 2A.

By Exeter Molecular Genetics Laboratory in United Kingdom.

RET
Specificity
100 %
Genes
4 %
Cancer Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

POLE, POLD1, NF1, RAD51D, BARD1, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM, MEN1, RET, TP53 , (...)

View the complete list with 11 more genes
Specificity
4 %
Genes
4 %
Multiple Endocrine Neoplasia Type 2A (MEN2A) and Familial Medullary Thyroid Carcinoma (FMTC) via the RET Gene - Tier 1.

By PreventionGenetics PreventionGenetics in United States.

RET
Specificity
100 %
Genes
4 %
Hereditary Paraganglioma-Pheochromocytoma Syndrome Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

NF1, MAX, SDHD, SDHA, MEN1, TMEM127, SDHB, FH, SDHC, RET, SDHAF2, VHL
Specificity
9 %
Genes
4 %
Multiple Endocrine Neoplasia Type 2.

By MGZ Medical Genetics Center in Germany.

RET
Specificity
100 %
Genes
4 %
Thyroid Cancer – Basic Diagnostics.

By MGZ Medical Genetics Center in Germany.

SDHD, SDHB, SDHC, RET, PTEN
Specificity
20 %
Genes
4 %
Pheochromozytoma-Paraganglioma syndrome.

By MGZ Medical Genetics Center in Germany.

NF1, PRKAR1A, MAX, SDHD, MEN1, TMEM127, SDHB, SDHC, RET, SDHAF2, VHL
Specificity
10 %
Genes
4 %
Sequencing of risk exons of the RET proto-oncogene (exons 10, 11, 13, 14, 15, 16).

By Department of Molecular Endocrinology Institute of Endocrinology in Czech Republic.

RET
Specificity
100 %
Genes
4 %
Central hypoventilation syndrome, congenital.

By Centogene AG - the Rare Disease Company in Germany.

RET
Specificity
100 %
Genes
4 %
Hirschsprung disease.

By Centogene AG - the Rare Disease Company in Germany.

RET
Specificity
100 %
Genes
4 %
RET, selective sequencing of exons 5, 8, 10, 11 and 13-16.

By Centogene AG - the Rare Disease Company in Germany.

RET
Specificity
100 %
Genes
4 %
Multiple endocrine neoplasia type IIB.

By Centogene AG - the Rare Disease Company in Germany.

RET
Specificity
100 %
Genes
4 %
Multiple Endocrine Neoplasia Type 2.

By Medical Genetics Laboratory Diagenom GmbH in Germany.

RET
Specificity
100 %
Genes
4 %
Multiple endocrine neoplasia.

By bio.logis Center for Human Genetics Diagnosticum in Germany.

MEN1, RET
Specificity
50 %
Genes
4 %
Familial Tumor Syndromes Panel.

By CeGaT GmbH in Germany.

RASAL1, CYLD, DICER1, WRN, AKT1, PIK3CA, BAP1, SMARCB1, SMARCA4, SMARCE1, ATR, SPRED1, LZTR1, NF1, CDC73, MET, SDHD, CDKN2A, NF2, NBN , (...)

View the complete list with 12 more genes
Specificity
4 %
Genes
4 %
Renal Dysplasia, Renal Agenesia, CAKUT Panel.

By CeGaT GmbH in Germany.

ALDH1A2, OSR1, DSTYK, CHD1L, SPRY1, TRAP1, UPK3A, TBX18, FGF20, ITGA8, BICC1, ROBO2, SOX17, GDNF, FRAS1, FREM2, GRIP1, BMP4, FREM1, SDCCAG8 , (...)

View the complete list with 12 more genes
Specificity
4 %
Genes
4 %
RET.

By Innovagenomics Innovagenomics S.L in Spain.

RET
Specificity
100 %
Genes
4 %
Multiple Endocrine Neoplasia Type 2.

By DNAbiolab Cretan Center for Research and Development of Applications on Genetics and Molecular Biology in Greece.

RET
Specificity
100 %
Genes
4 %
Multiple endocrine neoplasia type 2, RET sequencing.

By Molecular Diagnostics Laboratory Seoul National University Hospital in South Korea.

RET
Specificity
100 %
Genes
4 %
Hirschsprung Disease Panel.

By Molecular Vision Laboratory in United States.

EDNRB, EDN3, RET
Specificity
34 %
Genes
4 %
Waardenburg Syndrome panel.

By Molecular Vision Laboratory in United States.

MITF, SOX10, SNAI2, EDNRB, PAX3, EDN3, RET
Specificity
15 %
Genes
4 %
Central hypoventilation syndrome, congenital.

By Praxis fuer Humangenetik Wien in Austria.

RET
Specificity
100 %
Genes
4 %
Multiple endocrine Neoplasia 2A.

By Praxis fuer Humangenetik Wien in Austria.

RET
Specificity
100 %
Genes
4 %
Renal agenesis.

By Praxis fuer Humangenetik Wien in Austria.

RET
Specificity
100 %
Genes
4 %
Multiple endocrine neoplasia (MEN) 2A/FMTC (screening RET proto-oncogene).

By Molecular Diagnosis Centre National University Hospital in Singapore.

RET
Specificity
100 %
Genes
4 %
Central hypoventilation syndrome, congenital.

By MedGene in Slovakia.

RET
Specificity
100 %
Genes
4 %
Pheochromocytoma.

By MedGene in Slovakia.

RET
Specificity
100 %
Genes
4 %
Invitae Thyroid Cancer Panel.

By Invitae in United States.

DICER1, PRKAR1A, CHEK2, RET, TP53, PTEN, APC
Specificity
15 %
Genes
4 %
Invitae Hereditary Paraganglioma-Pheochromocytoma Panel.

By Invitae in United States.

NF1, MAX, SDHD, SDHA, TMEM127, SDHB, SDHC, RET, SDHAF2, VHL
Specificity
10 %
Genes
4 %
Multiple endocrine Neoplasia type 2 (MEN2): RET gene sequence analysis (exons 10, 11, 13-16).

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

RET
Specificity
100 %
Genes
4 %
Multiple endocrine Neoplasia type 2 (MEN2): RET gene sequence analysis (exons 13-16).

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

RET
Specificity
100 %
Genes
4 %
PARAGANGLIOMA-PHEOCHROMOCYTOMA.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

NF1, MAX, SDHD, SDHA, MEN1, TMEM127, SDHB, SDHC, RET, SDHAF2, VHL
Specificity
10 %
Genes
4 %
Congenital Central Hypoventilation Syndrome: Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

GDNF, ASCL1, BDNF, HOXA1, EDN3, PHOX2B, RET
Specificity
15 %
Genes
4 %
Pheochromocytoma-Paraganglioma: Sequencing and Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

MAX, SDHD, TMEM127, SDHB, SDHC, RET, SDHAF2, VHL
Specificity
13 %
Genes
4 %
Congenital Central Hypoventilation Syndrome: Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

GDNF, ASCL1, BDNF, HOXA1, EDN3, PHOX2B, RET
Specificity
15 %
Genes
4 %
Endocrine Cancer: Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

CDC73, PRKAR1A, MAX, SDHD, MEN1, TMEM127, SDHB, SDHC, RET, SDHAF2, TP53, PTEN, VHL
Specificity
8 %
Genes
4 %
Lung Disorders NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

GDNF, ASCL1, BDNF, SFTPA1, SFTPA2, DNAI1, SFTPB, BMPR2, DNAH5, NME8, SFTPC, ABCA3, DNAH11, DNAI2, DNAAF2, RSPH4A, RSPH9, LTBP4, DNAAF1, MUC5B , (...)

View the complete list with 31 more genes
Specificity
2 %
Genes
4 %
Central Hypoventilation Syndrome NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

GDNF, ASCL1, BDNF, EDN3, PHOX2B, RET
Specificity
17 %
Genes
4 %
Multiple Endocrine Neoplasia Type 1 NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

MEN1, RET
Specificity
50 %
Genes
4 %
RET.

By Fulgent Genetics Fulgent Genetics in United States.

RET
Specificity
100 %
Genes
4 %
Hyperparathyroidism Panel.

By Blueprint Genetics in Finland.

CDKN1A, CDKN2C, CDKN2B, GCM2, PTH, AP2S1, GNA11, CDKN1B, CASR, CDC73, AIRE, MEN1, RET
Specificity
8 %
Genes
4 %
Hirschsprung Disease Panel.

By Blueprint Genetics in Finland.

CELSR3, NRG1, NRTN, BDNF, MITF, SOX10, EDNRB, PAX3, EDN3, ZEB2, KIF1BP, L1CAM, PHOX2B, RMRP, RET
Specificity
7 %
Genes
4 %
Renal Malformation Panel.

By Blueprint Genetics in Finland.

DSTYK, PBX1, ROBO2, AGT, REN, CCNQ, FREM2, BMP4, FREM1, ACE, ACTG2, FANCB, FOXC2, GATA3, SIX1, SIX5, SALL1, PAX2, RET, HNF1B , (...)

View the complete list with 2 more genes
Specificity
5 %
Genes
4 %
Hereditary Paraganglioma-Pheochromocytoma Panel.

By Blueprint Genetics in Finland.

NF1, MAX, SDHD, SDHA, TMEM127, SDHB, FH, SDHC, RET, SDHAF2, VHL
Specificity
10 %
Genes
4 %
Central Hypoventilation and Apnea Panel.

By Blueprint Genetics in Finland.

SLC6A5, GLRA1, EDN3, ZEB2, CHRNB1, CHRND, CHRNA1, COLQ, SCN4A, RAPSN, CHRNE, PHOX2B, CHAT, MECP2, RET
Specificity
7 %
Genes
4 %
Hereditary Cancer High Risk Panel.

By Blueprint Genetics in Finland.

POLE, POLD1, BAP1, RAD51D, RAD51C, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, ATM, MEN1, RET, TP53, PTEN, MUTYH, MLH1 , (...)

View the complete list with 8 more genes
Specificity
4 %
Genes
4 %
protooncogene RET.

By Molecular Genetics Laboratory Centro de Investigaciones Endocrinologicas "Dr. Cesar Bergada" in Argentina.

RET
Specificity
100 %
Genes
4 %
RET Break Apart FISH.

By Cancer Genetics, Inc. Cancer Genetics, Inc. in United States.

RET
Specificity
100 %
Genes
4 %
Familial medullary thyroid carcinoma.

By Bioarray in Spain.

RET
Specificity
100 %
Genes
4 %
RET Gene Sequencing and Deletion/Duplication Analysis.

By DDC Clinic Molecular Diagnostics Laboratory DDC Clinic, Center for Special Needs Children in United States.

RET
Specificity
100 %
Genes
4 %
Genetic Test of single known genetic variant.

By National Taiwan University Hospital A1 Center National Taiwan University Hospital in Taiwan.

GNAS, PKD1, PKD2, TSC1, TSC2, MEN1, RET, TP53, BRCA2, BRCA1
Specificity
10 %
Genes
4 %
Circulo Thyroid.

By Circulogene Theranostics in United States.

RET
Specificity
100 %
Genes
4 %
HIRSCHSPRUNG´S DISEASE: NGS PANEL.

By Laboratorio de Genetica Clinica SL in Spain.

ECE1, GDNF, SEMA3A, SOX10, EDNRB, EDN3, ZEB2, KIF1BP, RET
Specificity
12 %
Genes
4 %
PHEOCHROMOCYTOMA-PARAGANGLIOMA.

By Laboratorio de Genetica Clinica SL in Spain.

MAX, SDHD, SDHA, TMEM127, SDHB, SDHC, RET, SDHAF2, VHL
Specificity
12 %
Genes
4 %
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2 (MEN2).

By Laboratorio de Genetica Clinica SL in Spain.

RET
Specificity
100 %
Genes
4 %
HIRSCHSPRUNG´S DISEASE.

By Laboratorio de Genetica Clinica SL in Spain.

GDNF, SOX10, EDNRB, EDN3, RET
Specificity
20 %
Genes
4 %
Ondine Syndrome, Sequencing RET Gene.

By Reference Laboratory Genetics in Spain.

RET
Specificity
100 %
Genes
4 %
Multiple Endocrine Neoplasia Type 2A, Sequencing Exons (10,11) RET Gene.

By Reference Laboratory Genetics in Spain.

RET
Specificity
100 %
Genes
4 %
Multiple Endocrine Neoplasia Type FMTC , Sequencing Exons (10,11,13,14) RET Gene.

By Reference Laboratory Genetics in Spain.

RET
Specificity
100 %
Genes
4 %
Multiple Endocrine Neoplasia Type 2, Deletions-Duplications (MLPA) RET Gene.

By Reference Laboratory Genetics in Spain.

RET
Specificity
100 %
Genes
4 %
Hirschsprung Disease, Panel Massive Sequencing (NGS) 6 Genes.

By Reference Laboratory Genetics in Spain.

ECE1, GDNF, EDNRB, EDN3, L1CAM, RET
Specificity
17 %
Genes
4 %
Ondine Syndrome (Congenital Central Hypoventilation Syndrome), Panel Massive Sequencing (NGS) 6 Genes.

By Reference Laboratory Genetics in Spain.

GDNF, ASCL1, BDNF, EDN3, PHOX2B, RET
Specificity
17 %
Genes
4 %
Hereditary Thyroid Cancer , Panel Massive Sequencing (NGS) 7 Genes.

By Reference Laboratory Genetics in Spain.

DICER1, PRKAR1A, CHEK2, RET, TP53, PTEN, APC
Specificity
15 %
Genes
4 %
Multiple endocrine neoplasia, type 2.

By Labor Dr. Wisplinghoff in Germany.

RET
Specificity
100 %
Genes
4 %
Phosphorus Thyroid Cancer Panel.

By Phosphorus Diagnostics LLC in United States.

DICER1, PRKAR1A, CHEK2, RET, TP53, PTEN, APC
Specificity
15 %
Genes
4 %
Non syndromic Hirschsprung Disease: gene sequencing panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

SEMA3C, SEMA3D, NRG3, NRG1, NRTN, ECE1, GDNF, EDNRB, EDN3, RET
Specificity
10 %
Genes
4 %
CEN4GEN Breast cancer: Extended gene sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

WEE1, ACVR1B, PTGFR, ZBED4, ZNF226, TRAF5, PPM1L, MAP2K4, PCGF2, PBRM1, FBXO32, EXOC2, NCOR1, MUC16, ESR1, KMT2C, ITCH, MYC, CBFB, ERBB2 , (...)

View the complete list with 25 more genes
Specificity
3 %
Genes
4 %
Multiple Endocrine Neoplasia Type 2: RET Gene Deletion/Duplication.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

RET
Specificity
100 %
Genes
4 %
Endocrine Cancer: gene deletion/duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

CDC73, PRKAR1A, MAX, SDHD, MEN1, TMEM127, SDHB, SDHC, RET, SDHAF2, TP53, PTEN, VHL
Specificity
8 %
Genes
4 %
Pheochromocytoma-Paraganglioma: Gene Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

MAX, SDHD, TMEM127, SDHB, FH, SDHC, RET, SDHAF2, VHL
Specificity
12 %
Genes
4 %
Pheochromocytoma-Paraganglioma: Gene Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

MAX, SDHD, TMEM127, SDHB, FH, SDHC, RET, SDHAF2, VHL
Specificity
12 %
Genes
4 %
NTRK1 DNA Sequencing Test.

By Athena Diagnostics Inc in United States.

NTRK1
Specificity
100 %
Genes
4 %
NTRK1. Complete sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

NTRK1
Specificity
100 %
Genes
4 %
Hereditary sensory and autonomic neuropathy IV (insensitivity to pain with anhidrosis, HSAN4, sequence analysis of NTRK1 gene).

By CGC Genetics in Portugal.

NTRK1
Specificity
100 %
Genes
4 %
Congenital Insensitivity to Pain with Anhidrosis via NTRK1 Gene Sequencing with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

NTRK1
Specificity
100 %
Genes
4 %
Hereditary Sensory and Autonomic Neuropathy Type IV.

By MGZ Medical Genetics Center in Germany.

NTRK1
Specificity
100 %
Genes
4 %
Neuropathic Pain Syndromes Panel.

By CeGaT GmbH in Germany.

TRPA1, SCN11A, SCN10A, SCN9A, NTRK1
Specificity
20 %
Genes
4 %
Congenital Insensitivity to Pain with Anhidrosis; HSAN Type IV, NTRK1 sequencing.

By Molecular Diagnostics Laboratory Seoul National University Hospital in South Korea.

NTRK1
Specificity
100 %
Genes
4 %
Invitae Hereditary Sensory and Autonomic Neuropathy Panel.

By Invitae in United States.

ATL3, SCN11A, NGF, RETREG1, DST, DNMT1, SCN9A, KIF1A, ATL1, SPTLC1, WNK1, NTRK1, RAB7A, ELP1, SPTLC2
Specificity
7 %
Genes
4 %
Neuropathy 4, Hereditary sensory and autonomic: NTRK1 gene sequence analysis.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

NTRK1
Specificity
100 %
Genes
4 %
Hereditary Neuropathies: Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

HOXD10, NGF, RETREG1, CTDP1, ZFYVE27, GAN, MED25, AARS, LRSAM1, DNAJB2, PLEKHG5, PRPS1, DNMT1, SCN9A, SPTBN2, TTBK2, FGF14, ITPR1, KCNC3, SIL1 , (...)

View the complete list with 70 more genes
Specificity
2 %
Genes
4 %
Hereditary Neuropathies: Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

HOXD10, NGF, RETREG1, CTDP1, ZFYVE27, GAN, MED25, AARS, LRSAM1, DNAJB2, PLEKHG5, PRPS1, DNMT1, SCN9A, SPTBN2, TTBK2, FGF14, ITPR1, KCNC3, SIL1 , (...)

View the complete list with 70 more genes
Specificity
2 %
Genes
4 %
Charcot Marie Tooth Disease Extended NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

NGF, RETREG1, GAN, MED25, AARS, LRSAM1, DNAJB2, PLEKHG5, PRPS1, DNMT1, SCN9A, IGHMBP2, DYNC1H1, KIF1A, BSCL2, ATL1, SPTLC1, WNK1, NTRK1, GJB1 , (...)

View the complete list with 29 more genes
Specificity
3 %
Genes
4 %
Familial medullary thyroid carcinoma.

By Bioarray in Spain.

NTRK1
Specificity
100 %
Genes
4 %
Hereditary sensory and autonomic neuropathy type 4.

By Bioarray in Spain.

NTRK1
Specificity
100 %
Genes
4 %
CarrierMap.

By Recombine in United States.

VPS53, SLC26A3, BCHE, HGD, GDF5, XPC, SLC7A9, LIFR, XPA, WRN, SEPSECS, MED17, ASNS, AMHR2, AMH, CYP19A1, HJV, HOGA1, TFR2, TTC37 , (...)

View the complete list with 281 more genes
Specificity
1 %
Genes
4 %
Hereditary Sensory and Autonomous Neuropathy Type IV , Sequencing NTRK1 Gene.

By Reference Laboratory Genetics in Spain.

NTRK1
Specificity
100 %
Genes
4 %
Early Onset Hereditary Sensory and Autonomic Neuropathy (HSAN) Evaluation.

By Athena Diagnostics Inc in United States.

WNK1, NTRK1
Specificity
50 %
Genes
4 %
NTRK1 Gene Sequencing.

By GeneDx in United States.

NTRK1
Specificity
100 %
Genes
4 %
NTRK1. Complete sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

NTRK1
Specificity
100 %
Genes
4 %
Hereditary Sensory and Autonomic Neuropathy Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

PRDM12, CLTCL1, ATL3, SCN11A, NGF, RETREG1, DST, CCT5, DNMT1, SCN9A, KIF1A, ATL1, SPTLC1, WNK1, NTRK1, RAB7A, ELP1, FLVCR1, SPTLC2, POLG
Specificity
5 %
Genes
4 %
Hereditary Sensory and Autonomic Neuropathy Type IV.

By Bioscientia GmbH Center for Human Genetics in Germany.

NTRK1
Specificity
100 %
Genes
4 %
HSAN4.

By Centogene AG - the Rare Disease Company in Germany.

NTRK1
Specificity
100 %
Genes
4 %
Familial medullary thyroid cancer, NTRK1.

By GGA - Galil Genetic Analysis in Israel.

NTRK1
Specificity
100 %
Genes
4 %
Thyroid carcinoma, familial medullary.

By Praxis fuer Humangenetik Wien in Austria.

NTRK1
Specificity
100 %
Genes
4 %
Thyroid carcinoma, familial medullary.

By MedGene in Slovakia.

NTRK1
Specificity
100 %
Genes
4 %
NTRK1.

By Fulgent Genetics Fulgent Genetics in United States.

NTRK1
Specificity
100 %
Genes
4 %
NRAS Sequence Analysis.

By Baylor Miraca Genetics Laboratories in United States.

NRAS
Specificity
100 %
Genes
4 %
NRAS Sequence Analysis (Familial Mutation/Variant Analysis).

By Baylor Miraca Genetics Laboratories in United States.

NRAS
Specificity
100 %
Genes
4 %
NRAS Sequence Analysis (Prenatal Diagnosis).

By Baylor Miraca Genetics Laboratories in United States.

NRAS
Specificity
100 %
Genes
4 %
NRAS Mutation Analysis.

By Molecular Genetics Diagnostic Laboratory Detroit Medical Center University Laboratories in United States.

NRAS
Specificity
100 %
Genes
4 %
NRAS Sequencing.

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center in United States.

NRAS
Specificity
100 %
Genes
4 %
NRAS Deletion/duplication analysis.

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center in United States.

NRAS
Specificity
100 %
Genes
4 %
Noonan Syndrome - NRAS Sequence Analysis.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

NRAS
Specificity
100 %
Genes
4 %
NRAS gene (sequence analysis).

By CGC Genetics in Portugal.

NRAS
Specificity
100 %
Genes
4 %
Epidermal nevus, somatic.

By Centogene AG - the Rare Disease Company in Germany.

NRAS
Specificity
100 %
Genes
4 %
Noonan syndrome type 6.

By Centogene AG - the Rare Disease Company in Germany.

NRAS
Specificity
100 %
Genes
4 %
Colorectal cancer, somatic.

By Centogene AG - the Rare Disease Company in Germany.

NRAS
Specificity
100 %
Genes
4 %
Melanocytic nevus syndrome, congenital, somatic.

By Centogene AG - the Rare Disease Company in Germany.

NRAS
Specificity
100 %
Genes
4 %
Thyroid carcinoma, follicular, somatic.

By Centogene AG - the Rare Disease Company in Germany.

NRAS
Specificity
100 %
Genes
4 %
NRAS.

By MVZ Dortmund Dr. Eberhard & Partner in Germany.

NRAS
Specificity
100 %
Genes
4 %
NRAS.

By Fulgent Genetics Fulgent Genetics in United States.

NRAS
Specificity
100 %
Genes
4 %
NRAS Mutation by Sequencing.

By Cancer Genetics, Inc. Cancer Genetics, Inc. in United States.

NRAS
Specificity
100 %
Genes
4 %
Noonan syndrome type 6.

By Bioarray in Spain.

NRAS
Specificity
100 %
Genes
4 %
NRAS Gene Sequencing and Deletion/Duplication Analysis.

By DDC Clinic Molecular Diagnostics Laboratory DDC Clinic, Center for Special Needs Children in United States.

NRAS
Specificity
100 %
Genes
4 %
Melanoma: Gene Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

WRN, BAP1, MGMT, KIT, CDKN2A, CDK4, NRAS, RB1, TP53, PTEN, BRCA1
Specificity
10 %
Genes
4 %
Noonan syndrome 6 (NRAS).

By Center for Human Genetics, Inc in United States.

NRAS
Specificity
100 %
Genes
4 %
NRAS-Related Noonan syndrome.

By Genetics Laboratory University of Oklahoma Health Sciences Center in United States.

NRAS
Specificity
100 %
Genes
4 %
NRAS. Complete sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

NRAS
Specificity
100 %
Genes
4 %
NRAS-related Noonan Syndrome.

By ChildLab Molecular Genetics Laboratory Nationwide Children's Hospital in United States.

NRAS
Specificity
100 %
Genes
4 %
Noonan Syndrome via the NRAS Gene.

By PreventionGenetics PreventionGenetics in United States.

NRAS
Specificity
100 %
Genes
4 %
Sudden Cardiac Arrest Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

MYL3, MYL2, DSC2, CSRP3, ACTN2, JPH2, TNNT2, TPM1, JUP, DSG2, NEXN, MYH6, TNNI3, TNNC1, MYLK2, KCNA5, SCN4B, AKAP9, CASQ2, SNTA1 , (...)

View the complete list with 29 more genes
Specificity
3 %
Genes
4 %
Autoimmune lymphoproliferative syndrome type 4.

By Centogene AG - the Rare Disease Company in Germany.

NRAS
Specificity
100 %
Genes
4 %
Epidermal nevus, somatic.

By Centogene AG - the Rare Disease Company in Germany.

NRAS
Specificity
100 %
Genes
4 %
Neurocutaneous melanosis, somatic.

By Centogene AG - the Rare Disease Company in Germany.

NRAS
Specificity
100 %
Genes
4 %
Colorectal cancer, hereditary.

By Centogene AG - the Rare Disease Company in Germany.

NRAS
Specificity
100 %
Genes
4 %
NRAS.

By MVZ Dortmund Dr. Eberhard & Partner in Germany.

NRAS
Specificity
100 %
Genes
4 %
NRAS Exons 2 and 3 Mutation Analysis.

By BloodCenter of Wisconsin Diagnostic Laboratories BloodCenter of Wisconsin, part of Versiti in United States.

NRAS
Specificity
100 %
Genes
4 %
Noonan syndrome 6.

By Praxis fuer Humangenetik Wien in Austria.

NRAS
Specificity
100 %
Genes
4 %
Noonan syndrome 6.

By MedGene in Slovakia.

NRAS
Specificity
100 %
Genes
4 %
Noonan Syndrome: NRAS Full Gene Sequencing.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

NRAS
Specificity
100 %
Genes
4 %
Noonan Syndrome: NRAS Gene Deletion/Duplication.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

NRAS
Specificity
100 %
Genes
4 %
Circulo Colorectal.

By Circulogene Theranostics in United States.

NRAS
Specificity
100 %
Genes
4 %
Circulo Lung.

By Circulogene Theranostics in United States.

NRAS
Specificity
100 %
Genes
4 %
Circulo Thyroid.

By Circulogene Theranostics in United States.

NRAS
Specificity
100 %
Genes
4 %
Circulo Melanoma.

By Circulogene Theranostics in United States.

NRAS
Specificity
100 %
Genes
4 %
Circulo Hematological.

By Circulogene Theranostics in United States.

NRAS
Specificity
100 %
Genes
4 %
LYMPHOPROLIFERATIVE SYNDROME, AUTOIMMUNE.

By Laboratorio de Genetica Clinica SL in Spain.

CASP10, FASLG, FAS, NRAS, CASP8
Specificity
20 %
Genes
4 %
Noonan Syndrome Type 6 , Sequencing NRAS Gene.

By Reference Laboratory Genetics in Spain.

NRAS
Specificity
100 %
Genes
4 %
NDUFA13 Comprehensive - Sequence & Deletion/Duplication Analysis.

By Baylor Miraca Genetics Laboratories in United States.

NDUFA13
Specificity
100 %
Genes
4 %
NDUFA13 Deletion/Duplication Analysis.

By Baylor Miraca Genetics Laboratories in United States.

NDUFA13
Specificity
100 %
Genes
4 %
NDUFA13 Sequence Analysis (Prenatal Diagnosis).

By Baylor Miraca Genetics Laboratories in United States.

NDUFA13
Specificity
100 %
Genes
4 %
Comprehensive Mitochondrial Metabolic Panel.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

MT-TA, MT-TW, MT-TY, MT-TV, MT-TL2, MT-TM, MT-TF, MT-TR, MT-TD, MT-TC, MT-TQ, MT-TH, MT-TE, MT-ND4L, MT-TN, MT-TI, MT-TG, MT-TP, SCO1, COX10 , (...)

View the complete list with 176 more genes
Specificity
1 %
Genes
4 %
Mitochondrial Complex I Deficiency Sequencing Panel with CNV Detection (Nuclear Genes).

By PreventionGenetics PreventionGenetics in United States.

NDUFB9, MTFMT, NDUFAF5, NDUFS2, NDUFS6, NDUFV2, NDUFV1, NDUFS1, NDUFAF4, NDUFA11, NDUFA1, NDUFAF3, NDUFAF6, NDUFS3, NDUFS7, NDUFS8, NDUFA2, NDUFA13, NUBPL, NDUFA10 , (...)

View the complete list with 9 more genes
Specificity
4 %
Genes
4 %
Mitochondrial Oxidative Phosphorylation Deficiency Sequencing Panel (Nuclear Genes Only) with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

COA7, TRIT1, SFXN4, NSUN3, COQ5, TMEM126B, TRMT10C, RMND1, VARS2, TARS2, LYRM4, MRPL12, TRMT5, PARS2, MRPS7, MRPS23, MRPL44, COX7B, NDUFB11, COQ7 , (...)

View the complete list with 154 more genes